{"data":{"filter_options":{"titles":[{"name":"Managing Partner Atlanta Office","value":"Managing Partner Atlanta Office"},{"name":"Partner","value":"Partner"},{"name":"Partner / Head of Pro Bono","value":"Partner / Head of Pro Bono"},{"name":"Partner / Chief Operating Officer","value":"Partner / Chief Operating Officer"},{"name":"Partner / General Counsel","value":"Partner / General Counsel"},{"name":"Partner / Dir. E-Discovery Ops","value":"Partner / Dir. E-Discovery Ops"},{"name":"Partner / Chairman, Saudi Arabia Practice","value":"Partner / Chairman, Saudi Arabia Practice"},{"name":"K\u0026S Talent Partner","value":"K\u0026S Talent Partner"},{"name":"Partner / Chief Human Resources Officer","value":"Partner / Chief Human Resources Officer"},{"name":"Chairman","value":"Chairman"},{"name":"Senior Counsel","value":"Senior Counsel"},{"name":"Associate Director, E-Discovery Operations","value":"Associate Director, E-Discovery Operations"},{"name":"Counsel","value":"Counsel"},{"name":"Senior Associate","value":"Senior Associate"},{"name":"Associate","value":"Associate"},{"name":"Senior Attorney","value":"Senior Attorney"},{"name":"Senior Lawyer","value":"Senior Lawyer"},{"name":"Attorney","value":"Attorney"},{"name":"Senior Counsel and Policy Advisor","value":"Senior Counsel and Policy Advisor"},{"name":"Managing Director - Capital Solutions","value":"Managing Director - Capital Solutions"},{"name":"Senior Government Relations Advisor","value":"Senior Government Relations Advisor"},{"name":"Associate General Counsel","value":"Associate General Counsel"},{"name":"Senior Advisor","value":"Senior Advisor"},{"name":"Patent Agent","value":"Patent Agent"},{"name":"Consultant","value":"Consultant"},{"name":"Government Relations Advisor","value":"Government Relations Advisor"},{"name":"Chief of Lateral Partner Recruiting \u0026 Integration","value":"Chief of Lateral Partner Recruiting \u0026 Integration"},{"name":"Chief Financial Officer","value":"Chief Financial Officer"},{"name":"Chief Information Officer","value":"Chief Information Officer"},{"name":"Chief Revenue Officer","value":"Chief Revenue Officer"},{"name":"Chief Recruiting Officer","value":"Chief Recruiting Officer"},{"name":"Chief Lawyer Talent Development Officer","value":"Chief Lawyer Talent Development Officer"},{"name":"Chief Marketing Officer","value":"Chief Marketing Officer"},{"name":"Tax Consultant","value":"Tax Consultant"},{"name":"Director of Community Affairs","value":"Director of Community Affairs"},{"name":"Director of Facilities \u0026 Admin Operations","value":"Director of Facilities \u0026 Admin Operations"},{"name":"Senior Office Manager","value":"Senior Office Manager"},{"name":"Director of Operations","value":"Director of Operations"},{"name":"Pro Bono Deputy","value":"Pro Bono Deputy"},{"name":"Director of Office Operations","value":"Director of Office Operations"},{"name":"Director of Operations Europe","value":"Director of Operations Europe"},{"name":"Law Clerk","value":"Law Clerk"},{"name":"Deputy General Counsel","value":"Deputy General Counsel"}],"schools":[{"name":"(Commercial Law), in front of Monash University, Australia","value":3045},{"name":"Aberystwyth University","value":3004},{"name":"Albany Law School","value":2118},{"name":"American University Washington College of Law","value":3042},{"name":"American University, Washington College of Law","value":3024},{"name":"Appalachian School of Law","value":2891},{"name":"Ateneo de Manila University","value":2914},{"name":"Ave Maria School of Law","value":2892},{"name":"Baylor University School of Law","value":181},{"name":"Benjamin N. Cardozo School of Law","value":2619},{"name":"Binghamton University","value":3002},{"name":"Boston College Law School","value":245},{"name":"Boston University School of Law","value":247},{"name":"BPP Law School Leeds","value":2642},{"name":"BPP Law School London","value":2782},{"name":"BPP University","value":2984},{"name":"Brooklyn Law School","value":2705},{"name":"Cairo University, Law School","value":2962},{"name":"California Western School of Law","value":315},{"name":"Capital University Law School","value":327},{"name":"Case Western Reserve University School of Law","value":345},{"name":"Cecil C. Humphreys School of Law","value":2235},{"name":"Chapman University School of Law","value":377},{"name":"Charleston School of Law","value":2910},{"name":"City Law School, London","value":2998},{"name":"City Law School","value":2857},{"name":"Clark University","value":3006},{"name":"Cleveland-Marshall College of Law","value":426},{"name":"Columbia University School of International and Public Affairs","value":3008},{"name":"Columbia University School of Law","value":485},{"name":"Columbia University","value":3126},{"name":"Columbus School of Law, Catholic University of America","value":3010},{"name":"Columbus School of Law","value":350},{"name":"Concord Law School of Kaplan University","value":1026},{"name":"Cornell Law School","value":512},{"name":"Creighton University School of Law","value":518},{"name":"Creighton University","value":3025},{"name":"Cumberland School of Law","value":1759},{"name":"CUNY School of Law","value":2893},{"name":"David A. Clarke School of Law","value":2399},{"name":"Deakin University School of Law","value":2907},{"name":"DePaul University College of Law","value":565},{"name":"DePaul University College of Law","value":3060},{"name":"Dickinson School of Law","value":2719},{"name":"Drake University Law School","value":609},{"name":"Duke University School of Law","value":613},{"name":"Duquesne University School of Law","value":614},{"name":"Dwayne O. Andreas School of Law","value":173},{"name":"Edinburgh Law School","value":3160},{"name":"Emory University School of Law","value":659},{"name":"ESADE Business and Law School – Universidad Ramon Llull","value":3215},{"name":"Fachseminare von Fürstenberg","value":2918},{"name":"Faculté Libre de Droit, Université Catholique de Lille","value":3055},{"name":"Faculty of Law, University of Zagreb","value":2983},{"name":"Faculty of Law","value":2944},{"name":"Faculty of Law","value":3039},{"name":"Federal University of Rio de Janeiro","value":3022},{"name":"Federal University of Rio Grande do Sul School of Law (Brazil)","value":3062},{"name":"Florida A\u0026M University College of Law","value":699},{"name":"Florida Coastal School of Law","value":2894},{"name":"Florida International College of Law","value":707},{"name":"Florida State University College of Law","value":720},{"name":"Fordham University School of Law","value":722},{"name":"Franklin Pierce Law Center","value":734},{"name":"Friedrich-Schiller-Universität Jena","value":3015},{"name":"George Mason University School of Law","value":752},{"name":"George Washington University Law School","value":753},{"name":"Georgetown University Law Center","value":755},{"name":"Georgia State University College of Law","value":761},{"name":"Ghent Law School","value":2793},{"name":"Golden Gate University School of Law","value":770},{"name":"Gonzaga University School of Law","value":772},{"name":"Graduate Institute of International and Development Studies, Geneva","value":2997},{"name":"Hamline University School of Law","value":811},{"name":"Harvard Law School","value":824},{"name":"Hebrew University of Jerusalem Faculty of Law","value":2994},{"name":"Hofstra University School of Law","value":858},{"name":"Howard University School of Law","value":872},{"name":"Huazhong University of Science and Technology","value":3016},{"name":"Humboldt University of Berlin","value":3012},{"name":"Indiana University School of Law","value":2711},{"name":"Indiana University School of Law","value":890},{"name":"International Association of Privacy Professionals","value":3009},{"name":"J. Reuben Clark Law School","value":262},{"name":"Jacob D. Fuchsberg Law Center","value":2084},{"name":"James Cook University of North Queensland","value":3034},{"name":"Jean Moulin University Lyon 3, France","value":2938},{"name":"Johns Hopkins Bloomberg School of Public Health","value":2992},{"name":"Justus-Liebig-Universität Gießen Rechtswissenschaft (Germany)","value":3063},{"name":"Kansas City School of Law","value":2247},{"name":"Keio University","value":2968},{"name":"Kent College of Law","value":883},{"name":"Kline School of Law","value":611},{"name":"KU Leuven","value":3007},{"name":"Levin College of Law","value":2189},{"name":"Lewis and Clark Law School","value":1089},{"name":"Liberty University School of Law","value":1094},{"name":"Lincoln College of Law","value":2253},{"name":"LL.M. in International Crime and Justice UNICRI","value":2937},{"name":"Loyola Law School","value":2895},{"name":"Loyola University Chicago School of Law","value":1135},{"name":"Loyola University New Orleans College of Law","value":1136},{"name":"Marquette University Law School","value":1176},{"name":"McGeorge School of Law","value":2402},{"name":"McGill University","value":2659},{"name":"Melbourne Law School","value":2899},{"name":"Mercer University Walter F. George School of Law","value":1221},{"name":"Mexico Autonomous Institute of Technology","value":2996},{"name":"Michael E. Moritz College of Law","value":2728},{"name":"Michigan State University College of Law","value":1245},{"name":"Mississippi College School of Law","value":1285},{"name":"Moscow State University","value":2815},{"name":"National and Kapodistrian University of Athens","value":3032},{"name":"National Law University Jodhpur","value":3020},{"name":"National University of Singapore, Faculty of Law","value":2662},{"name":"New England School of Law","value":2886},{"name":"New York Law School","value":1403},{"name":"New York University School of Law","value":1406},{"name":"Norman Adrian Wiggins School of Law","value":323},{"name":"North Carolina Central University School of Law","value":1417},{"name":"Northeastern University School of Law","value":1430},{"name":"Northern Illinois University College of Law","value":1432},{"name":"Northwestern Pritzker School of Law","value":1451},{"name":"Notre Dame Law School","value":2278},{"name":"Ohio Northern University Law School","value":3036},{"name":"Oklahoma City University School of Law","value":1487},{"name":"Osgoode Hall Law School","value":3124},{"name":"Pace University School of Law","value":1516},{"name":"Panteion University","value":3033},{"name":"Paul M. Hebert Law Center","value":2713},{"name":"Pennsylvania State University, Dickinson School of Law","value":1562},{"name":"Pepperdine University School of Law","value":1570},{"name":"Pettit College of Law","value":1473},{"name":"Pontificia Universidad Catolica de Chile","value":3203},{"name":"Pontificia Universidad Catolica del Peru","value":3011},{"name":"Pontificia Universidad Javeriana","value":3013},{"name":"Pontificia Universidade Catolica de Sao Paulo","value":3095},{"name":"Prince Sultan University College of Law","value":3167},{"name":"Queens College, Cambridge","value":3003},{"name":"Quinnipiac University School of Law","value":1626},{"name":"Ralph R. Papitto School of Law","value":1686},{"name":"Regent University School of Law","value":1649},{"name":"Rice University","value":3043},{"name":"Ruprecht-Karls-Universität Heidelberg","value":3049},{"name":"Rutgers University School of Law-Newark","value":1699},{"name":"Rutgers University School of Law","value":1697},{"name":"S.J. Quinney College of Law","value":2408},{"name":"Saint Louis University School of Law","value":1732},{"name":"Salmon P. Chase College of Law","value":1433},{"name":"Sandra Day O'Connor College of Law","value":103},{"name":"Santa Clara University School of Law","value":1771},{"name":"Seattle University School of Law","value":1787},{"name":"Seton Hall University School of Law","value":1790},{"name":"Shepard Broad Law Center","value":1460},{"name":"South Texas College of Law","value":2721},{"name":"Southern Illinois University School of Law","value":1849},{"name":"Southern Methodist University Dedman School of Law","value":1852},{"name":"Southern University Law Center","value":1857},{"name":"Southwestern Law School","value":1876},{"name":"St. John's University School of Law","value":2724},{"name":"St. Mary's University School of Law","value":1896},{"name":"St. Thomas University School of Law","value":1746},{"name":"Stanford Law School","value":1904},{"name":"Stetson University College of Law","value":1910},{"name":"Sturm College of Law","value":2184},{"name":"Suffolk University Law School","value":1921},{"name":"Syracuse University College of Law","value":1956},{"name":"Temple University Beasley School of Law","value":1974},{"name":"Texas A\u0026M School of Law","value":1980},{"name":"Texas Tech University School of Law","value":1994},{"name":"Texas Wesleyan University School of Law","value":1996},{"name":"The College of Law Australia","value":3091},{"name":"The College of Law, London","value":2935},{"name":"The John Marshall Law School","value":2034},{"name":"The Judge Advocate General's Legal Center and School","value":2896},{"name":"The Ohio State University Moritz College of Law","value":2990},{"name":"The University of Akron School of Law","value":2143},{"name":"The University of Alabama School of Law","value":2045},{"name":"The University of Birmingham, U.K.","value":2796},{"name":"The University of Iowa College of Law","value":2206},{"name":"The University of Texas School of Law","value":2055},{"name":"The University of Tulsa College of Law","value":2407},{"name":"Thomas Jefferson School of Law","value":685},{"name":"Thomas M. Cooley Law School","value":2729},{"name":"Thurgood Marshall School of Law","value":1992},{"name":"Tianjin University of Commerce","value":2995},{"name":"Tulane University Law School","value":2113},{"name":"UC Davis School of Law","value":2160},{"name":"UCLA School of Law","value":2162},{"name":"Universidad Católica de Honduras","value":2916},{"name":"Universidad Francisco Marroquin","value":3090},{"name":"Universidad Panamericana","value":2904},{"name":"Universidad Torcuato di Tella","value":3035},{"name":"Universidade de São Paulo, Faculdade de Direito","value":3028},{"name":"Universidade Presbiteriana Mackenzie","value":2977},{"name":"Università Commerciale Luigi Bocconi","value":3135},{"name":"University at Buffalo Law School","value":1928},{"name":"University College Dublin Law School","value":2900},{"name":"University of Alberta Faculty of Law","value":3088},{"name":"University of Amsterdam","value":2980},{"name":"University of Arizona, James E. Rogers College of Law","value":2149},{"name":"University of Arkansas School of Law","value":2154},{"name":"University of Baltimore School of Law","value":2156},{"name":"University of California College of the Law","value":3196},{"name":"University of California Hastings College of Law","value":2158},{"name":"University of California Irvine School of Law","value":2161},{"name":"University of California, Berkeley, School of Law","value":2159},{"name":"University of California, Davis","value":3019},{"name":"University of Cambridge, U.K","value":2991},{"name":"University of Canterbury","value":2981},{"name":"University of Central Florida","value":3027},{"name":"University of Chester Law School","value":3005},{"name":"University of Chicago Law School","value":2174},{"name":"University of Chicago","value":3038},{"name":"University of Cincinnati College of Law","value":2175},{"name":"University of Colorado School of Law","value":2177},{"name":"University of Connecticut School of Law","value":2180},{"name":"University of Dayton School of Law","value":2182},{"name":"University of Detroit Mercy School of Law","value":2185},{"name":"University of East Anglia","value":3000},{"name":"University of Florida, Levin College of Law","value":3188},{"name":"University of Georgia School of Law","value":2190},{"name":"University of Houston Law Center","value":2197},{"name":"University of Hull","value":3040},{"name":"University of Idaho College of Law","value":2201},{"name":"University of Illinois College of Law","value":2204},{"name":"University of Kansas School of Law","value":2208},{"name":"University of Kentucky College of Law","value":2210},{"name":"University of La Verne College of Law","value":2211},{"name":"University of Law, London","value":2999},{"name":"University of Lethbridge","value":3030},{"name":"University of Louisville Brandeis School of Law","value":2214},{"name":"University of Maine School of Law","value":2391},{"name":"University of Maryland School of Law","value":2224},{"name":"University of Miami School of Law","value":2236},{"name":"University of Michigan Law School","value":2237},{"name":"University of Minnesota Law School","value":2243},{"name":"University of Mississippi School of Law","value":2244},{"name":"University of Missouri School of Law","value":2246},{"name":"University of Montana School of Law","value":2048},{"name":"University of Nebraska College of Law","value":2744},{"name":"University of New Mexico School of Law","value":2262},{"name":"University of North Carolina School of Law","value":2266},{"name":"University of North Dakota School of Law","value":2271},{"name":"University of Oklahoma Law Center","value":2747},{"name":"University of Oregon School of Law","value":2281},{"name":"University of Pennsylvania Law School","value":2282},{"name":"University of Pittsburgh School of Law","value":2354},{"name":"University of Richmond School of Law","value":2370},{"name":"University of San Diego School of Law","value":2377},{"name":"University of San Francisco School of Law","value":2378},{"name":"University of South Carolina School of Law","value":2750},{"name":"University of South Dakota School of Law","value":2387},{"name":"University of Southern California Gould School of Law","value":3051},{"name":"University of St. Thomas School of Law","value":2751},{"name":"University of Sydney Law School","value":3031},{"name":"University of Tennessee College of Law","value":2051},{"name":"University of the West of England, Bristol","value":3001},{"name":"University of Toledo College of Law","value":2406},{"name":"University of Toronto","value":2912},{"name":"University of Utah","value":3026},{"name":"University of Virginia School of Law","value":2410},{"name":"University of Washington School of Law","value":2412},{"name":"University of Wisconsin Law School","value":2419},{"name":"University of Wyoming College of Law","value":2429},{"name":"University of Zürich","value":3037},{"name":"University Paris Dauphine","value":2976},{"name":"University Paris II Assas","value":2975},{"name":"University Paris II Assas","value":3052},{"name":"USC Gould School of Law","value":2389},{"name":"Utrecht University","value":3085},{"name":"Valparaiso University School of Law","value":2441},{"name":"Vanderbilt University School of Law","value":2442},{"name":"Vermont Law School","value":2451},{"name":"Villanova University School of Law","value":2454},{"name":"Wake Forest University School of Law","value":2471},{"name":"Washburn University School of Law","value":2482},{"name":"Washington and Lee University School of Law","value":2484},{"name":"Washington College of Law","value":61},{"name":"Washington University in St. Louis School of Law","value":2489},{"name":"Wayne State University Law School","value":2493},{"name":"West Virginia University College of Law","value":2517},{"name":"Western New England College School of Law","value":2528},{"name":"Western State College of Law","value":2897},{"name":"Wharton School of Business","value":3044},{"name":"Whittier Law School","value":2564},{"name":"Widener University Delaware Law School","value":2569},{"name":"Willamette University College of Law","value":2573},{"name":"William \u0026 Mary Law School","value":462},{"name":"William H. Bowen School of Law","value":2150},{"name":"William Mitchell College of Law","value":2758},{"name":"William S. Boyd School of Law","value":2256},{"name":"William S. Richardson School of Law","value":2195},{"name":"Wilmington University","value":2993},{"name":"Yale Law School","value":2605}],"offices":[{"name":"Abu Dhabi","value":13},{"name":"Atlanta","value":1},{"name":"Austin","value":12},{"name":"Brussels","value":23},{"name":"Charlotte","value":8},{"name":"Chicago","value":21},{"name":"Dallas","value":28},{"name":"Denver","value":22},{"name":"Dubai","value":6},{"name":"Frankfurt","value":9},{"name":"Geneva","value":15},{"name":"Houston","value":4},{"name":"London","value":5},{"name":"Los Angeles","value":19},{"name":"Miami","value":25},{"name":"New York","value":3},{"name":"Northern Virginia","value":24},{"name":"Paris","value":14},{"name":"Riyadh","value":27},{"name":"Sacramento","value":20},{"name":"San Francisco","value":10},{"name":"Silicon Valley","value":11},{"name":"Singapore","value":16},{"name":"Sydney","value":26},{"name":"Tokyo","value":18},{"name":"Washington, D.C.","value":2}],"capabilities":[{"name":"Corporate, Finance and Investments","value":"cg-1"},{"name":null,"value":72},{"name":null,"value":26},{"name":null,"value":40},{"name":null,"value":27},{"name":null,"value":80},{"name":null,"value":28},{"name":null,"value":35},{"name":null,"value":10},{"name":null,"value":134},{"name":null,"value":121},{"name":null,"value":78},{"name":null,"value":29},{"name":null,"value":32},{"name":null,"value":31},{"name":null,"value":33},{"name":null,"value":126},{"name":null,"value":36},{"name":null,"value":82},{"name":null,"value":37},{"name":null,"value":115},{"name":"Government Matters","value":"cg-2"},{"name":null,"value":1},{"name":null,"value":6},{"name":null,"value":71},{"name":null,"value":21},{"name":null,"value":23},{"name":null,"value":116},{"name":null,"value":24},{"name":null,"value":135},{"name":null,"value":25},{"name":null,"value":110},{"name":null,"value":20},{"name":null,"value":11},{"name":"Trial and Global Disputes","value":"cg-3"},{"name":null,"value":129},{"name":null,"value":2},{"name":null,"value":38},{"name":null,"value":3},{"name":null,"value":5},{"name":null,"value":19},{"name":null,"value":7},{"name":null,"value":4},{"name":null,"value":136},{"name":null,"value":13},{"name":null,"value":14},{"name":null,"value":15},{"name":null,"value":17},{"name":null,"value":18},{"name":null,"value":16},{"name":"Industries / Issues","value":"cg-4"},{"name":null,"value":133},{"name":null,"value":106},{"name":null,"value":124},{"name":null,"value":111},{"name":null,"value":132},{"name":null,"value":131},{"name":null,"value":102},{"name":null,"value":125},{"name":null,"value":127},{"name":null,"value":107},{"name":null,"value":112},{"name":null,"value":105},{"name":null,"value":109},{"name":null,"value":103},{"name":null,"value":128},{"name":null,"value":123},{"name":null,"value":118}]},"title_id":null,"school_id":null,"office_id":null,"capability_id":"11","extra_filter_id":null,"extra_filter_type":null,"q":null,"starts_with":null,"per_page":12,"people":[{"id":445969,"version":1,"owner_type":"Person","owner_id":6173,"payload":{"bio":"\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eGary Adamson represents clients in regulatory proceedings, investigations and complex commercial litigation. He frequently represents accounting firms and individual accountants in litigation, arbitration, and regulatory investigations by the US Securities \u0026amp; Exchange Commission (SEC), Public Company Accounting Oversight Board (PCAOB), and state authorities. Gary also represents clients in complex disputes about items such as fiduciary relationships, breach of contract, civil RICO, and fraud-related matters. He has sophisticated experience representing clients before investigative agencies and in the federal, state, and appeals cases.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eFluent in Spanish, Gary also has unique experience in Latin American investigations and enforcement actions.\u003c/p\u003e\n\u003cp\u003e*\u003cem\u003eAdmitted in New York and Washington, D.C.\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e\u003cbr data-cke-eol=\"1\" /\u003e\u003cbr /\u003e\u003c/p\u003e","slug":"gary-adamson","email":"gadamson@kslaw.com","phone":null,"matters":["\u003cp\u003eSuccessfully represented major US public audit firms and individual professionals in connection with investigations by the Divisions of Enforcement of the SEC and PCAOB.\u003c/p\u003e","\u003cp\u003eSuccessfully represented foreign public audit firms and their professionals in England, Mexico and Brazil in connection with litigation and regulatory matters, including investigations by the SEC and PCAOB Division of Enforcement.\u003c/p\u003e","\u003cp\u003eRepresented a generic pharmaceutical company in a contract dispute concerning the scope of an exclusive license; obtained an order from the Third Circuit reversing a decision granting summary judgment in favor of the opposing party, and subsequently obtained a multimillion-dollar jury verdict at trial.\u003c/p\u003e","\u003cp\u003eSecured a favorable settlement on behalf of an international investment company in a suit against an international financial institution concerning unauthorized withdrawals of funds.\u003c/p\u003e","\u003cp\u003eRepresented a government agency in an international arbitration in London concerning breach of a multimillion Euro construction contract.\u003c/p\u003e","\u003cp\u003eRepresented a Canadian citizen in cross-border litigation seeking to set aside the fraudulent conveyance of various artworks; secured order of attachment and successfully defended multiple attempts to dismiss the cause of action.\u003c/p\u003e","\u003cp\u003eRepresented an individual defendant in a civil RICO matter involving construction contracts with the New York Department of Environmental Protection; secured early dismissal of all claims, including the successful defense of an appeal to the Second Circuit.\u003c/p\u003e","\u003cp\u003eRepresented an international oil refinery in a contract dispute concerning a counterparty\u0026rsquo;s fraudulent attempt to draw on a letter of credit.\u003c/p\u003e","\u003cp\u003eRepresented an international financial institution in Mexico in an SEC investigation and other internal investigations.\u003c/p\u003e","\u003cp\u003eRepresented an international financial institution in an internal investigation related to a shareholder demand.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":3616}]},"expertise":[{"id":11,"guid":"11.capabilities","index":0,"source":"capabilities"},{"id":18,"guid":"18.capabilities","index":1,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":2,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":3,"source":"capabilities"},{"id":699,"guid":"699.smart_tags","index":4,"source":"smartTags"},{"id":1241,"guid":"1241.smart_tags","index":5,"source":"smartTags"},{"id":132,"guid":"132.capabilities","index":6,"source":"capabilities"},{"id":108,"guid":"108.capabilities","index":7,"source":"capabilities"},{"id":1248,"guid":"1248.smart_tags","index":8,"source":"smartTags"},{"id":688,"guid":"688.smart_tags","index":9,"source":"smartTags"}],"is_active":true,"last_name":"Adamson","nick_name":"Gary","clerkships":[],"first_name":"Gary","title_rank":9999,"updated_by":32,"law_schools":[{"id":512,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"2009-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":null,"linked_in_url":"https://www.linkedin.com/in/gary-adamson-9b11545/","seodescription":"Gary Adamson is a lawyer of our Special Matters \u0026 Government Investigations Practice Group. Read more about him.","primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eGary Adamson represents clients in regulatory proceedings, investigations and complex commercial litigation. He frequently represents accounting firms and individual accountants in litigation, arbitration, and regulatory investigations by the US Securities \u0026amp; Exchange Commission (SEC), Public Company Accounting Oversight Board (PCAOB), and state authorities. Gary also represents clients in complex disputes about items such as fiduciary relationships, breach of contract, civil RICO, and fraud-related matters. He has sophisticated experience representing clients before investigative agencies and in the federal, state, and appeals cases.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eFluent in Spanish, Gary also has unique experience in Latin American investigations and enforcement actions.\u003c/p\u003e\n\u003cp\u003e*\u003cem\u003eAdmitted in New York and Washington, D.C.\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e\u003cbr data-cke-eol=\"1\" /\u003e\u003cbr /\u003e\u003c/p\u003e","matters":["\u003cp\u003eSuccessfully represented major US public audit firms and individual professionals in connection with investigations by the Divisions of Enforcement of the SEC and PCAOB.\u003c/p\u003e","\u003cp\u003eSuccessfully represented foreign public audit firms and their professionals in England, Mexico and Brazil in connection with litigation and regulatory matters, including investigations by the SEC and PCAOB Division of Enforcement.\u003c/p\u003e","\u003cp\u003eRepresented a generic pharmaceutical company in a contract dispute concerning the scope of an exclusive license; obtained an order from the Third Circuit reversing a decision granting summary judgment in favor of the opposing party, and subsequently obtained a multimillion-dollar jury verdict at trial.\u003c/p\u003e","\u003cp\u003eSecured a favorable settlement on behalf of an international investment company in a suit against an international financial institution concerning unauthorized withdrawals of funds.\u003c/p\u003e","\u003cp\u003eRepresented a government agency in an international arbitration in London concerning breach of a multimillion Euro construction contract.\u003c/p\u003e","\u003cp\u003eRepresented a Canadian citizen in cross-border litigation seeking to set aside the fraudulent conveyance of various artworks; secured order of attachment and successfully defended multiple attempts to dismiss the cause of action.\u003c/p\u003e","\u003cp\u003eRepresented an individual defendant in a civil RICO matter involving construction contracts with the New York Department of Environmental Protection; secured early dismissal of all claims, including the successful defense of an appeal to the Second Circuit.\u003c/p\u003e","\u003cp\u003eRepresented an international oil refinery in a contract dispute concerning a counterparty\u0026rsquo;s fraudulent attempt to draw on a letter of credit.\u003c/p\u003e","\u003cp\u003eRepresented an international financial institution in Mexico in an SEC investigation and other internal investigations.\u003c/p\u003e","\u003cp\u003eRepresented an international financial institution in an internal investigation related to a shareholder demand.\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":9331}]},"capability_group_id":2},"created_at":"2026-02-18T22:01:14.000Z","updated_at":"2026-02-18T22:01:14.000Z","searchable_text":"Adamson{{ FIELD }}Successfully represented major US public audit firms and individual professionals in connection with investigations by the Divisions of Enforcement of the SEC and PCAOB.{{ FIELD }}Successfully represented foreign public audit firms and their professionals in England, Mexico and Brazil in connection with litigation and regulatory matters, including investigations by the SEC and PCAOB Division of Enforcement.{{ FIELD }}Represented a generic pharmaceutical company in a contract dispute concerning the scope of an exclusive license; obtained an order from the Third Circuit reversing a decision granting summary judgment in favor of the opposing party, and subsequently obtained a multimillion-dollar jury verdict at trial.{{ FIELD }}Secured a favorable settlement on behalf of an international investment company in a suit against an international financial institution concerning unauthorized withdrawals of funds.{{ FIELD }}Represented a government agency in an international arbitration in London concerning breach of a multimillion Euro construction contract.{{ FIELD }}Represented a Canadian citizen in cross-border litigation seeking to set aside the fraudulent conveyance of various artworks; secured order of attachment and successfully defended multiple attempts to dismiss the cause of action.{{ FIELD }}Represented an individual defendant in a civil RICO matter involving construction contracts with the New York Department of Environmental Protection; secured early dismissal of all claims, including the successful defense of an appeal to the Second Circuit.{{ FIELD }}Represented an international oil refinery in a contract dispute concerning a counterparty’s fraudulent attempt to draw on a letter of credit.{{ FIELD }}Represented an international financial institution in Mexico in an SEC investigation and other internal investigations.{{ FIELD }}Represented an international financial institution in an internal investigation related to a shareholder demand.{{ FIELD }} \nGary Adamson represents clients in regulatory proceedings, investigations and complex commercial litigation. He frequently represents accounting firms and individual accountants in litigation, arbitration, and regulatory investigations by the US Securities \u0026amp; Exchange Commission (SEC), Public Company Accounting Oversight Board (PCAOB), and state authorities. Gary also represents clients in complex disputes about items such as fiduciary relationships, breach of contract, civil RICO, and fraud-related matters. He has sophisticated experience representing clients before investigative agencies and in the federal, state, and appeals cases.\nFluent in Spanish, Gary also has unique experience in Latin American investigations and enforcement actions.\n*Admitted in New York and Washington, D.C.\n Gary Adamson lawyer Partner Brigham Young University J. Reuben Clark Law School Cornell University Cornell Law School District of Columbia New York Utah Successfully represented major US public audit firms and individual professionals in connection with investigations by the Divisions of Enforcement of the SEC and PCAOB. Successfully represented foreign public audit firms and their professionals in England, Mexico and Brazil in connection with litigation and regulatory matters, including investigations by the SEC and PCAOB Division of Enforcement. Represented a generic pharmaceutical company in a contract dispute concerning the scope of an exclusive license; obtained an order from the Third Circuit reversing a decision granting summary judgment in favor of the opposing party, and subsequently obtained a multimillion-dollar jury verdict at trial. Secured a favorable settlement on behalf of an international investment company in a suit against an international financial institution concerning unauthorized withdrawals of funds. Represented a government agency in an international arbitration in London concerning breach of a multimillion Euro construction contract. Represented a Canadian citizen in cross-border litigation seeking to set aside the fraudulent conveyance of various artworks; secured order of attachment and successfully defended multiple attempts to dismiss the cause of action. Represented an individual defendant in a civil RICO matter involving construction contracts with the New York Department of Environmental Protection; secured early dismissal of all claims, including the successful defense of an appeal to the Second Circuit. Represented an international oil refinery in a contract dispute concerning a counterparty’s fraudulent attempt to draw on a letter of credit. Represented an international financial institution in Mexico in an SEC investigation and other internal investigations. Represented an international financial institution in an internal investigation related to a shareholder demand.","searchable_name":"Gary Adamson","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":32,"capability_group_featured":null,"home_page_featured":null},{"id":447303,"version":1,"owner_type":"Person","owner_id":7295,"payload":{"bio":"\u003cp\u003eCorey Amundson is a first-chair trial lawyer, expert at leading and conducting complex corporate investigations on both sides of the table, and former DOJ bipartisan leader and public servant known for his judgment and problem-solving ability in high-stakes enforcement and crisis matters. As a partner of the Special Matters \u0026amp; Government Investigations practice group, he represents corporations, boards of directors, and senior executives in a broad array of government investigations, internal reviews, white-collar and civil litigation.\u003c/p\u003e\n\u003cp\u003eHis experience spans matters involving alleged corporate financial fraud, bribery and corruption, false claims and statements, obstruction, cyber crime, and other enforcement risks across the financial services, energy, life sciences, accounting, defense, chemical, construction, technology \u0026amp; trade secrets, and public sectors. He regularly advises clients facing scrutiny from DOJ and state Attorneys General, congressional committees, Inspectors General, and domestic and international enforcement authorities.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eCorey has more than two decades of public service as a career official at DOJ under multiple administrations, both in the field trying cases and leading the U.S. Attorney\u0026rsquo;s Office in the Middle District of Louisiana, and in Washington, D.C. as chief of multiple offices. He has tried over 20 federal jury trials, primarily involving complex corporate\u0026nbsp;fraud and bribery \u0026amp; corruption, along with supervising more than 100 trials in over 20 federal districts throughout the U.S. across a wide range of industries.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eIn Washington, D.C. at Main Justice, Corey served with distinction for over six years in two roles, first as the Director and Chief Counsel of DOJ\u0026rsquo;s internal affairs department, the Office of Professional Responsibility, and then as Chief of DOJ\u0026rsquo;s Public Integrity Section across multiple administrations. He previously served in leadership roles while at the U.S. Attorney\u0026rsquo;s Office in the Middle District of Louisiana for more than fifteen years, including overseeing all civil and criminal litigation for four years as Acting United States Attorney and First Assistant United States Attorney, and leading all criminal matters as Criminal Chief, including as DOJ\u0026rsquo;s Fifth Circuit representative advising on national criminal policies.\u003c/p\u003e\n\u003cp\u003eIn these capacities he led multiple crisis response efforts and implemented or developed a variety of proactive enforcement initiatives consistent with DOJ priorities, including one of the first healthcare fraud strike forces in the country, the Criminal Division Corporate Whistleblower Awards Pilot Program, a financial fraud task force focused on data-mining, a lauded multi-agency initiative with the state AG to combat the online sexual exploitation of children, and a violent criminal enterprises strike force targeting gangs and other violent groups.\u003c/p\u003e\n\u003cp\u003eHe also led, as Executive Director, the National Center for Disaster Fraud, a multi-agency entity responsible for coordinating nationwide disaster fraud enforcement, recovery and policies, many of which still are deployed today to address disaster-related fraud. He was a DOJ instructor for 20 years, teaching federal prosecutors and agents how to conduct investigations and try cases at the National Advocacy Center, the FBI Academy, and the Federal Law Enforcement Training Center, and was an Adjunct Law Professor at LSU teaching corporate and white collar crime.\u003c/p\u003e\n\u003cp\u003eDuring his years of public service, Corey received numerous awards and recognition for outstanding service, including the Assistant Attorney General Award for Exceptional Service, the EOUSA Director\u0026rsquo;s Award for Superior Performance by a Litigative Team, the HHS-OIG Integrity Award, the IRS-Criminal Investigations Honorary Special Agent Award, the FBI Exceptional Service Award, as well as numerous commendations from the Attorney General, DEA, DHS, FBI, and Treasury.\u003c/p\u003e","slug":"corey-amundson","email":"camundson@kslaw.com","phone":null,"matters":["\u003cp\u003eSupervised financial fraud, false claims, bribery and corruption, and national security investigations and prosecutions involving public and private corporations, including a multinational investment company, a state-owned oil company in Azerbaijan, an online payment processing company, a Turkish construction firm, a domestic footwear manufacturer, a financial institution in Mexico, a Missouri-based healthcare entity, a defense contracting firm, numerous political action committees, and an international bank based in South America.\u003c/p\u003e","\u003cp\u003eLead counsel in the investigation and prosecution of three engineers for stealing Dow Chemical trade secrets surrounding a highly regarded chemical manufacturing process and selling secrets to state-affiliated firms in the People\u0026rsquo;s Republic of China, culminating in the lead defendant being convicted following a four-week jury trial and the others pleading guilty.\u003c/p\u003e","\u003cp\u003eCo-counsel in defending federal healthcare fraud matter prosecuted by the U.S. Attorney\u0026rsquo;s Office in Boston, in which our team persuaded prosecutors to dismiss a 17-count healthcare fraud indictment against our client, a product manager for a major medical device and healthcare company that had pled guilty and agreed to pay more than $500 million, the largest such fine in history at the time.\u003c/p\u003e","\u003cp\u003eCo-counsel in defending a civil matter filed in the District of Columbia against a major tobacco company, seeking class certification and alleging violations of the Racketeer Influenced Corrupt Organizations (RICO) Act. Our team successfully defended the suit by prevailing on class certification after extensive discovery.\u003c/p\u003e","\u003cp\u003eLead counsel in the investigation and prosecution of a multinational defense and energy firm, for criminal Clean Air Act violations associated with the death of a worker at a chemical manufacturing facility, resulting in a criminal conviction and $12 million in fines and restitution.\u003c/p\u003e","\u003cp\u003eSupervised the investigation and prosecution of insider trading associated with the public sale of a Fortune 500 energy and chemical company, resulting in the convictions of a senior corporate executive, among others.\u003c/p\u003e","\u003cp\u003eCo-counsel in the investigation and prosecution of a subsidiary of a multinational medical device and healthcare company for a healthcare fraud scheme involving kickbacks and off-label promotion, resulting in a global resolution involving over $40 million in criminal and civil penalties.\u003c/p\u003e","\u003cp\u003eSupervised the creation and implementation of one of the first Medicare Fraud Strike Forces in the country, in partnership with the DOJ\u0026rsquo;s Fraud Section, the Inspector General for the U.S. Department of Health and Human Services, and the Louisiana AG\u0026rsquo;s Office, resulting in the successful prosecution of more than 80 corporate and individual defendants involving more than $300 million in fraudulent claims.\u003c/p\u003e","\u003cp\u003eLead counsel in the investigation and prosecution of an accounting firm president, a government tax auditor, and four prominent business owners for a multi-million-dollar tax fraud and bribery scheme, including the funneling of money to Syria.\u003c/p\u003e","\u003cp\u003eLead counsel in the investigation and prosecution of an Audit Manager with the Internal Revenue Service for criminal conflict of interest and illegally accessing government databases in connection with undisclosed private tax business.\u003c/p\u003e","\u003cp\u003eLead counsel in the investigation and prosecution of the state deputy insurance commissioner, four mayors, two police chiefs, and a city council member involving the corrupt passage of state and municipal legislation and multi-million-dollar federal procurement fraud and extortion schemes, resulting in four multi-week jury trials on charges under the RICO Act and the longest corruption sentence in Louisiana history.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":11,"guid":"11.capabilities","index":0,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":1,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":2,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":3,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":4,"source":"capabilities"},{"id":102,"guid":"102.capabilities","index":5,"source":"capabilities"},{"id":111,"guid":"111.capabilities","index":6,"source":"capabilities"},{"id":687,"guid":"687.smart_tags","index":7,"source":"smartTags"},{"id":1114,"guid":"1114.smart_tags","index":8,"source":"smartTags"},{"id":699,"guid":"699.smart_tags","index":9,"source":"smartTags"},{"id":118,"guid":"118.capabilities","index":10,"source":"capabilities"},{"id":952,"guid":"952.smart_tags","index":11,"source":"smartTags"},{"id":780,"guid":"780.smart_tags","index":12,"source":"smartTags"},{"id":1199,"guid":"1199.smart_tags","index":13,"source":"smartTags"},{"id":1409,"guid":"1409.smart_tags","index":14,"source":"smartTags"}],"is_active":true,"last_name":"Amundson","nick_name":"Corey","clerkships":[{"name":"Law Clerk, The Honorable Sarah Evans Barker, U.S. District Court for the Southern District of Indiana","years_held":"1997 - 1999"}],"first_name":"Corey","title_rank":9999,"updated_by":202,"law_schools":[{"id":659,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"1997-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"R.","name_suffix":"","recognitions":[{"title":"Exceptional Service Award","detail":"U.S. Department of Justice, 2024 and 2022"},{"title":"Honorary Special Agent Award","detail":"Internal Revenue Service, Criminal Investigations, 2018"},{"title":"Commendation","detail":"U.S. Drug Enforcement Agency, 2018"},{"title":"Commendations","detail":"Federal Bureau of Investigation, 2017, 2008, 2004"},{"title":"Commendation","detail":"Inspector General, Tax Administration, U.S. Department of the Treasury, 2016"},{"title":"Director’s Award for Superior Performance by a Litigative Group","detail":"U.S. Department of Justice, 2013"},{"title":"Commendations","detail":"Inspector General, U.S. Department of Homeland Security, 2013 and 2010"},{"title":"Commendation","detail":"U.S. Attorney General, 2013"},{"title":"Extraordinary Efforts Award","detail":"Federal Bureau of Investigation, 2012"},{"title":"Integrity Award","detail":"Inspector General, U.S. Department of Health and Human Services, 2008"},{"title":"Exceptional Service in the Public Interest Award","detail":"Federal Bureau of Investigation, 2008"}],"linked_in_url":"https://www.linkedin.com/in/corey-r-amundson-6632ab18b/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eCorey Amundson is a first-chair trial lawyer, expert at leading and conducting complex corporate investigations on both sides of the table, and former DOJ bipartisan leader and public servant known for his judgment and problem-solving ability in high-stakes enforcement and crisis matters. As a partner of the Special Matters \u0026amp; Government Investigations practice group, he represents corporations, boards of directors, and senior executives in a broad array of government investigations, internal reviews, white-collar and civil litigation.\u003c/p\u003e\n\u003cp\u003eHis experience spans matters involving alleged corporate financial fraud, bribery and corruption, false claims and statements, obstruction, cyber crime, and other enforcement risks across the financial services, energy, life sciences, accounting, defense, chemical, construction, technology \u0026amp; trade secrets, and public sectors. He regularly advises clients facing scrutiny from DOJ and state Attorneys General, congressional committees, Inspectors General, and domestic and international enforcement authorities.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eCorey has more than two decades of public service as a career official at DOJ under multiple administrations, both in the field trying cases and leading the U.S. Attorney\u0026rsquo;s Office in the Middle District of Louisiana, and in Washington, D.C. as chief of multiple offices. He has tried over 20 federal jury trials, primarily involving complex corporate\u0026nbsp;fraud and bribery \u0026amp; corruption, along with supervising more than 100 trials in over 20 federal districts throughout the U.S. across a wide range of industries.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eIn Washington, D.C. at Main Justice, Corey served with distinction for over six years in two roles, first as the Director and Chief Counsel of DOJ\u0026rsquo;s internal affairs department, the Office of Professional Responsibility, and then as Chief of DOJ\u0026rsquo;s Public Integrity Section across multiple administrations. He previously served in leadership roles while at the U.S. Attorney\u0026rsquo;s Office in the Middle District of Louisiana for more than fifteen years, including overseeing all civil and criminal litigation for four years as Acting United States Attorney and First Assistant United States Attorney, and leading all criminal matters as Criminal Chief, including as DOJ\u0026rsquo;s Fifth Circuit representative advising on national criminal policies.\u003c/p\u003e\n\u003cp\u003eIn these capacities he led multiple crisis response efforts and implemented or developed a variety of proactive enforcement initiatives consistent with DOJ priorities, including one of the first healthcare fraud strike forces in the country, the Criminal Division Corporate Whistleblower Awards Pilot Program, a financial fraud task force focused on data-mining, a lauded multi-agency initiative with the state AG to combat the online sexual exploitation of children, and a violent criminal enterprises strike force targeting gangs and other violent groups.\u003c/p\u003e\n\u003cp\u003eHe also led, as Executive Director, the National Center for Disaster Fraud, a multi-agency entity responsible for coordinating nationwide disaster fraud enforcement, recovery and policies, many of which still are deployed today to address disaster-related fraud. He was a DOJ instructor for 20 years, teaching federal prosecutors and agents how to conduct investigations and try cases at the National Advocacy Center, the FBI Academy, and the Federal Law Enforcement Training Center, and was an Adjunct Law Professor at LSU teaching corporate and white collar crime.\u003c/p\u003e\n\u003cp\u003eDuring his years of public service, Corey received numerous awards and recognition for outstanding service, including the Assistant Attorney General Award for Exceptional Service, the EOUSA Director\u0026rsquo;s Award for Superior Performance by a Litigative Team, the HHS-OIG Integrity Award, the IRS-Criminal Investigations Honorary Special Agent Award, the FBI Exceptional Service Award, as well as numerous commendations from the Attorney General, DEA, DHS, FBI, and Treasury.\u003c/p\u003e","matters":["\u003cp\u003eSupervised financial fraud, false claims, bribery and corruption, and national security investigations and prosecutions involving public and private corporations, including a multinational investment company, a state-owned oil company in Azerbaijan, an online payment processing company, a Turkish construction firm, a domestic footwear manufacturer, a financial institution in Mexico, a Missouri-based healthcare entity, a defense contracting firm, numerous political action committees, and an international bank based in South America.\u003c/p\u003e","\u003cp\u003eLead counsel in the investigation and prosecution of three engineers for stealing Dow Chemical trade secrets surrounding a highly regarded chemical manufacturing process and selling secrets to state-affiliated firms in the People\u0026rsquo;s Republic of China, culminating in the lead defendant being convicted following a four-week jury trial and the others pleading guilty.\u003c/p\u003e","\u003cp\u003eCo-counsel in defending federal healthcare fraud matter prosecuted by the U.S. Attorney\u0026rsquo;s Office in Boston, in which our team persuaded prosecutors to dismiss a 17-count healthcare fraud indictment against our client, a product manager for a major medical device and healthcare company that had pled guilty and agreed to pay more than $500 million, the largest such fine in history at the time.\u003c/p\u003e","\u003cp\u003eCo-counsel in defending a civil matter filed in the District of Columbia against a major tobacco company, seeking class certification and alleging violations of the Racketeer Influenced Corrupt Organizations (RICO) Act. Our team successfully defended the suit by prevailing on class certification after extensive discovery.\u003c/p\u003e","\u003cp\u003eLead counsel in the investigation and prosecution of a multinational defense and energy firm, for criminal Clean Air Act violations associated with the death of a worker at a chemical manufacturing facility, resulting in a criminal conviction and $12 million in fines and restitution.\u003c/p\u003e","\u003cp\u003eSupervised the investigation and prosecution of insider trading associated with the public sale of a Fortune 500 energy and chemical company, resulting in the convictions of a senior corporate executive, among others.\u003c/p\u003e","\u003cp\u003eCo-counsel in the investigation and prosecution of a subsidiary of a multinational medical device and healthcare company for a healthcare fraud scheme involving kickbacks and off-label promotion, resulting in a global resolution involving over $40 million in criminal and civil penalties.\u003c/p\u003e","\u003cp\u003eSupervised the creation and implementation of one of the first Medicare Fraud Strike Forces in the country, in partnership with the DOJ\u0026rsquo;s Fraud Section, the Inspector General for the U.S. Department of Health and Human Services, and the Louisiana AG\u0026rsquo;s Office, resulting in the successful prosecution of more than 80 corporate and individual defendants involving more than $300 million in fraudulent claims.\u003c/p\u003e","\u003cp\u003eLead counsel in the investigation and prosecution of an accounting firm president, a government tax auditor, and four prominent business owners for a multi-million-dollar tax fraud and bribery scheme, including the funneling of money to Syria.\u003c/p\u003e","\u003cp\u003eLead counsel in the investigation and prosecution of an Audit Manager with the Internal Revenue Service for criminal conflict of interest and illegally accessing government databases in connection with undisclosed private tax business.\u003c/p\u003e","\u003cp\u003eLead counsel in the investigation and prosecution of the state deputy insurance commissioner, four mayors, two police chiefs, and a city council member involving the corrupt passage of state and municipal legislation and multi-million-dollar federal procurement fraud and extortion schemes, resulting in four multi-week jury trials on charges under the RICO Act and the longest corruption sentence in Louisiana history.\u003c/p\u003e"],"recognitions":[{"title":"Exceptional Service Award","detail":"U.S. Department of Justice, 2024 and 2022"},{"title":"Honorary Special Agent Award","detail":"Internal Revenue Service, Criminal Investigations, 2018"},{"title":"Commendation","detail":"U.S. Drug Enforcement Agency, 2018"},{"title":"Commendations","detail":"Federal Bureau of Investigation, 2017, 2008, 2004"},{"title":"Commendation","detail":"Inspector General, Tax Administration, U.S. Department of the Treasury, 2016"},{"title":"Director’s Award for Superior Performance by a Litigative Group","detail":"U.S. Department of Justice, 2013"},{"title":"Commendations","detail":"Inspector General, U.S. Department of Homeland Security, 2013 and 2010"},{"title":"Commendation","detail":"U.S. Attorney General, 2013"},{"title":"Extraordinary Efforts Award","detail":"Federal Bureau of Investigation, 2012"},{"title":"Integrity Award","detail":"Inspector General, U.S. Department of Health and Human Services, 2008"},{"title":"Exceptional Service in the Public Interest Award","detail":"Federal Bureau of Investigation, 2008"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":13326}]},"capability_group_id":2},"created_at":"2026-04-04T09:08:37.000Z","updated_at":"2026-04-04T09:08:37.000Z","searchable_text":"Amundson{{ FIELD }}{:title=\u0026gt;\"Exceptional Service Award\", :detail=\u0026gt;\"U.S. Department of Justice, 2024 and 2022\"}{{ FIELD }}{:title=\u0026gt;\"Honorary Special Agent Award\", :detail=\u0026gt;\"Internal Revenue Service, Criminal Investigations, 2018\"}{{ FIELD }}{:title=\u0026gt;\"Commendation\", :detail=\u0026gt;\"U.S. Drug Enforcement Agency, 2018\"}{{ FIELD }}{:title=\u0026gt;\"Commendations\", :detail=\u0026gt;\"Federal Bureau of Investigation, 2017, 2008, 2004\"}{{ FIELD }}{:title=\u0026gt;\"Commendation\", :detail=\u0026gt;\"Inspector General, Tax Administration, U.S. Department of the Treasury, 2016\"}{{ FIELD }}{:title=\u0026gt;\"Director’s Award for Superior Performance by a Litigative Group\", :detail=\u0026gt;\"U.S. Department of Justice, 2013\"}{{ FIELD }}{:title=\u0026gt;\"Commendations\", :detail=\u0026gt;\"Inspector General, U.S. Department of Homeland Security, 2013 and 2010\"}{{ FIELD }}{:title=\u0026gt;\"Commendation\", :detail=\u0026gt;\"U.S. Attorney General, 2013\"}{{ FIELD }}{:title=\u0026gt;\"Extraordinary Efforts Award\", :detail=\u0026gt;\"Federal Bureau of Investigation, 2012\"}{{ FIELD }}{:title=\u0026gt;\"Integrity Award\", :detail=\u0026gt;\"Inspector General, U.S. Department of Health and Human Services, 2008\"}{{ FIELD }}{:title=\u0026gt;\"Exceptional Service in the Public Interest Award\", :detail=\u0026gt;\"Federal Bureau of Investigation, 2008\"}{{ FIELD }}Supervised financial fraud, false claims, bribery and corruption, and national security investigations and prosecutions involving public and private corporations, including a multinational investment company, a state-owned oil company in Azerbaijan, an online payment processing company, a Turkish construction firm, a domestic footwear manufacturer, a financial institution in Mexico, a Missouri-based healthcare entity, a defense contracting firm, numerous political action committees, and an international bank based in South America.{{ FIELD }}Lead counsel in the investigation and prosecution of three engineers for stealing Dow Chemical trade secrets surrounding a highly regarded chemical manufacturing process and selling secrets to state-affiliated firms in the People’s Republic of China, culminating in the lead defendant being convicted following a four-week jury trial and the others pleading guilty.{{ FIELD }}Co-counsel in defending federal healthcare fraud matter prosecuted by the U.S. Attorney’s Office in Boston, in which our team persuaded prosecutors to dismiss a 17-count healthcare fraud indictment against our client, a product manager for a major medical device and healthcare company that had pled guilty and agreed to pay more than $500 million, the largest such fine in history at the time.{{ FIELD }}Co-counsel in defending a civil matter filed in the District of Columbia against a major tobacco company, seeking class certification and alleging violations of the Racketeer Influenced Corrupt Organizations (RICO) Act. Our team successfully defended the suit by prevailing on class certification after extensive discovery.{{ FIELD }}Lead counsel in the investigation and prosecution of a multinational defense and energy firm, for criminal Clean Air Act violations associated with the death of a worker at a chemical manufacturing facility, resulting in a criminal conviction and $12 million in fines and restitution.{{ FIELD }}Supervised the investigation and prosecution of insider trading associated with the public sale of a Fortune 500 energy and chemical company, resulting in the convictions of a senior corporate executive, among others.{{ FIELD }}Co-counsel in the investigation and prosecution of a subsidiary of a multinational medical device and healthcare company for a healthcare fraud scheme involving kickbacks and off-label promotion, resulting in a global resolution involving over $40 million in criminal and civil penalties.{{ FIELD }}Supervised the creation and implementation of one of the first Medicare Fraud Strike Forces in the country, in partnership with the DOJ’s Fraud Section, the Inspector General for the U.S. Department of Health and Human Services, and the Louisiana AG’s Office, resulting in the successful prosecution of more than 80 corporate and individual defendants involving more than $300 million in fraudulent claims.{{ FIELD }}Lead counsel in the investigation and prosecution of an accounting firm president, a government tax auditor, and four prominent business owners for a multi-million-dollar tax fraud and bribery scheme, including the funneling of money to Syria.{{ FIELD }}Lead counsel in the investigation and prosecution of an Audit Manager with the Internal Revenue Service for criminal conflict of interest and illegally accessing government databases in connection with undisclosed private tax business.{{ FIELD }}Lead counsel in the investigation and prosecution of the state deputy insurance commissioner, four mayors, two police chiefs, and a city council member involving the corrupt passage of state and municipal legislation and multi-million-dollar federal procurement fraud and extortion schemes, resulting in four multi-week jury trials on charges under the RICO Act and the longest corruption sentence in Louisiana history.{{ FIELD }}Corey Amundson is a first-chair trial lawyer, expert at leading and conducting complex corporate investigations on both sides of the table, and former DOJ bipartisan leader and public servant known for his judgment and problem-solving ability in high-stakes enforcement and crisis matters. As a partner of the Special Matters \u0026amp; Government Investigations practice group, he represents corporations, boards of directors, and senior executives in a broad array of government investigations, internal reviews, white-collar and civil litigation.\nHis experience spans matters involving alleged corporate financial fraud, bribery and corruption, false claims and statements, obstruction, cyber crime, and other enforcement risks across the financial services, energy, life sciences, accounting, defense, chemical, construction, technology \u0026amp; trade secrets, and public sectors. He regularly advises clients facing scrutiny from DOJ and state Attorneys General, congressional committees, Inspectors General, and domestic and international enforcement authorities. \nCorey has more than two decades of public service as a career official at DOJ under multiple administrations, both in the field trying cases and leading the U.S. Attorney’s Office in the Middle District of Louisiana, and in Washington, D.C. as chief of multiple offices. He has tried over 20 federal jury trials, primarily involving complex corporate fraud and bribery \u0026amp; corruption, along with supervising more than 100 trials in over 20 federal districts throughout the U.S. across a wide range of industries.  \nIn Washington, D.C. at Main Justice, Corey served with distinction for over six years in two roles, first as the Director and Chief Counsel of DOJ’s internal affairs department, the Office of Professional Responsibility, and then as Chief of DOJ’s Public Integrity Section across multiple administrations. He previously served in leadership roles while at the U.S. Attorney’s Office in the Middle District of Louisiana for more than fifteen years, including overseeing all civil and criminal litigation for four years as Acting United States Attorney and First Assistant United States Attorney, and leading all criminal matters as Criminal Chief, including as DOJ’s Fifth Circuit representative advising on national criminal policies.\nIn these capacities he led multiple crisis response efforts and implemented or developed a variety of proactive enforcement initiatives consistent with DOJ priorities, including one of the first healthcare fraud strike forces in the country, the Criminal Division Corporate Whistleblower Awards Pilot Program, a financial fraud task force focused on data-mining, a lauded multi-agency initiative with the state AG to combat the online sexual exploitation of children, and a violent criminal enterprises strike force targeting gangs and other violent groups.\nHe also led, as Executive Director, the National Center for Disaster Fraud, a multi-agency entity responsible for coordinating nationwide disaster fraud enforcement, recovery and policies, many of which still are deployed today to address disaster-related fraud. He was a DOJ instructor for 20 years, teaching federal prosecutors and agents how to conduct investigations and try cases at the National Advocacy Center, the FBI Academy, and the Federal Law Enforcement Training Center, and was an Adjunct Law Professor at LSU teaching corporate and white collar crime.\nDuring his years of public service, Corey received numerous awards and recognition for outstanding service, including the Assistant Attorney General Award for Exceptional Service, the EOUSA Director’s Award for Superior Performance by a Litigative Team, the HHS-OIG Integrity Award, the IRS-Criminal Investigations Honorary Special Agent Award, the FBI Exceptional Service Award, as well as numerous commendations from the Attorney General, DEA, DHS, FBI, and Treasury. Partner Exceptional Service Award U.S. Department of Justice, 2024 and 2022 Honorary Special Agent Award Internal Revenue Service, Criminal Investigations, 2018 Commendation U.S. Drug Enforcement Agency, 2018 Commendations Federal Bureau of Investigation, 2017, 2008, 2004 Commendation Inspector General, Tax Administration, U.S. Department of the Treasury, 2016 Director’s Award for Superior Performance by a Litigative Group U.S. Department of Justice, 2013 Commendations Inspector General, U.S. Department of Homeland Security, 2013 and 2010 Commendation U.S. Attorney General, 2013 Extraordinary Efforts Award Federal Bureau of Investigation, 2012 Integrity Award Inspector General, U.S. Department of Health and Human Services, 2008 Exceptional Service in the Public Interest Award Federal Bureau of Investigation, 2008 Indiana University Indiana University School of Law Emory University Emory University School of Law U.S. Court of Appeals for the Fifth Circuit U.S. Court of Appeals for the Seventh Circuit U.S. Court of Appeals for the Eleventh Circuit U.S. District Court for the Middle District of Louisiana U.S. District Court for the Southern District of Indiana Supreme Court of Louisiana American Bar Association Law Clerk, The Honorable Sarah Evans Barker, U.S. District Court for the Southern District of Indiana Supervised financial fraud, false claims, bribery and corruption, and national security investigations and prosecutions involving public and private corporations, including a multinational investment company, a state-owned oil company in Azerbaijan, an online payment processing company, a Turkish construction firm, a domestic footwear manufacturer, a financial institution in Mexico, a Missouri-based healthcare entity, a defense contracting firm, numerous political action committees, and an international bank based in South America. Lead counsel in the investigation and prosecution of three engineers for stealing Dow Chemical trade secrets surrounding a highly regarded chemical manufacturing process and selling secrets to state-affiliated firms in the People’s Republic of China, culminating in the lead defendant being convicted following a four-week jury trial and the others pleading guilty. Co-counsel in defending federal healthcare fraud matter prosecuted by the U.S. Attorney’s Office in Boston, in which our team persuaded prosecutors to dismiss a 17-count healthcare fraud indictment against our client, a product manager for a major medical device and healthcare company that had pled guilty and agreed to pay more than $500 million, the largest such fine in history at the time. Co-counsel in defending a civil matter filed in the District of Columbia against a major tobacco company, seeking class certification and alleging violations of the Racketeer Influenced Corrupt Organizations (RICO) Act. Our team successfully defended the suit by prevailing on class certification after extensive discovery. Lead counsel in the investigation and prosecution of a multinational defense and energy firm, for criminal Clean Air Act violations associated with the death of a worker at a chemical manufacturing facility, resulting in a criminal conviction and $12 million in fines and restitution. Supervised the investigation and prosecution of insider trading associated with the public sale of a Fortune 500 energy and chemical company, resulting in the convictions of a senior corporate executive, among others. Co-counsel in the investigation and prosecution of a subsidiary of a multinational medical device and healthcare company for a healthcare fraud scheme involving kickbacks and off-label promotion, resulting in a global resolution involving over $40 million in criminal and civil penalties. Supervised the creation and implementation of one of the first Medicare Fraud Strike Forces in the country, in partnership with the DOJ’s Fraud Section, the Inspector General for the U.S. Department of Health and Human Services, and the Louisiana AG’s Office, resulting in the successful prosecution of more than 80 corporate and individual defendants involving more than $300 million in fraudulent claims. Lead counsel in the investigation and prosecution of an accounting firm president, a government tax auditor, and four prominent business owners for a multi-million-dollar tax fraud and bribery scheme, including the funneling of money to Syria. Lead counsel in the investigation and prosecution of an Audit Manager with the Internal Revenue Service for criminal conflict of interest and illegally accessing government databases in connection with undisclosed private tax business. Lead counsel in the investigation and prosecution of the state deputy insurance commissioner, four mayors, two police chiefs, and a city council member involving the corrupt passage of state and municipal legislation and multi-million-dollar federal procurement fraud and extortion schemes, resulting in four multi-week jury trials on charges under the RICO Act and the longest corruption sentence in Louisiana history.","searchable_name":"Corey R. Amundson","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":427219,"version":1,"owner_type":"Person","owner_id":6490,"payload":{"bio":"\u003cp\u003eAdam Baker represents global financial institutions, healthcare and life sciences companies, and other public corporations in complex government and internal investigations and regulatory matters. He has extensive experience counseling clients facing investigations by the Department of Justice, Securities and Exchange Commission, State Attorneys General, Financial Industry Regulatory Authority, as well as other criminal and civil authorities. In particular, Adam has defended clients in matters implicating various federal laws and regulations, including insider trading, Foreign Corrupt Practices Act, Anti-Kickback Statute, healthcare fraud, and the Food, Drug \u0026amp; Cosmetic Act. [[--readmore--]]\u003c/p\u003e\n\u003cp\u003ePreviously, Adam served as a criminal Assistant United States Attorney in the Health Care Fraud/Opioid Abuse Prevention and Enforcement Unit in the District of New Jersey. In that role, he led a number of large-scale investigations and prosecutions of major pharmaceutical companies for healthcare fraud, diversion of controlled substances, and violations of the Federal Anti-Kickback Statute.\u0026nbsp; He also partnered with the DOJ\u0026rsquo;s Consumer Protection Branch on a significant investigation into potential violations by an opioid manufacturer and related individuals of the Food, Drug \u0026amp; Cosmetic Act.\u0026nbsp;\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003ePrior to his government service, Adam was a Partner at another AmLaw 50 firm where he oversaw complex investigations and regulatory matters for financial institutions and its employees.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eAdam is active within the LGBTQ+ community. He helped found Boston Colleges\u0026rsquo; first gay-straight alliance and served on his prior firm\u0026rsquo;s Diversity \u0026amp; LGBTQ+ committees. He serves on Boston College Law School\u0026rsquo;s national alumni board and formerly served as a Corp member for Teach For America.\u0026nbsp;\u0026nbsp;\u003c/p\u003e","slug":"adam-baker","email":"abaker@kslaw.com","phone":null,"matters":["\u003cp\u003eConducted an internal investigation on behalf of the Special Committee of an international corporation concerning potential financial improprieties resulting in a restatement and violations of the Foreign Corrupt Practices Act, and represented the Special Committee in resulting parallel investigations by the DOJ and SEC.\u003c/p\u003e","\u003cp\u003eRepresented a multinational financial services institution in investigations by the SEC and FINRA related to potential insider trading by current and former employees involved in a nonpublic M\u0026amp;A deal.\u003c/p\u003e","\u003cp\u003eRepresented a multinational financial services institution in an internal investigation of potential violations of the Foreign Corrupt Practices Act and OFAC regulations by an employee who attempted to broker deals with the Iranian government.\u003c/p\u003e","\u003cp\u003eRepresented the former CEO of a publicly-traded company in insider trading investigations by the DOJ and SEC.\u003c/p\u003e","\u003cp\u003eRepresented a men\u0026rsquo;s college basketball coach in investigations by the DOJ and NCAA Enforcement regarding potential provision of payments and benefits to players.\u003c/p\u003e","\u003cp\u003eRepresented a key figure in the \u0026ldquo;Bridgegate\u0026rdquo; matter in parallel investigations by the New Jersey Legislative Select Committee and U.S. Attorney\u0026rsquo;s Office, District of New Jersey.\u003c/p\u003e","\u003cp\u003eRepresented a former Dewey \u0026amp; Leboeuf employee in the New York County District Attorney\u0026rsquo;s Office\u0026rsquo;s investigation of the downfall of the firm, successfully obtaining immunity for the client.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":11,"guid":"11.capabilities","index":0,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":1,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":2,"source":"capabilities"},{"id":20,"guid":"20.capabilities","index":3,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":4,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":5,"source":"capabilities"},{"id":952,"guid":"952.smart_tags","index":6,"source":"smartTags"},{"id":780,"guid":"780.smart_tags","index":7,"source":"smartTags"},{"id":750,"guid":"750.smart_tags","index":8,"source":"smartTags"},{"id":1248,"guid":"1248.smart_tags","index":9,"source":"smartTags"},{"id":1434,"guid":"1434.smart_tags","index":10,"source":"smartTags"}],"is_active":true,"last_name":"Baker","nick_name":"Adam","clerkships":[],"first_name":"Adam","title_rank":9999,"updated_by":32,"law_schools":[{"id":245,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"2008-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":null,"linked_in_url":"https://www.linkedin.com/in/adam-baker-4a471038/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eAdam Baker represents global financial institutions, healthcare and life sciences companies, and other public corporations in complex government and internal investigations and regulatory matters. He has extensive experience counseling clients facing investigations by the Department of Justice, Securities and Exchange Commission, State Attorneys General, Financial Industry Regulatory Authority, as well as other criminal and civil authorities. In particular, Adam has defended clients in matters implicating various federal laws and regulations, including insider trading, Foreign Corrupt Practices Act, Anti-Kickback Statute, healthcare fraud, and the Food, Drug \u0026amp; Cosmetic Act. [[--readmore--]]\u003c/p\u003e\n\u003cp\u003ePreviously, Adam served as a criminal Assistant United States Attorney in the Health Care Fraud/Opioid Abuse Prevention and Enforcement Unit in the District of New Jersey. In that role, he led a number of large-scale investigations and prosecutions of major pharmaceutical companies for healthcare fraud, diversion of controlled substances, and violations of the Federal Anti-Kickback Statute.\u0026nbsp; He also partnered with the DOJ\u0026rsquo;s Consumer Protection Branch on a significant investigation into potential violations by an opioid manufacturer and related individuals of the Food, Drug \u0026amp; Cosmetic Act.\u0026nbsp;\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003ePrior to his government service, Adam was a Partner at another AmLaw 50 firm where he oversaw complex investigations and regulatory matters for financial institutions and its employees.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eAdam is active within the LGBTQ+ community. He helped found Boston Colleges\u0026rsquo; first gay-straight alliance and served on his prior firm\u0026rsquo;s Diversity \u0026amp; LGBTQ+ committees. He serves on Boston College Law School\u0026rsquo;s national alumni board and formerly served as a Corp member for Teach For America.\u0026nbsp;\u0026nbsp;\u003c/p\u003e","matters":["\u003cp\u003eConducted an internal investigation on behalf of the Special Committee of an international corporation concerning potential financial improprieties resulting in a restatement and violations of the Foreign Corrupt Practices Act, and represented the Special Committee in resulting parallel investigations by the DOJ and SEC.\u003c/p\u003e","\u003cp\u003eRepresented a multinational financial services institution in investigations by the SEC and FINRA related to potential insider trading by current and former employees involved in a nonpublic M\u0026amp;A deal.\u003c/p\u003e","\u003cp\u003eRepresented a multinational financial services institution in an internal investigation of potential violations of the Foreign Corrupt Practices Act and OFAC regulations by an employee who attempted to broker deals with the Iranian government.\u003c/p\u003e","\u003cp\u003eRepresented the former CEO of a publicly-traded company in insider trading investigations by the DOJ and SEC.\u003c/p\u003e","\u003cp\u003eRepresented a men\u0026rsquo;s college basketball coach in investigations by the DOJ and NCAA Enforcement regarding potential provision of payments and benefits to players.\u003c/p\u003e","\u003cp\u003eRepresented a key figure in the \u0026ldquo;Bridgegate\u0026rdquo; matter in parallel investigations by the New Jersey Legislative Select Committee and U.S. Attorney\u0026rsquo;s Office, District of New Jersey.\u003c/p\u003e","\u003cp\u003eRepresented a former Dewey \u0026amp; Leboeuf employee in the New York County District Attorney\u0026rsquo;s Office\u0026rsquo;s investigation of the downfall of the firm, successfully obtaining immunity for the client.\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":10412}]},"capability_group_id":2},"created_at":"2025-05-26T04:59:19.000Z","updated_at":"2025-05-26T04:59:19.000Z","searchable_text":"Baker{{ FIELD }}Conducted an internal investigation on behalf of the Special Committee of an international corporation concerning potential financial improprieties resulting in a restatement and violations of the Foreign Corrupt Practices Act, and represented the Special Committee in resulting parallel investigations by the DOJ and SEC.{{ FIELD }}Represented a multinational financial services institution in investigations by the SEC and FINRA related to potential insider trading by current and former employees involved in a nonpublic M\u0026amp;A deal.{{ FIELD }}Represented a multinational financial services institution in an internal investigation of potential violations of the Foreign Corrupt Practices Act and OFAC regulations by an employee who attempted to broker deals with the Iranian government.{{ FIELD }}Represented the former CEO of a publicly-traded company in insider trading investigations by the DOJ and SEC.{{ FIELD }}Represented a men’s college basketball coach in investigations by the DOJ and NCAA Enforcement regarding potential provision of payments and benefits to players.{{ FIELD }}Represented a key figure in the “Bridgegate” matter in parallel investigations by the New Jersey Legislative Select Committee and U.S. Attorney’s Office, District of New Jersey.{{ FIELD }}Represented a former Dewey \u0026amp; Leboeuf employee in the New York County District Attorney’s Office’s investigation of the downfall of the firm, successfully obtaining immunity for the client.{{ FIELD }}Adam Baker represents global financial institutions, healthcare and life sciences companies, and other public corporations in complex government and internal investigations and regulatory matters. He has extensive experience counseling clients facing investigations by the Department of Justice, Securities and Exchange Commission, State Attorneys General, Financial Industry Regulatory Authority, as well as other criminal and civil authorities. In particular, Adam has defended clients in matters implicating various federal laws and regulations, including insider trading, Foreign Corrupt Practices Act, Anti-Kickback Statute, healthcare fraud, and the Food, Drug \u0026amp; Cosmetic Act. \nPreviously, Adam served as a criminal Assistant United States Attorney in the Health Care Fraud/Opioid Abuse Prevention and Enforcement Unit in the District of New Jersey. In that role, he led a number of large-scale investigations and prosecutions of major pharmaceutical companies for healthcare fraud, diversion of controlled substances, and violations of the Federal Anti-Kickback Statute.  He also partnered with the DOJ’s Consumer Protection Branch on a significant investigation into potential violations by an opioid manufacturer and related individuals of the Food, Drug \u0026amp; Cosmetic Act.   \nPrior to his government service, Adam was a Partner at another AmLaw 50 firm where he oversaw complex investigations and regulatory matters for financial institutions and its employees. \nAdam is active within the LGBTQ+ community. He helped found Boston Colleges’ first gay-straight alliance and served on his prior firm’s Diversity \u0026amp; LGBTQ+ committees. He serves on Boston College Law School’s national alumni board and formerly served as a Corp member for Teach For America.   Partner Boston College Boston College Law School Boston College Boston College Law School Fordham University Fordham University School of Law U.S. District Court for the Eastern District of New York U.S. District Court for the Southern District of New York New York Conducted an internal investigation on behalf of the Special Committee of an international corporation concerning potential financial improprieties resulting in a restatement and violations of the Foreign Corrupt Practices Act, and represented the Special Committee in resulting parallel investigations by the DOJ and SEC. Represented a multinational financial services institution in investigations by the SEC and FINRA related to potential insider trading by current and former employees involved in a nonpublic M\u0026amp;A deal. Represented a multinational financial services institution in an internal investigation of potential violations of the Foreign Corrupt Practices Act and OFAC regulations by an employee who attempted to broker deals with the Iranian government. Represented the former CEO of a publicly-traded company in insider trading investigations by the DOJ and SEC. Represented a men’s college basketball coach in investigations by the DOJ and NCAA Enforcement regarding potential provision of payments and benefits to players. Represented a key figure in the “Bridgegate” matter in parallel investigations by the New Jersey Legislative Select Committee and U.S. Attorney’s Office, District of New Jersey. Represented a former Dewey \u0026amp; Leboeuf employee in the New York County District Attorney’s Office’s investigation of the downfall of the firm, successfully obtaining immunity for the client.","searchable_name":"Adam Baker","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":32,"capability_group_featured":null,"home_page_featured":null},{"id":445014,"version":1,"owner_type":"Person","owner_id":3436,"payload":{"bio":"\u003cp\u003eLohr's practice focuses on high-stakes business disputes with an emphasis on antitrust matters and consumer protection matters. Lohr\u0026nbsp;represents clients in relation to high exposure civil litigation, including class actions, multi-district litigation, and matters with complex e-discovery issues. Lohr also represents clients in relation to government investigations and counsels clients regarding antitrust and consumer protection issues.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eLeadership and\u0026nbsp;Community Service\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eCenter for Puppetry Arts, Board member\u003c/p\u003e\n\u003cp\u003eGeorgia Lawyers for the Arts,\u0026nbsp;Board member\u003c/p\u003e\n\u003cp\u003eAtlanta Women's Foundation, Inspire Atlanta Leadership Program Class of 2019\u003c/p\u003e","slug":"lohr-beck","email":"lohr.beck@kslaw.com","phone":null,"matters":["\u003cp\u003eDefense of\u0026nbsp;\u003cstrong\u003eNovo Nordisk Inc.\u003c/strong\u003e\u0026nbsp;in a nationwide antitrust putative class action filed against pharmaceutical company manufacturers of diabetes medications alleging conspiracy to artificially fix prices of diabetes medications by agreeing to coordinate and eliminate, reduce, or limit the availability of Contract Pharmacy 340B Drug Discounts.\u003c/p\u003e","\u003cp\u003eDefense of \u003cstrong\u003eECI Management, LLC\u003c/strong\u003e in antitrust MDL proceeding in Nashville, Tennessee alleging that owners and managers of multifamily rental housing conspired to raise prices through use of algorithmic revenue management software.\u003c/p\u003e","\u003cp\u003eDefense of\u0026nbsp;\u003cstrong\u003eSix Continents Hotels, Inc.\u003c/strong\u003e\u0026nbsp;in a nationwide antitrust putative class action filed against Six Continents and other major hotel companies alleging that defendant hotel companies conspired to eliminate competition for branded keyword search advertising against each other, illegally raising consumers\u0026rsquo; costs to find and book hotel rooms, and seeking damages and injunctive relief under the Sherman Act.\u003c/p\u003e","\u003cp\u003eDefense of\u0026nbsp;\u003cstrong\u003eKemira Chemicals Inc.\u003c/strong\u003e\u0026nbsp;in MDL proceeding in Newark, New Jersey, alleging conspiracy to fix prices in sale of liquid aluminum sulfate.\u003c/p\u003e","\u003cp\u003eDefense of\u0026nbsp;\u003cstrong\u003eKan Am (US)\u003c/strong\u003e\u0026nbsp;in litigation filed by Simon Property Group affiliates in the Delaware Court of Chancery involving the interpretation of buy/sell provisions in joint venture agreements regarding major retail shopping malls throughout the United States.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":3205}]},"expertise":[{"id":74,"guid":"74.capabilities","index":0,"source":"capabilities"},{"id":1,"guid":"1.capabilities","index":1,"source":"capabilities"},{"id":3,"guid":"3.capabilities","index":2,"source":"capabilities"},{"id":5,"guid":"5.capabilities","index":3,"source":"capabilities"},{"id":11,"guid":"11.capabilities","index":4,"source":"capabilities"},{"id":129,"guid":"129.capabilities","index":5,"source":"capabilities"}],"is_active":true,"last_name":"Beck","nick_name":"Lohr","clerkships":[],"first_name":"Lohr","title_rank":9999,"updated_by":202,"law_schools":[{"id":659,"meta":{"degree":"J.D.","honors":"with honors, Order of the Coif","is_law_school":"1","graduation_date":"2014-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"A.","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":"Lohr Beck is a partner at King \u0026 Spalding. Read more about her.","primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eLohr's practice focuses on high-stakes business disputes with an emphasis on antitrust matters and consumer protection matters. Lohr\u0026nbsp;represents clients in relation to high exposure civil litigation, including class actions, multi-district litigation, and matters with complex e-discovery issues. Lohr also represents clients in relation to government investigations and counsels clients regarding antitrust and consumer protection issues.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eLeadership and\u0026nbsp;Community Service\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eCenter for Puppetry Arts, Board member\u003c/p\u003e\n\u003cp\u003eGeorgia Lawyers for the Arts,\u0026nbsp;Board member\u003c/p\u003e\n\u003cp\u003eAtlanta Women's Foundation, Inspire Atlanta Leadership Program Class of 2019\u003c/p\u003e","matters":["\u003cp\u003eDefense of\u0026nbsp;\u003cstrong\u003eNovo Nordisk Inc.\u003c/strong\u003e\u0026nbsp;in a nationwide antitrust putative class action filed against pharmaceutical company manufacturers of diabetes medications alleging conspiracy to artificially fix prices of diabetes medications by agreeing to coordinate and eliminate, reduce, or limit the availability of Contract Pharmacy 340B Drug Discounts.\u003c/p\u003e","\u003cp\u003eDefense of \u003cstrong\u003eECI Management, LLC\u003c/strong\u003e in antitrust MDL proceeding in Nashville, Tennessee alleging that owners and managers of multifamily rental housing conspired to raise prices through use of algorithmic revenue management software.\u003c/p\u003e","\u003cp\u003eDefense of\u0026nbsp;\u003cstrong\u003eSix Continents Hotels, Inc.\u003c/strong\u003e\u0026nbsp;in a nationwide antitrust putative class action filed against Six Continents and other major hotel companies alleging that defendant hotel companies conspired to eliminate competition for branded keyword search advertising against each other, illegally raising consumers\u0026rsquo; costs to find and book hotel rooms, and seeking damages and injunctive relief under the Sherman Act.\u003c/p\u003e","\u003cp\u003eDefense of\u0026nbsp;\u003cstrong\u003eKemira Chemicals Inc.\u003c/strong\u003e\u0026nbsp;in MDL proceeding in Newark, New Jersey, alleging conspiracy to fix prices in sale of liquid aluminum sulfate.\u003c/p\u003e","\u003cp\u003eDefense of\u0026nbsp;\u003cstrong\u003eKan Am (US)\u003c/strong\u003e\u0026nbsp;in litigation filed by Simon Property Group affiliates in the Delaware Court of Chancery involving the interpretation of buy/sell provisions in joint venture agreements regarding major retail shopping malls throughout the United States.\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":11787}]},"capability_group_id":3},"created_at":"2026-01-13T21:27:06.000Z","updated_at":"2026-01-13T21:27:06.000Z","searchable_text":"Beck{{ FIELD }}Defense of Novo Nordisk Inc. in a nationwide antitrust putative class action filed against pharmaceutical company manufacturers of diabetes medications alleging conspiracy to artificially fix prices of diabetes medications by agreeing to coordinate and eliminate, reduce, or limit the availability of Contract Pharmacy 340B Drug Discounts.{{ FIELD }}Defense of ECI Management, LLC in antitrust MDL proceeding in Nashville, Tennessee alleging that owners and managers of multifamily rental housing conspired to raise prices through use of algorithmic revenue management software.{{ FIELD }}Defense of Six Continents Hotels, Inc. in a nationwide antitrust putative class action filed against Six Continents and other major hotel companies alleging that defendant hotel companies conspired to eliminate competition for branded keyword search advertising against each other, illegally raising consumers’ costs to find and book hotel rooms, and seeking damages and injunctive relief under the Sherman Act.{{ FIELD }}Defense of Kemira Chemicals Inc. in MDL proceeding in Newark, New Jersey, alleging conspiracy to fix prices in sale of liquid aluminum sulfate.{{ FIELD }}Defense of Kan Am (US) in litigation filed by Simon Property Group affiliates in the Delaware Court of Chancery involving the interpretation of buy/sell provisions in joint venture agreements regarding major retail shopping malls throughout the United States.{{ FIELD }}Lohr's practice focuses on high-stakes business disputes with an emphasis on antitrust matters and consumer protection matters. Lohr represents clients in relation to high exposure civil litigation, including class actions, multi-district litigation, and matters with complex e-discovery issues. Lohr also represents clients in relation to government investigations and counsels clients regarding antitrust and consumer protection issues. \nLeadership and Community Service\nCenter for Puppetry Arts, Board member\nGeorgia Lawyers for the Arts, Board member\nAtlanta Women's Foundation, Inspire Atlanta Leadership Program Class of 2019 Lohr Beck lawyer Partner George Washington University George Washington University Law School Emory University Emory University School of Law Georgia Defense of Novo Nordisk Inc. in a nationwide antitrust putative class action filed against pharmaceutical company manufacturers of diabetes medications alleging conspiracy to artificially fix prices of diabetes medications by agreeing to coordinate and eliminate, reduce, or limit the availability of Contract Pharmacy 340B Drug Discounts. Defense of ECI Management, LLC in antitrust MDL proceeding in Nashville, Tennessee alleging that owners and managers of multifamily rental housing conspired to raise prices through use of algorithmic revenue management software. Defense of Six Continents Hotels, Inc. in a nationwide antitrust putative class action filed against Six Continents and other major hotel companies alleging that defendant hotel companies conspired to eliminate competition for branded keyword search advertising against each other, illegally raising consumers’ costs to find and book hotel rooms, and seeking damages and injunctive relief under the Sherman Act. Defense of Kemira Chemicals Inc. in MDL proceeding in Newark, New Jersey, alleging conspiracy to fix prices in sale of liquid aluminum sulfate. Defense of Kan Am (US) in litigation filed by Simon Property Group affiliates in the Delaware Court of Chancery involving the interpretation of buy/sell provisions in joint venture agreements regarding major retail shopping malls throughout the United States.","searchable_name":"Lohr A. Beck","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":426841,"version":1,"owner_type":"Person","owner_id":5738,"payload":{"bio":"\u003cp\u003eCraig Bessenger focuses on complex civil litigation and white-collar criminal defense. His clients include Fortune 200 companies, entertainment companies, healthcare providers, and financial institutions. He represents both plaintiffs and defendants in federal and state courts. Craig has litigated business, partnership, and contractual disputes, professional liability, banking and mortgage cases, and intellectual property matters. His white-collar experience spans various areas, including securities, antitrust, healthcare, and environmental violations, complex fraud and money laundering schemes, and internal investigations.\u003c/p\u003e","slug":"craig-bessenger","email":"cbessenger@kslaw.com","phone":null,"matters":["\u003cp\u003eObtained summary judgment on behalf of the\u0026nbsp;\u003cstrong\u003emovie studio, directors, and producer\u003c/strong\u003e\u0026nbsp;involved in the creation of a multibillion-dollar movie franchise in a copyright infringement case.\u003c/p\u003e","\u003cp\u003eSuccessfully defended a\u0026nbsp;\u003cstrong\u003emajor movie studio\u003c/strong\u003e\u0026nbsp;against claims relating to the collection of foreign revenue, and obtained an affirmance of the trial court\u0026rsquo;s ruling on appeal.\u003c/p\u003e","\u003cp\u003eDefeated an anti-SLAPP motion brought against a\u0026nbsp;\u003cstrong\u003emajor media company\u003c/strong\u003e, and obtained an affirmance of the trial court\u0026rsquo;s ruling on appeal.\u003c/p\u003e","\u003cp\u003eAchieved a multimillion-dollar settlement in a professional liability action brought on behalf of a\u0026nbsp;\u003cstrong\u003eclosely held corporation\u003c/strong\u003e.\u003c/p\u003e","\u003cp\u003eRepresented publicly-traded\u0026nbsp;\u003cstrong\u003ehealthcare company\u003c/strong\u003e\u0026nbsp;in numerous class actions.\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003eforeign national\u003c/strong\u003e\u0026nbsp;in a federal criminal investigation into an allegedly fraudulent scheme to circumvent state and federal environmental regulations.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003ebank directors\u003c/strong\u003e\u0026nbsp;in civil enforcement actions brought by federal regulatory authorities.\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003emedical device manufacturer\u003c/strong\u003e\u0026nbsp;in an investigation by state regulatory authorities.\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003eproducer of high-quality automotive images\u003c/strong\u003e\u0026nbsp;in a copyright infringement action against an online tech company arising from the unauthorized use of its photographs. A confidential settlement agreement was reached on the eve of trial.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":74,"guid":"74.capabilities","index":0,"source":"capabilities"},{"id":5,"guid":"5.capabilities","index":1,"source":"capabilities"},{"id":3,"guid":"3.capabilities","index":2,"source":"capabilities"},{"id":11,"guid":"11.capabilities","index":3,"source":"capabilities"},{"id":18,"guid":"18.capabilities","index":4,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":5,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":6,"source":"capabilities"},{"id":1248,"guid":"1248.smart_tags","index":7,"source":"smartTags"}],"is_active":true,"last_name":"Bessenger","nick_name":"Craig","clerkships":[{"name":"Judicial Clerk, Hon. A. Howard Matz, U.S. District Court for the Central District of California","years_held":"2010 - 2011"}],"first_name":"Craig","title_rank":9999,"updated_by":32,"law_schools":[{"id":2158,"meta":{"degree":"J.D.","honors":"Magna Cum Laude","is_law_school":"1","graduation_date":"2006-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"H.","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eCraig Bessenger focuses on complex civil litigation and white-collar criminal defense. His clients include Fortune 200 companies, entertainment companies, healthcare providers, and financial institutions. He represents both plaintiffs and defendants in federal and state courts. Craig has litigated business, partnership, and contractual disputes, professional liability, banking and mortgage cases, and intellectual property matters. His white-collar experience spans various areas, including securities, antitrust, healthcare, and environmental violations, complex fraud and money laundering schemes, and internal investigations.\u003c/p\u003e","matters":["\u003cp\u003eObtained summary judgment on behalf of the\u0026nbsp;\u003cstrong\u003emovie studio, directors, and producer\u003c/strong\u003e\u0026nbsp;involved in the creation of a multibillion-dollar movie franchise in a copyright infringement case.\u003c/p\u003e","\u003cp\u003eSuccessfully defended a\u0026nbsp;\u003cstrong\u003emajor movie studio\u003c/strong\u003e\u0026nbsp;against claims relating to the collection of foreign revenue, and obtained an affirmance of the trial court\u0026rsquo;s ruling on appeal.\u003c/p\u003e","\u003cp\u003eDefeated an anti-SLAPP motion brought against a\u0026nbsp;\u003cstrong\u003emajor media company\u003c/strong\u003e, and obtained an affirmance of the trial court\u0026rsquo;s ruling on appeal.\u003c/p\u003e","\u003cp\u003eAchieved a multimillion-dollar settlement in a professional liability action brought on behalf of a\u0026nbsp;\u003cstrong\u003eclosely held corporation\u003c/strong\u003e.\u003c/p\u003e","\u003cp\u003eRepresented publicly-traded\u0026nbsp;\u003cstrong\u003ehealthcare company\u003c/strong\u003e\u0026nbsp;in numerous class actions.\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003eforeign national\u003c/strong\u003e\u0026nbsp;in a federal criminal investigation into an allegedly fraudulent scheme to circumvent state and federal environmental regulations.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003ebank directors\u003c/strong\u003e\u0026nbsp;in civil enforcement actions brought by federal regulatory authorities.\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003emedical device manufacturer\u003c/strong\u003e\u0026nbsp;in an investigation by state regulatory authorities.\u003c/p\u003e","\u003cp\u003eRepresented a\u0026nbsp;\u003cstrong\u003eproducer of high-quality automotive images\u003c/strong\u003e\u0026nbsp;in a copyright infringement action against an online tech company arising from the unauthorized use of its photographs. A confidential settlement agreement was reached on the eve of trial.\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":8096}]},"capability_group_id":3},"created_at":"2025-05-26T04:57:19.000Z","updated_at":"2025-05-26T04:57:19.000Z","searchable_text":"Bessenger{{ FIELD }}Obtained summary judgment on behalf of the movie studio, directors, and producer involved in the creation of a multibillion-dollar movie franchise in a copyright infringement case.{{ FIELD }}Successfully defended a major movie studio against claims relating to the collection of foreign revenue, and obtained an affirmance of the trial court’s ruling on appeal.{{ FIELD }}Defeated an anti-SLAPP motion brought against a major media company, and obtained an affirmance of the trial court’s ruling on appeal.{{ FIELD }}Achieved a multimillion-dollar settlement in a professional liability action brought on behalf of a closely held corporation.{{ FIELD }}Represented publicly-traded healthcare company in numerous class actions.{{ FIELD }}Represented a foreign national in a federal criminal investigation into an allegedly fraudulent scheme to circumvent state and federal environmental regulations.{{ FIELD }}Represented bank directors in civil enforcement actions brought by federal regulatory authorities.{{ FIELD }}Represented a medical device manufacturer in an investigation by state regulatory authorities.{{ FIELD }}Represented a producer of high-quality automotive images in a copyright infringement action against an online tech company arising from the unauthorized use of its photographs. A confidential settlement agreement was reached on the eve of trial.{{ FIELD }}Craig Bessenger focuses on complex civil litigation and white-collar criminal defense. His clients include Fortune 200 companies, entertainment companies, healthcare providers, and financial institutions. He represents both plaintiffs and defendants in federal and state courts. Craig has litigated business, partnership, and contractual disputes, professional liability, banking and mortgage cases, and intellectual property matters. His white-collar experience spans various areas, including securities, antitrust, healthcare, and environmental violations, complex fraud and money laundering schemes, and internal investigations. Partner Brown University  University of California Hastings College of Law University of California Hastings College of Law U.S. District Court for the Central District of California U.S. District Court for the Northern District of California U.S. District Court for the Southern District of California California District of Columbia Judicial Clerk, Hon. A. Howard Matz, U.S. District Court for the Central District of California Obtained summary judgment on behalf of the movie studio, directors, and producer involved in the creation of a multibillion-dollar movie franchise in a copyright infringement case. Successfully defended a major movie studio against claims relating to the collection of foreign revenue, and obtained an affirmance of the trial court’s ruling on appeal. Defeated an anti-SLAPP motion brought against a major media company, and obtained an affirmance of the trial court’s ruling on appeal. Achieved a multimillion-dollar settlement in a professional liability action brought on behalf of a closely held corporation. Represented publicly-traded healthcare company in numerous class actions. Represented a foreign national in a federal criminal investigation into an allegedly fraudulent scheme to circumvent state and federal environmental regulations. Represented bank directors in civil enforcement actions brought by federal regulatory authorities. Represented a medical device manufacturer in an investigation by state regulatory authorities. Represented a producer of high-quality automotive images in a copyright infringement action against an online tech company arising from the unauthorized use of its photographs. A confidential settlement agreement was reached on the eve of trial.","searchable_name":"Craig H. Bessenger","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":32,"capability_group_featured":null,"home_page_featured":null},{"id":446151,"version":1,"owner_type":"Person","owner_id":6369,"payload":{"bio":"\u003cp\u003eMatthew Biben focuses his practice on complex negotiation and litigation of disputes, including regulatory and enforcement matters on behalf of both individuals and organizations. His diverse litigation practice includes representing financial institutions and FinTech companies in civil disputes, securities and bankruptcy litigation, and complex matters involving the government.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAs a former general counsel of a large bank and federal prosecutor, Matthew routinely acts as counsel in litigated disputes and internal investigations of both domestic and international matters involving, among others, the Department of Justice (DOJ), Securities Exchange Commission (SEC), Federal Reserve Board (FRB), Office of Comptroller of the Currency (OCC), Consumer Financial Protection Bureau (CFPB), New York Department of Financial Services (NYDFS), state attorneys general and foreign regulators.\u003c/p\u003e\n\u003cp\u003ePrior to joining private practice, Matthew served for three-and-a-half years at JPMorgan Chase, where he was Executive Vice President and General Counsel for Chase Consumer \u0026amp; Community Banking, which included JPMorgan Chase\u0026rsquo;s Private Wealth Management, Card and Merchant Services, Auto Finance, Student Loan, Consumer Banking, Business Banking and Mortgage Banking businesses.\u003c/p\u003e\n\u003cp\u003eMatthew also served as Executive Vice President and Deputy General Counsel of The Bank of New York Mellon Corporation for almost seven years, becoming the second youngest person in BNY\u0026rsquo;s history to be promoted to Executive Vice President. He also served as BNY Mellon\u0026rsquo;s Global Head of Litigation and supervised various corporate functions that included the Office of the Corporate Secretary.\u003c/p\u003e\n\u003cp\u003eMatthew spent the first 12 years of his career in government, serving in the U.S. Attorney\u0026rsquo;s Office for the Southern District of New York, where he was an Assistant U.S. Attorney in the Criminal Division and received the Attorney General\u0026rsquo;s Director Award for superior performance. Previously, he was an Assistant District Attorney in the New York County District Attorney\u0026rsquo;s Office. He argued numerous appeals in the Second Circuit Court of Appeals and was lead counsel in more than 25 federal and state trials.\u003c/p\u003e","slug":"matthew-biben","email":"mbiben@kslaw.com","phone":null,"matters":["\u003cp\u003e\u003cstrong\u003e\u003cem\u003eAnti-Money Laundering\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRoutinely advise banks and non-banks on BSA/AML compliance and enforcement issues including:\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eSociete Generale\u003c/strong\u003e\u0026nbsp;before the FRB and the Federal Reserve Bank of New York and separately before the NYDFS in negotiating a successful settlement regarding the bank\u0026rsquo;s BSA/AML compliance and risk management programs\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eMashreq Bank\u003c/strong\u003e\u0026nbsp;in negotiating a favorable settlement with the NYDFS, NYFed, FRB, and OFAC resolving wide ranging BSA/AML and Sanctions issues\u003c/p\u003e","\u003cp\u003eSuccessfully defended\u0026nbsp;\u003cstrong\u003eHabib Bank\u003c/strong\u003e\u0026nbsp;against a $630 million lawsuit by the NYDFS and negotiating a $225 million settlement relating to long-running AML/BSA compliance issues and assisting Habib in winding down the business of their NY branch\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eCoinbase\u003c/strong\u003e\u0026nbsp;in sweeping NYDFS investigation relating to BSA/AML and other compliance issues\u003c/p\u003e","\u003cp\u003eAdvised\u0026nbsp;\u003cstrong\u003ea large foreign bank\u003c/strong\u003e\u0026nbsp;in responding to the DOJ investigation of Mossack Fonseca \u0026amp; and the \u0026ldquo;Panama Papers\u0026rdquo;\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eComplex Civil Litigation\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eFanDuel\u003c/strong\u003e\u0026nbsp;and\u0026nbsp;\u003cstrong\u003eDraftKings\u003c/strong\u003e\u0026nbsp;in a landmark victory in the NY Court of Appeals legalizing interactive fantasy sports in New York State (garnering American Lawyer Litigator of the Week runner-up honors)\u003c/p\u003e","\u003cp\u003eRepresent\u0026nbsp;\u003cstrong\u003eFanDuel\u003c/strong\u003e\u0026nbsp;in a New York State Court litigation brought on by the former founders of FanDuel relating to merger acquisition violation\u003c/p\u003e","\u003cp\u003eRepresent\u0026nbsp;\u003cstrong\u003eBlackRock\u003c/strong\u003e\u0026nbsp;in litigation relating to mortgage-era fraud allegations\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eMacquarie Asset Management\u003c/strong\u003e\u0026nbsp;in a joint venture dispute relating to drag-along rights\u003c/p\u003e","\u003cp\u003eRepresent leading\u0026nbsp;\u003cstrong\u003eglobal investment bank\u003c/strong\u003e\u0026nbsp;in arbitration relating to a joint venture dispute\u003c/p\u003e","\u003cp\u003eRepresented ad hoc\u0026nbsp;\u003cstrong\u003e1st lien term lenders\u003c/strong\u003e\u0026nbsp;in the Mallinckrodt bankruptcy\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eFanDuel\u003c/strong\u003e\u0026nbsp;in a lawsuit and settlement with the New York Attorney General (NYAG) over the legality of daily fantasy sports and later resolving allegations of false advertising whereby the NYAG dropped its claims challenging the legality of FanDuel\u0026rsquo;s contests after a change in the New York State law permitting daily fantasy sports\u003c/p\u003e","\u003cp\u003eSuccessfully represented the Chairman of the board of\u003cstrong\u003e\u0026nbsp;Rio Tinto\u003c/strong\u003e\u0026nbsp;in a broad ranging SEC investigation into accounting fraud\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eBanks and Financial Institutions\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eIn addition to BSA/AML advice, I have extensively advised on bank regulatory compliance and enforcement issues, including the CFPB, the FRB, NYDFS, FDIC, OCC and others, including:\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eTruist\u003c/strong\u003e\u0026nbsp;in a long-running DOJ FIRREA investigation of their trust businesses in a cost-of-litigation settlement where all allegations were denied\u003c/p\u003e","\u003cp\u003eAdvised\u0026nbsp;\u003cstrong\u003ea global bank\u003c/strong\u003e\u0026nbsp;on fair lender compliance issue in relation to DFS investigation\u003c/p\u003e","\u003cp\u003eSuccessfully represented a\u0026nbsp;\u003cstrong\u003esuperregional bank\u003c/strong\u003e\u0026nbsp;in a CFPB into investigation into TISA compliance avoiding an enforcement action\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003efinancial institutions and individuals\u003c/strong\u003e\u0026nbsp;in SEC investigations, including the Chairman of the Board of a Fortune 100 company\u003c/p\u003e","\u003cp\u003eRepresented a leading\u0026nbsp;\u003cstrong\u003eFintech company\u003c/strong\u003e\u0026nbsp;in a CFPB investigation relating to FCRA and UDAAP allegations\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eToyota Financial Services\u003c/strong\u003e\u0026nbsp;in a DOJ and CFPB investigation and negotiating a favorable settlement relating to the indirect auto lender\u0026rsquo;s fair lending practices\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003ea senior executive of one of the largest global banks\u003c/strong\u003e\u0026nbsp;in a DOJ investigation of RMBS and a separate OCC investigation persuading both agencies after years of investigation to close their investigations without action\u003c/p\u003e","\u003cp\u003eLead an extensive internal investigation and representing\u0026nbsp;\u003cstrong\u003ea large foreign bank\u003c/strong\u003e\u0026nbsp;before the FRB and NYDFS concerning Regulation W compliance issues\u003c/p\u003e","\u003cp\u003eAdvised\u0026nbsp;\u003cstrong\u003ea large foreign bank\u003c/strong\u003e\u0026nbsp;in responding to a multi-state attorneys general investigation of its auto lending and securitization practices\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003esenior finance and actuarial employees\u003c/strong\u003e\u0026nbsp;of\u0026nbsp;\u003cstrong\u003eAMBAC\u003c/strong\u003e\u0026nbsp;in SEC investigation of accounting fraud\u003c/p\u003e","\u003cp\u003eRepresented the\u0026nbsp;\u003cstrong\u003eCFO of an insurance company\u003c/strong\u003e\u0026nbsp;in an investigation before the NYDFS which resulted in the matter being closed without action\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eAdmirals Bank\u003c/strong\u003e, as it restructured operations in the face of significant regulatory scrutiny and complex bank regulatory and enforcement issues\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eRoot Insurance\u003c/strong\u003e\u0026nbsp;in a New York Attorney General investigation relating to data breach allegations\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eGovernance\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eServed as a Director and Chair of the\u0026nbsp;\u003cstrong\u003eGovernance Committee\u003c/strong\u003e\u0026nbsp;of the largest privately held bank. BNY Melon Corporate Secretary was a direct report. Extensive pro bono governance work. Write and lecture on the topic. A sample of representations include:\u003c/p\u003e","\u003cp\u003eProvided\u0026nbsp;\u003cstrong\u003ethe Board of Directors of multiple financial institutions\u003c/strong\u003e\u0026nbsp;with advice on their annual self-evaluation as well as broader governance issues including expectations and guidance as applied to bank boards\u003c/p\u003e","\u003cp\u003eRepresented the\u0026nbsp;\u003cstrong\u003eBoard of Directors of Bed Bath \u0026amp; Beyond\u003c/strong\u003e\u0026nbsp;in an internal investigation concerning compensation and disclosure issues\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":3543}]},"expertise":[{"id":74,"guid":"74.capabilities","index":0,"source":"capabilities"},{"id":19,"guid":"19.capabilities","index":1,"source":"capabilities"},{"id":38,"guid":"38.capabilities","index":2,"source":"capabilities"},{"id":20,"guid":"20.capabilities","index":3,"source":"capabilities"},{"id":11,"guid":"11.capabilities","index":4,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":5,"source":"capabilities"},{"id":118,"guid":"118.capabilities","index":6,"source":"capabilities"},{"id":111,"guid":"111.capabilities","index":7,"source":"capabilities"},{"id":923,"guid":"923.smart_tags","index":8,"source":"smartTags"},{"id":699,"guid":"699.smart_tags","index":9,"source":"smartTags"},{"id":765,"guid":"765.smart_tags","index":10,"source":"smartTags"},{"id":1243,"guid":"1243.smart_tags","index":11,"source":"smartTags"},{"id":1248,"guid":"1248.smart_tags","index":12,"source":"smartTags"},{"id":1261,"guid":"1261.smart_tags","index":13,"source":"smartTags"},{"id":803,"guid":"803.smart_tags","index":14,"source":"smartTags"},{"id":1327,"guid":"1327.smart_tags","index":15,"source":"smartTags"}],"is_active":true,"last_name":"Biben","nick_name":"Matt","clerkships":[],"first_name":"Matthew","title_rank":9999,"updated_by":202,"law_schools":[],"middle_name":"L.","name_suffix":"","recognitions":[{"title":"Ranked for his “standout expertise” in the category of “Banking (Enforcement \u0026 Investigations)”","detail":"Chamber USA – Nationwide (Band 3) 2020-2026"},{"title":"Nationally recommended in the category of Financial Services Litigation, “tenacious but balanced litigator” ","detail":"The Legal 500 US 2016-2026"},{"title":"Recognized as Benchmark Litigation “Litigation Star”","detail":"Benchmark Litigation"},{"title":"Recognized as Lawdragon 500 Leading Global Entertainment, Sports \u0026 Media Lawyer","detail":"Lawdragon, 2024-2026"}],"linked_in_url":"https://www.linkedin.com/in/matthew-biben-480bb2a/","seodescription":"Matthew L. Biben is a partner of our Business Litigation Practice Group. Read more about him.","primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eMatthew Biben focuses his practice on complex negotiation and litigation of disputes, including regulatory and enforcement matters on behalf of both individuals and organizations. His diverse litigation practice includes representing financial institutions and FinTech companies in civil disputes, securities and bankruptcy litigation, and complex matters involving the government.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAs a former general counsel of a large bank and federal prosecutor, Matthew routinely acts as counsel in litigated disputes and internal investigations of both domestic and international matters involving, among others, the Department of Justice (DOJ), Securities Exchange Commission (SEC), Federal Reserve Board (FRB), Office of Comptroller of the Currency (OCC), Consumer Financial Protection Bureau (CFPB), New York Department of Financial Services (NYDFS), state attorneys general and foreign regulators.\u003c/p\u003e\n\u003cp\u003ePrior to joining private practice, Matthew served for three-and-a-half years at JPMorgan Chase, where he was Executive Vice President and General Counsel for Chase Consumer \u0026amp; Community Banking, which included JPMorgan Chase\u0026rsquo;s Private Wealth Management, Card and Merchant Services, Auto Finance, Student Loan, Consumer Banking, Business Banking and Mortgage Banking businesses.\u003c/p\u003e\n\u003cp\u003eMatthew also served as Executive Vice President and Deputy General Counsel of The Bank of New York Mellon Corporation for almost seven years, becoming the second youngest person in BNY\u0026rsquo;s history to be promoted to Executive Vice President. He also served as BNY Mellon\u0026rsquo;s Global Head of Litigation and supervised various corporate functions that included the Office of the Corporate Secretary.\u003c/p\u003e\n\u003cp\u003eMatthew spent the first 12 years of his career in government, serving in the U.S. Attorney\u0026rsquo;s Office for the Southern District of New York, where he was an Assistant U.S. Attorney in the Criminal Division and received the Attorney General\u0026rsquo;s Director Award for superior performance. Previously, he was an Assistant District Attorney in the New York County District Attorney\u0026rsquo;s Office. He argued numerous appeals in the Second Circuit Court of Appeals and was lead counsel in more than 25 federal and state trials.\u003c/p\u003e","matters":["\u003cp\u003e\u003cstrong\u003e\u003cem\u003eAnti-Money Laundering\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRoutinely advise banks and non-banks on BSA/AML compliance and enforcement issues including:\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eSociete Generale\u003c/strong\u003e\u0026nbsp;before the FRB and the Federal Reserve Bank of New York and separately before the NYDFS in negotiating a successful settlement regarding the bank\u0026rsquo;s BSA/AML compliance and risk management programs\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eMashreq Bank\u003c/strong\u003e\u0026nbsp;in negotiating a favorable settlement with the NYDFS, NYFed, FRB, and OFAC resolving wide ranging BSA/AML and Sanctions issues\u003c/p\u003e","\u003cp\u003eSuccessfully defended\u0026nbsp;\u003cstrong\u003eHabib Bank\u003c/strong\u003e\u0026nbsp;against a $630 million lawsuit by the NYDFS and negotiating a $225 million settlement relating to long-running AML/BSA compliance issues and assisting Habib in winding down the business of their NY branch\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eCoinbase\u003c/strong\u003e\u0026nbsp;in sweeping NYDFS investigation relating to BSA/AML and other compliance issues\u003c/p\u003e","\u003cp\u003eAdvised\u0026nbsp;\u003cstrong\u003ea large foreign bank\u003c/strong\u003e\u0026nbsp;in responding to the DOJ investigation of Mossack Fonseca \u0026amp; and the \u0026ldquo;Panama Papers\u0026rdquo;\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eComplex Civil Litigation\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eFanDuel\u003c/strong\u003e\u0026nbsp;and\u0026nbsp;\u003cstrong\u003eDraftKings\u003c/strong\u003e\u0026nbsp;in a landmark victory in the NY Court of Appeals legalizing interactive fantasy sports in New York State (garnering American Lawyer Litigator of the Week runner-up honors)\u003c/p\u003e","\u003cp\u003eRepresent\u0026nbsp;\u003cstrong\u003eFanDuel\u003c/strong\u003e\u0026nbsp;in a New York State Court litigation brought on by the former founders of FanDuel relating to merger acquisition violation\u003c/p\u003e","\u003cp\u003eRepresent\u0026nbsp;\u003cstrong\u003eBlackRock\u003c/strong\u003e\u0026nbsp;in litigation relating to mortgage-era fraud allegations\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eMacquarie Asset Management\u003c/strong\u003e\u0026nbsp;in a joint venture dispute relating to drag-along rights\u003c/p\u003e","\u003cp\u003eRepresent leading\u0026nbsp;\u003cstrong\u003eglobal investment bank\u003c/strong\u003e\u0026nbsp;in arbitration relating to a joint venture dispute\u003c/p\u003e","\u003cp\u003eRepresented ad hoc\u0026nbsp;\u003cstrong\u003e1st lien term lenders\u003c/strong\u003e\u0026nbsp;in the Mallinckrodt bankruptcy\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eFanDuel\u003c/strong\u003e\u0026nbsp;in a lawsuit and settlement with the New York Attorney General (NYAG) over the legality of daily fantasy sports and later resolving allegations of false advertising whereby the NYAG dropped its claims challenging the legality of FanDuel\u0026rsquo;s contests after a change in the New York State law permitting daily fantasy sports\u003c/p\u003e","\u003cp\u003eSuccessfully represented the Chairman of the board of\u003cstrong\u003e\u0026nbsp;Rio Tinto\u003c/strong\u003e\u0026nbsp;in a broad ranging SEC investigation into accounting fraud\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eBanks and Financial Institutions\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eIn addition to BSA/AML advice, I have extensively advised on bank regulatory compliance and enforcement issues, including the CFPB, the FRB, NYDFS, FDIC, OCC and others, including:\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eTruist\u003c/strong\u003e\u0026nbsp;in a long-running DOJ FIRREA investigation of their trust businesses in a cost-of-litigation settlement where all allegations were denied\u003c/p\u003e","\u003cp\u003eAdvised\u0026nbsp;\u003cstrong\u003ea global bank\u003c/strong\u003e\u0026nbsp;on fair lender compliance issue in relation to DFS investigation\u003c/p\u003e","\u003cp\u003eSuccessfully represented a\u0026nbsp;\u003cstrong\u003esuperregional bank\u003c/strong\u003e\u0026nbsp;in a CFPB into investigation into TISA compliance avoiding an enforcement action\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003efinancial institutions and individuals\u003c/strong\u003e\u0026nbsp;in SEC investigations, including the Chairman of the Board of a Fortune 100 company\u003c/p\u003e","\u003cp\u003eRepresented a leading\u0026nbsp;\u003cstrong\u003eFintech company\u003c/strong\u003e\u0026nbsp;in a CFPB investigation relating to FCRA and UDAAP allegations\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eToyota Financial Services\u003c/strong\u003e\u0026nbsp;in a DOJ and CFPB investigation and negotiating a favorable settlement relating to the indirect auto lender\u0026rsquo;s fair lending practices\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003ea senior executive of one of the largest global banks\u003c/strong\u003e\u0026nbsp;in a DOJ investigation of RMBS and a separate OCC investigation persuading both agencies after years of investigation to close their investigations without action\u003c/p\u003e","\u003cp\u003eLead an extensive internal investigation and representing\u0026nbsp;\u003cstrong\u003ea large foreign bank\u003c/strong\u003e\u0026nbsp;before the FRB and NYDFS concerning Regulation W compliance issues\u003c/p\u003e","\u003cp\u003eAdvised\u0026nbsp;\u003cstrong\u003ea large foreign bank\u003c/strong\u003e\u0026nbsp;in responding to a multi-state attorneys general investigation of its auto lending and securitization practices\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003esenior finance and actuarial employees\u003c/strong\u003e\u0026nbsp;of\u0026nbsp;\u003cstrong\u003eAMBAC\u003c/strong\u003e\u0026nbsp;in SEC investigation of accounting fraud\u003c/p\u003e","\u003cp\u003eRepresented the\u0026nbsp;\u003cstrong\u003eCFO of an insurance company\u003c/strong\u003e\u0026nbsp;in an investigation before the NYDFS which resulted in the matter being closed without action\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eAdmirals Bank\u003c/strong\u003e, as it restructured operations in the face of significant regulatory scrutiny and complex bank regulatory and enforcement issues\u003c/p\u003e","\u003cp\u003eSuccessfully represented\u0026nbsp;\u003cstrong\u003eRoot Insurance\u003c/strong\u003e\u0026nbsp;in a New York Attorney General investigation relating to data breach allegations\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003e\u003cem\u003eGovernance\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eServed as a Director and Chair of the\u0026nbsp;\u003cstrong\u003eGovernance Committee\u003c/strong\u003e\u0026nbsp;of the largest privately held bank. BNY Melon Corporate Secretary was a direct report. Extensive pro bono governance work. Write and lecture on the topic. A sample of representations include:\u003c/p\u003e","\u003cp\u003eProvided\u0026nbsp;\u003cstrong\u003ethe Board of Directors of multiple financial institutions\u003c/strong\u003e\u0026nbsp;with advice on their annual self-evaluation as well as broader governance issues including expectations and guidance as applied to bank boards\u003c/p\u003e","\u003cp\u003eRepresented the\u0026nbsp;\u003cstrong\u003eBoard of Directors of Bed Bath \u0026amp; Beyond\u003c/strong\u003e\u0026nbsp;in an internal investigation concerning compensation and disclosure issues\u003c/p\u003e"],"recognitions":[{"title":"Ranked for his “standout expertise” in the category of “Banking (Enforcement \u0026 Investigations)”","detail":"Chamber USA – Nationwide (Band 3) 2020-2026"},{"title":"Nationally recommended in the category of Financial Services Litigation, “tenacious but balanced litigator” ","detail":"The Legal 500 US 2016-2026"},{"title":"Recognized as Benchmark Litigation “Litigation Star”","detail":"Benchmark Litigation"},{"title":"Recognized as Lawdragon 500 Leading Global Entertainment, Sports \u0026 Media Lawyer","detail":"Lawdragon, 2024-2026"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":9814}]},"capability_group_id":3},"created_at":"2026-02-24T23:17:27.000Z","updated_at":"2026-02-24T23:17:27.000Z","searchable_text":"Biben{{ FIELD }}{:title=\u0026gt;\"Ranked for his “standout expertise” in the category of “Banking (Enforcement \u0026amp; Investigations)”\", :detail=\u0026gt;\"Chamber USA – Nationwide (Band 3) 2020-2026\"}{{ FIELD }}{:title=\u0026gt;\"Nationally recommended in the category of Financial Services Litigation, “tenacious but balanced litigator” \", :detail=\u0026gt;\"The Legal 500 US 2016-2026\"}{{ FIELD }}{:title=\u0026gt;\"Recognized as Benchmark Litigation “Litigation Star”\", :detail=\u0026gt;\"Benchmark Litigation\"}{{ FIELD }}{:title=\u0026gt;\"Recognized as Lawdragon 500 Leading Global Entertainment, Sports \u0026amp; Media Lawyer\", :detail=\u0026gt;\"Lawdragon, 2024-2026\"}{{ FIELD }}Anti-Money Laundering\nRoutinely advise banks and non-banks on BSA/AML compliance and enforcement issues including:{{ FIELD }}Represented Societe Generale before the FRB and the Federal Reserve Bank of New York and separately before the NYDFS in negotiating a successful settlement regarding the bank’s BSA/AML compliance and risk management programs{{ FIELD }}Successfully represented Mashreq Bank in negotiating a favorable settlement with the NYDFS, NYFed, FRB, and OFAC resolving wide ranging BSA/AML and Sanctions issues{{ FIELD }}Successfully defended Habib Bank against a $630 million lawsuit by the NYDFS and negotiating a $225 million settlement relating to long-running AML/BSA compliance issues and assisting Habib in winding down the business of their NY branch{{ FIELD }}Successfully represented Coinbase in sweeping NYDFS investigation relating to BSA/AML and other compliance issues{{ FIELD }}Advised a large foreign bank in responding to the DOJ investigation of Mossack Fonseca \u0026amp; and the “Panama Papers”{{ FIELD }}Complex Civil Litigation\nRepresented FanDuel and DraftKings in a landmark victory in the NY Court of Appeals legalizing interactive fantasy sports in New York State (garnering American Lawyer Litigator of the Week runner-up honors){{ FIELD }}Represent FanDuel in a New York State Court litigation brought on by the former founders of FanDuel relating to merger acquisition violation{{ FIELD }}Represent BlackRock in litigation relating to mortgage-era fraud allegations{{ FIELD }}Represented Macquarie Asset Management in a joint venture dispute relating to drag-along rights{{ FIELD }}Represent leading global investment bank in arbitration relating to a joint venture dispute{{ FIELD }}Represented ad hoc 1st lien term lenders in the Mallinckrodt bankruptcy{{ FIELD }}Represented FanDuel in a lawsuit and settlement with the New York Attorney General (NYAG) over the legality of daily fantasy sports and later resolving allegations of false advertising whereby the NYAG dropped its claims challenging the legality of FanDuel’s contests after a change in the New York State law permitting daily fantasy sports{{ FIELD }}Successfully represented the Chairman of the board of Rio Tinto in a broad ranging SEC investigation into accounting fraud{{ FIELD }}Banks and Financial Institutions\nIn addition to BSA/AML advice, I have extensively advised on bank regulatory compliance and enforcement issues, including the CFPB, the FRB, NYDFS, FDIC, OCC and others, including:{{ FIELD }}Successfully represented Truist in a long-running DOJ FIRREA investigation of their trust businesses in a cost-of-litigation settlement where all allegations were denied{{ FIELD }}Advised a global bank on fair lender compliance issue in relation to DFS investigation{{ FIELD }}Successfully represented a superregional bank in a CFPB into investigation into TISA compliance avoiding an enforcement action{{ FIELD }}Represented financial institutions and individuals in SEC investigations, including the Chairman of the Board of a Fortune 100 company{{ FIELD }}Represented a leading Fintech company in a CFPB investigation relating to FCRA and UDAAP allegations{{ FIELD }}Successfully represented Toyota Financial Services in a DOJ and CFPB investigation and negotiating a favorable settlement relating to the indirect auto lender’s fair lending practices{{ FIELD }}Represented a senior executive of one of the largest global banks in a DOJ investigation of RMBS and a separate OCC investigation persuading both agencies after years of investigation to close their investigations without action{{ FIELD }}Lead an extensive internal investigation and representing a large foreign bank before the FRB and NYDFS concerning Regulation W compliance issues{{ FIELD }}Advised a large foreign bank in responding to a multi-state attorneys general investigation of its auto lending and securitization practices{{ FIELD }}Represented senior finance and actuarial employees of AMBAC in SEC investigation of accounting fraud{{ FIELD }}Represented the CFO of an insurance company in an investigation before the NYDFS which resulted in the matter being closed without action{{ FIELD }}Represented Admirals Bank, as it restructured operations in the face of significant regulatory scrutiny and complex bank regulatory and enforcement issues{{ FIELD }}Successfully represented Root Insurance in a New York Attorney General investigation relating to data breach allegations{{ FIELD }}Governance\nServed as a Director and Chair of the Governance Committee of the largest privately held bank. BNY Melon Corporate Secretary was a direct report. Extensive pro bono governance work. Write and lecture on the topic. A sample of representations include:{{ FIELD }}Provided the Board of Directors of multiple financial institutions with advice on their annual self-evaluation as well as broader governance issues including expectations and guidance as applied to bank boards{{ FIELD }}Represented the Board of Directors of Bed Bath \u0026amp; Beyond in an internal investigation concerning compensation and disclosure issues{{ FIELD }}Matthew Biben focuses his practice on complex negotiation and litigation of disputes, including regulatory and enforcement matters on behalf of both individuals and organizations. His diverse litigation practice includes representing financial institutions and FinTech companies in civil disputes, securities and bankruptcy litigation, and complex matters involving the government.\nAs a former general counsel of a large bank and federal prosecutor, Matthew routinely acts as counsel in litigated disputes and internal investigations of both domestic and international matters involving, among others, the Department of Justice (DOJ), Securities Exchange Commission (SEC), Federal Reserve Board (FRB), Office of Comptroller of the Currency (OCC), Consumer Financial Protection Bureau (CFPB), New York Department of Financial Services (NYDFS), state attorneys general and foreign regulators.\nPrior to joining private practice, Matthew served for three-and-a-half years at JPMorgan Chase, where he was Executive Vice President and General Counsel for Chase Consumer \u0026amp; Community Banking, which included JPMorgan Chase’s Private Wealth Management, Card and Merchant Services, Auto Finance, Student Loan, Consumer Banking, Business Banking and Mortgage Banking businesses.\nMatthew also served as Executive Vice President and Deputy General Counsel of The Bank of New York Mellon Corporation for almost seven years, becoming the second youngest person in BNY’s history to be promoted to Executive Vice President. He also served as BNY Mellon’s Global Head of Litigation and supervised various corporate functions that included the Office of the Corporate Secretary.\nMatthew spent the first 12 years of his career in government, serving in the U.S. Attorney’s Office for the Southern District of New York, where he was an Assistant U.S. Attorney in the Criminal Division and received the Attorney General’s Director Award for superior performance. Previously, he was an Assistant District Attorney in the New York County District Attorney’s Office. He argued numerous appeals in the Second Circuit Court of Appeals and was lead counsel in more than 25 federal and state trials. Matthew Biben lawyer Partner Ranked for his “standout expertise” in the category of “Banking (Enforcement \u0026amp; Investigations)” Chamber USA – Nationwide (Band 3) 2020-2026 Nationally recommended in the category of Financial Services Litigation, “tenacious but balanced litigator”  The Legal 500 US 2016-2026 Recognized as Benchmark Litigation “Litigation Star” Benchmark Litigation Recognized as Lawdragon 500 Leading Global Entertainment, Sports \u0026amp; Media Lawyer Lawdragon, 2024-2026 Cornell University Cornell Law School University of Pennsylvania University of Pennsylvania Law School Supreme Court of the United States U.S. Court of Appeals for the Second Circuit U.S. District Court for the Eastern District of New York U.S. District Court for the Southern District of New York New York University of Pennsylvania Carey Law School – Board of Trustees American Arbitration Association – Board Member New York Legal Assistance Group - Member Board of Directors New York Lawyers for the Public Interest - Director Anti-Money Laundering\nRoutinely advise banks and non-banks on BSA/AML compliance and enforcement issues including: Represented Societe Generale before the FRB and the Federal Reserve Bank of New York and separately before the NYDFS in negotiating a successful settlement regarding the bank’s BSA/AML compliance and risk management programs Successfully represented Mashreq Bank in negotiating a favorable settlement with the NYDFS, NYFed, FRB, and OFAC resolving wide ranging BSA/AML and Sanctions issues Successfully defended Habib Bank against a $630 million lawsuit by the NYDFS and negotiating a $225 million settlement relating to long-running AML/BSA compliance issues and assisting Habib in winding down the business of their NY branch Successfully represented Coinbase in sweeping NYDFS investigation relating to BSA/AML and other compliance issues Advised a large foreign bank in responding to the DOJ investigation of Mossack Fonseca \u0026amp; and the “Panama Papers” Complex Civil Litigation\nRepresented FanDuel and DraftKings in a landmark victory in the NY Court of Appeals legalizing interactive fantasy sports in New York State (garnering American Lawyer Litigator of the Week runner-up honors) Represent FanDuel in a New York State Court litigation brought on by the former founders of FanDuel relating to merger acquisition violation Represent BlackRock in litigation relating to mortgage-era fraud allegations Represented Macquarie Asset Management in a joint venture dispute relating to drag-along rights Represent leading global investment bank in arbitration relating to a joint venture dispute Represented ad hoc 1st lien term lenders in the Mallinckrodt bankruptcy Represented FanDuel in a lawsuit and settlement with the New York Attorney General (NYAG) over the legality of daily fantasy sports and later resolving allegations of false advertising whereby the NYAG dropped its claims challenging the legality of FanDuel’s contests after a change in the New York State law permitting daily fantasy sports Successfully represented the Chairman of the board of Rio Tinto in a broad ranging SEC investigation into accounting fraud Banks and Financial Institutions\nIn addition to BSA/AML advice, I have extensively advised on bank regulatory compliance and enforcement issues, including the CFPB, the FRB, NYDFS, FDIC, OCC and others, including: Successfully represented Truist in a long-running DOJ FIRREA investigation of their trust businesses in a cost-of-litigation settlement where all allegations were denied Advised a global bank on fair lender compliance issue in relation to DFS investigation Successfully represented a superregional bank in a CFPB into investigation into TISA compliance avoiding an enforcement action Represented financial institutions and individuals in SEC investigations, including the Chairman of the Board of a Fortune 100 company Represented a leading Fintech company in a CFPB investigation relating to FCRA and UDAAP allegations Successfully represented Toyota Financial Services in a DOJ and CFPB investigation and negotiating a favorable settlement relating to the indirect auto lender’s fair lending practices Represented a senior executive of one of the largest global banks in a DOJ investigation of RMBS and a separate OCC investigation persuading both agencies after years of investigation to close their investigations without action Lead an extensive internal investigation and representing a large foreign bank before the FRB and NYDFS concerning Regulation W compliance issues Advised a large foreign bank in responding to a multi-state attorneys general investigation of its auto lending and securitization practices Represented senior finance and actuarial employees of AMBAC in SEC investigation of accounting fraud Represented the CFO of an insurance company in an investigation before the NYDFS which resulted in the matter being closed without action Represented Admirals Bank, as it restructured operations in the face of significant regulatory scrutiny and complex bank regulatory and enforcement issues Successfully represented Root Insurance in a New York Attorney General investigation relating to data breach allegations Governance\nServed as a Director and Chair of the Governance Committee of the largest privately held bank. BNY Melon Corporate Secretary was a direct report. Extensive pro bono governance work. Write and lecture on the topic. A sample of representations include: Provided the Board of Directors of multiple financial institutions with advice on their annual self-evaluation as well as broader governance issues including expectations and guidance as applied to bank boards Represented the Board of Directors of Bed Bath \u0026amp; Beyond in an internal investigation concerning compensation and disclosure issues","searchable_name":"Matthew L. Biben (Matt)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":447104,"version":1,"owner_type":"Person","owner_id":6224,"payload":{"bio":"\u003cp\u003eSara Brinkmann represents healthcare and life sciences clients in investigations and litigation in federal courts, state courts, arbitrations, and administrative proceedings across the country.\u0026nbsp; Sara has particular expertise in handling matters that arise under the federal False Claims Act and its state law analogues.\u0026nbsp; Sara also focuses on managed care litigation and has successfully recovered millions of dollars for healthcare providers in disputes against heath plans.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAn experienced litigator, Sara also represents her clients in disputes involving contracts, business torts, antitrust, and products liability issues. Sara's clients include hospitals, academic medical centers, medical groups, retail pharmacies, medical device companies, pharmaceutical companies, and other life sciences companies.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eIn additional to her litigation practice, she regularly advises clients on regulatory and compliance matters, including those that involved the Stark Law, the Anti-Kickback Statute, and other fraud and abuse laws. She also provides counseling and training regarding policies, compliance programs, self-disclosures, and billing matters.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eThrough \u003cem\u003eChambers USA\u003c/em\u003e, her clients have said:\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp; \"Sara Brinkmann is an excellent litigator. She is very knowledgeable, highly organized, and a pleasure to work with.\"\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp; \"She cares about each of her cases and comes up with creative ideas to problem-solve.\" \u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp; \"Sara Brinkmann is a fantastic lawyer.\"\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003eSara is regularly recognized by publications like \u003cem\u003eChambers,\u0026nbsp;\u003c/em\u003e\u003cem\u003eBest Lawyers in America, \u003c/em\u003eand \u003cem\u003eSuper Lawyers\u003c/em\u003e. She is the past\u0026nbsp;Chair of the Health Law Section of the Houston Bar Association. She is also a frequent speaker and presenter on a variety of healthcare topics.\u003c/p\u003e","slug":"sara-brinkmann","email":"sbrinkmann@kslaw.com","phone":"+1 713 295 9930","matters":["\u003cp\u003eSuccessfully defended a nationwide retail pharmacy client in a False Claims Act case in the Southern District of Texas and on appeal in the Fifth Circuit Court of Appeals involving allegations of regulatory violations related to the dispensing of certain pharmaceuticals, resulting in a full dismissal of the case prior to discovery and was affirmed on appeal at the Fifth Circuit.\u003c/p\u003e","\u003cp\u003eSuccessfully defended a hospital system in a False Claims Act case in the Southern District of Texas involving allegations of Stark Law and Anti-Kickback Statute violations related to physician recruitment and compensation arrangements, resulting in a favorable settlement for the client.\u003c/p\u003e","\u003cp\u003eSuccessfully defended a hospital system in a False Claims Act case in the Eastern District of Wisconsin involving allegations of Stark Law and Anti-Kickback Statute violations related to physician group compensation, resulting in a favorable settlement for the client.\u003c/p\u003e","\u003cp\u003eSuccessfully defended an international medical device company in a False Claims Act case in the District of New Jersey involving allegations of coding errors on claim submissions, resulting in a favorable settlement for the client.\u003c/p\u003e","\u003cp\u003eSuccessfully defended nationwide retail pharmacy in a False Claims Act case in the Central District of Illinois involving allegations related to usual and customary pricing, resulting in the Court\u0026rsquo;s grant of a Motion for Summary Judgment and dismissal of case.\u003c/p\u003e","\u003cp\u003eSuccessfully defended several higher education institutions, academic medical centers, and life sciences companies in responding to Civil Investigative Demands and other government investigation, including conducting internal investigations and presenting to the government.\u003c/p\u003e","\u003cp\u003eAdvised several higher education institutions on legal and compliance issues, including developing, implementing, and providing training to employees.\u003c/p\u003e","\u003cp\u003eAdvised hospital systems regarding affiliation agreements and other complex transactions.\u003c/p\u003e","\u003cp\u003eAdvised and provided due diligence support to healthcare companies and hospital systems for mergers and acquisitions.\u003c/p\u003e","\u003cp\u003eAdvised hospital system regarding data privacy and HIPAA compliance issues in responding to third-party subpoenas.\u003c/p\u003e","\u003cp\u003eSuccessfully defended a government defense contractor in a False Claims Act case in the Eastern District of Texas involving allegations of kickbacks and failure to comply with certain Federal Acquisition Regulations.\u003c/p\u003e","\u003cp\u003eSuccessfully defended a pharmaceutical company in several product liability cases in federal and state courts across the country.\u003c/p\u003e","\u003cp\u003eSuccessfully represented hospitals systems and other healthcare providers in Texas federal and state court cases involving allegations of breach of contract, violations of Texas Deceptive Trade Practices Act and Texas Uniform Fraudulent Transfer Act, and health care liability claim cases.\u003c/p\u003e","\u003cp\u003eSuccessfully represented a hospital system in responding to Medicare RAC audits, securing full reimbursements for hospital system.\u003c/p\u003e","\u003cp\u003eRepresented a Louisiana hospital system in federal antitrust case.\u003c/p\u003e","\u003cp\u003eSuccessfully defended a managed care organization in response to investigation by the Texas Office of Inspector General, resulting in a favorable result for the client.\u003c/p\u003e","\u003cp\u003eSuccessfully represented a hospital system in responding to third-party subpoenas successfully securing full reimbursements for hospital systems, including obtaining recovery of attorneys\u0026rsquo; fees after prosecuting numerous motions to quash and motions for protection of medical and forensic records in civil, family, and criminal cases.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":81,"guid":"81.capabilities","index":0,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":1,"source":"capabilities"},{"id":11,"guid":"11.capabilities","index":2,"source":"capabilities"},{"id":74,"guid":"74.capabilities","index":3,"source":"capabilities"},{"id":21,"guid":"21.capabilities","index":4,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":5,"source":"capabilities"},{"id":109,"guid":"109.capabilities","index":6,"source":"capabilities"},{"id":102,"guid":"102.capabilities","index":7,"source":"capabilities"},{"id":952,"guid":"952.smart_tags","index":8,"source":"smartTags"},{"id":761,"guid":"761.smart_tags","index":9,"source":"smartTags"},{"id":780,"guid":"780.smart_tags","index":10,"source":"smartTags"}],"is_active":true,"last_name":"Brinkmann","nick_name":"Sara","clerkships":[{"name":"Law Clerk, Hon. David Hittner, Texas","years_held":"2009 - 2011"}],"first_name":"Sara","title_rank":9999,"updated_by":202,"law_schools":[{"id":2197,"meta":{"degree":"J.D.","honors":"cum laude","is_law_school":"1","graduation_date":"2009-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":[{"title":"\"She is very calm, organized and responsive.\"","detail":"Chambers USA, 2025"},{"title":"\"Sara has a very service-oriented ethos in how she practices.\"","detail":"Chambers USA, 2025"},{"title":"Ranked as a Band 3 lawyer for Healthcare: Government Matters \u0026 Regulation","detail":"Chambers USA, 2025"},{"title":"Ranked as a Key Lawyer for Healthcare: Service Providers","detail":"Legal 500 USA, 2025"},{"title":"\"Sara is very good at keeping larger business outcomes in mind.\"","detail":"Chambers USA 2024"},{"title":"\"Sara is intelligent and customer-focused, responsive and competent.\"","detail":"Chambers USA 2024"},{"title":"\"Sara is an exceptional attorney who provided outstanding legal analysis.\"","detail":"Chambers USA 2024"},{"title":"Ranked Band 3 for Healthcare in Texas","detail":"Chambers USA 2024"},{"title":"Women in the Law","detail":"Best Lawyers, 2022"},{"title":"Top Rated Houston, TX Health Care Attorney","detail":"Super Lawyers, 2023-2024"},{"title":"Top Women Attorneys in Texas","detail":"2024"},{"title":"Best Lawyers in America","detail":"Best Lawyers - Texas, 2021 - 2023"},{"title":"Top Ranked Lawyer, Healthcare","detail":"Chambers USA, Texas, 2021-2023"},{"title":"“Sara Brinkmann comes recommended for her expert handling of qui tam actions brought under the False Claims Act.”","detail":"Chambers USA 2022"},{"title":"“Sara offers notable experience in litigation and administrative proceedings.”","detail":"Chambers USA 2022"},{"title":"“Sara Brinkmann possesses significant experience and knowledge on complex issues.”","detail":"Chambers USA 2022"},{"title":"Sara is “organized and approachable, and offers thoughtful approaches on ways to achieve the desired result.”","detail":"Chambers USA 2022"},{"title":"“She is a really sharp lawyer.”","detail":"Chambers USA 2022"}],"linked_in_url":"https://www.linkedin.com/in/sara-brinkmann-23b78335","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eSara Brinkmann represents healthcare and life sciences clients in investigations and litigation in federal courts, state courts, arbitrations, and administrative proceedings across the country.\u0026nbsp; Sara has particular expertise in handling matters that arise under the federal False Claims Act and its state law analogues.\u0026nbsp; Sara also focuses on managed care litigation and has successfully recovered millions of dollars for healthcare providers in disputes against heath plans.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAn experienced litigator, Sara also represents her clients in disputes involving contracts, business torts, antitrust, and products liability issues. Sara's clients include hospitals, academic medical centers, medical groups, retail pharmacies, medical device companies, pharmaceutical companies, and other life sciences companies.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eIn additional to her litigation practice, she regularly advises clients on regulatory and compliance matters, including those that involved the Stark Law, the Anti-Kickback Statute, and other fraud and abuse laws. She also provides counseling and training regarding policies, compliance programs, self-disclosures, and billing matters.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eThrough \u003cem\u003eChambers USA\u003c/em\u003e, her clients have said:\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp; \"Sara Brinkmann is an excellent litigator. She is very knowledgeable, highly organized, and a pleasure to work with.\"\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp; \"She cares about each of her cases and comes up with creative ideas to problem-solve.\" \u003c/em\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003e\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp; \"Sara Brinkmann is a fantastic lawyer.\"\u003c/em\u003e\u003c/p\u003e\n\u003cp\u003eSara is regularly recognized by publications like \u003cem\u003eChambers,\u0026nbsp;\u003c/em\u003e\u003cem\u003eBest Lawyers in America, \u003c/em\u003eand \u003cem\u003eSuper Lawyers\u003c/em\u003e. She is the past\u0026nbsp;Chair of the Health Law Section of the Houston Bar Association. She is also a frequent speaker and presenter on a variety of healthcare topics.\u003c/p\u003e","matters":["\u003cp\u003eSuccessfully defended a nationwide retail pharmacy client in a False Claims Act case in the Southern District of Texas and on appeal in the Fifth Circuit Court of Appeals involving allegations of regulatory violations related to the dispensing of certain pharmaceuticals, resulting in a full dismissal of the case prior to discovery and was affirmed on appeal at the Fifth Circuit.\u003c/p\u003e","\u003cp\u003eSuccessfully defended a hospital system in a False Claims Act case in the Southern District of Texas involving allegations of Stark Law and Anti-Kickback Statute violations related to physician recruitment and compensation arrangements, resulting in a favorable settlement for the client.\u003c/p\u003e","\u003cp\u003eSuccessfully defended a hospital system in a False Claims Act case in the Eastern District of Wisconsin involving allegations of Stark Law and Anti-Kickback Statute violations related to physician group compensation, resulting in a favorable settlement for the client.\u003c/p\u003e","\u003cp\u003eSuccessfully defended an international medical device company in a False Claims Act case in the District of New Jersey involving allegations of coding errors on claim submissions, resulting in a favorable settlement for the client.\u003c/p\u003e","\u003cp\u003eSuccessfully defended nationwide retail pharmacy in a False Claims Act case in the Central District of Illinois involving allegations related to usual and customary pricing, resulting in the Court\u0026rsquo;s grant of a Motion for Summary Judgment and dismissal of case.\u003c/p\u003e","\u003cp\u003eSuccessfully defended several higher education institutions, academic medical centers, and life sciences companies in responding to Civil Investigative Demands and other government investigation, including conducting internal investigations and presenting to the government.\u003c/p\u003e","\u003cp\u003eAdvised several higher education institutions on legal and compliance issues, including developing, implementing, and providing training to employees.\u003c/p\u003e","\u003cp\u003eAdvised hospital systems regarding affiliation agreements and other complex transactions.\u003c/p\u003e","\u003cp\u003eAdvised and provided due diligence support to healthcare companies and hospital systems for mergers and acquisitions.\u003c/p\u003e","\u003cp\u003eAdvised hospital system regarding data privacy and HIPAA compliance issues in responding to third-party subpoenas.\u003c/p\u003e","\u003cp\u003eSuccessfully defended a government defense contractor in a False Claims Act case in the Eastern District of Texas involving allegations of kickbacks and failure to comply with certain Federal Acquisition Regulations.\u003c/p\u003e","\u003cp\u003eSuccessfully defended a pharmaceutical company in several product liability cases in federal and state courts across the country.\u003c/p\u003e","\u003cp\u003eSuccessfully represented hospitals systems and other healthcare providers in Texas federal and state court cases involving allegations of breach of contract, violations of Texas Deceptive Trade Practices Act and Texas Uniform Fraudulent Transfer Act, and health care liability claim cases.\u003c/p\u003e","\u003cp\u003eSuccessfully represented a hospital system in responding to Medicare RAC audits, securing full reimbursements for hospital system.\u003c/p\u003e","\u003cp\u003eRepresented a Louisiana hospital system in federal antitrust case.\u003c/p\u003e","\u003cp\u003eSuccessfully defended a managed care organization in response to investigation by the Texas Office of Inspector General, resulting in a favorable result for the client.\u003c/p\u003e","\u003cp\u003eSuccessfully represented a hospital system in responding to third-party subpoenas successfully securing full reimbursements for hospital systems, including obtaining recovery of attorneys\u0026rsquo; fees after prosecuting numerous motions to quash and motions for protection of medical and forensic records in civil, family, and criminal cases.\u003c/p\u003e"],"recognitions":[{"title":"\"She is very calm, organized and responsive.\"","detail":"Chambers USA, 2025"},{"title":"\"Sara has a very service-oriented ethos in how she practices.\"","detail":"Chambers USA, 2025"},{"title":"Ranked as a Band 3 lawyer for Healthcare: Government Matters \u0026 Regulation","detail":"Chambers USA, 2025"},{"title":"Ranked as a Key Lawyer for Healthcare: Service Providers","detail":"Legal 500 USA, 2025"},{"title":"\"Sara is very good at keeping larger business outcomes in mind.\"","detail":"Chambers USA 2024"},{"title":"\"Sara is intelligent and customer-focused, responsive and competent.\"","detail":"Chambers USA 2024"},{"title":"\"Sara is an exceptional attorney who provided outstanding legal analysis.\"","detail":"Chambers USA 2024"},{"title":"Ranked Band 3 for Healthcare in Texas","detail":"Chambers USA 2024"},{"title":"Women in the Law","detail":"Best Lawyers, 2022"},{"title":"Top Rated Houston, TX Health Care Attorney","detail":"Super Lawyers, 2023-2024"},{"title":"Top Women Attorneys in Texas","detail":"2024"},{"title":"Best Lawyers in America","detail":"Best Lawyers - Texas, 2021 - 2023"},{"title":"Top Ranked Lawyer, Healthcare","detail":"Chambers USA, Texas, 2021-2023"},{"title":"“Sara Brinkmann comes recommended for her expert handling of qui tam actions brought under the False Claims Act.”","detail":"Chambers USA 2022"},{"title":"“Sara offers notable experience in litigation and administrative proceedings.”","detail":"Chambers USA 2022"},{"title":"“Sara Brinkmann possesses significant experience and knowledge on complex issues.”","detail":"Chambers USA 2022"},{"title":"Sara is “organized and approachable, and offers thoughtful approaches on ways to achieve the desired result.”","detail":"Chambers USA 2022"},{"title":"“She is a really sharp lawyer.”","detail":"Chambers USA 2022"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":9607}]},"capability_group_id":2},"created_at":"2026-03-27T19:04:30.000Z","updated_at":"2026-03-27T19:04:30.000Z","searchable_text":"Brinkmann{{ FIELD }}{:title=\u0026gt;\"\\\"She is very calm, organized and responsive.\\\"\", :detail=\u0026gt;\"Chambers USA, 2025\"}{{ FIELD }}{:title=\u0026gt;\"\\\"Sara has a very service-oriented ethos in how she practices.\\\"\", :detail=\u0026gt;\"Chambers USA, 2025\"}{{ FIELD }}{:title=\u0026gt;\"Ranked as a Band 3 lawyer for Healthcare: Government Matters \u0026amp; Regulation\", :detail=\u0026gt;\"Chambers USA, 2025\"}{{ FIELD }}{:title=\u0026gt;\"Ranked as a Key Lawyer for Healthcare: Service Providers\", :detail=\u0026gt;\"Legal 500 USA, 2025\"}{{ FIELD }}{:title=\u0026gt;\"\\\"Sara is very good at keeping larger business outcomes in mind.\\\"\", :detail=\u0026gt;\"Chambers USA 2024\"}{{ FIELD }}{:title=\u0026gt;\"\\\"Sara is intelligent and customer-focused, responsive and competent.\\\"\", :detail=\u0026gt;\"Chambers USA 2024\"}{{ FIELD }}{:title=\u0026gt;\"\\\"Sara is an exceptional attorney who provided outstanding legal analysis.\\\"\", :detail=\u0026gt;\"Chambers USA 2024\"}{{ FIELD }}{:title=\u0026gt;\"Ranked Band 3 for Healthcare in Texas\", :detail=\u0026gt;\"Chambers USA 2024\"}{{ FIELD }}{:title=\u0026gt;\"Women in the Law\", :detail=\u0026gt;\"Best Lawyers, 2022\"}{{ FIELD }}{:title=\u0026gt;\"Top Rated Houston, TX Health Care Attorney\", :detail=\u0026gt;\"Super Lawyers, 2023-2024\"}{{ FIELD }}{:title=\u0026gt;\"Top Women Attorneys in Texas\", :detail=\u0026gt;\"2024\"}{{ FIELD }}{:title=\u0026gt;\"Best Lawyers in America\", :detail=\u0026gt;\"Best Lawyers - Texas, 2021 - 2023\"}{{ FIELD }}{:title=\u0026gt;\"Top Ranked Lawyer, Healthcare\", :detail=\u0026gt;\"Chambers USA, Texas, 2021-2023\"}{{ FIELD }}{:title=\u0026gt;\"“Sara Brinkmann comes recommended for her expert handling of qui tam actions brought under the False Claims Act.”\", :detail=\u0026gt;\"Chambers USA 2022\"}{{ FIELD }}{:title=\u0026gt;\"“Sara offers notable experience in litigation and administrative proceedings.”\", :detail=\u0026gt;\"Chambers USA 2022\"}{{ FIELD }}{:title=\u0026gt;\"“Sara Brinkmann possesses significant experience and knowledge on complex issues.”\", :detail=\u0026gt;\"Chambers USA 2022\"}{{ FIELD }}{:title=\u0026gt;\"Sara is “organized and approachable, and offers thoughtful approaches on ways to achieve the desired result.”\", :detail=\u0026gt;\"Chambers USA 2022\"}{{ FIELD }}{:title=\u0026gt;\"“She is a really sharp lawyer.”\", :detail=\u0026gt;\"Chambers USA 2022\"}{{ FIELD }}Successfully defended a nationwide retail pharmacy client in a False Claims Act case in the Southern District of Texas and on appeal in the Fifth Circuit Court of Appeals involving allegations of regulatory violations related to the dispensing of certain pharmaceuticals, resulting in a full dismissal of the case prior to discovery and was affirmed on appeal at the Fifth Circuit.{{ FIELD }}Successfully defended a hospital system in a False Claims Act case in the Southern District of Texas involving allegations of Stark Law and Anti-Kickback Statute violations related to physician recruitment and compensation arrangements, resulting in a favorable settlement for the client.{{ FIELD }}Successfully defended a hospital system in a False Claims Act case in the Eastern District of Wisconsin involving allegations of Stark Law and Anti-Kickback Statute violations related to physician group compensation, resulting in a favorable settlement for the client.{{ FIELD }}Successfully defended an international medical device company in a False Claims Act case in the District of New Jersey involving allegations of coding errors on claim submissions, resulting in a favorable settlement for the client.{{ FIELD }}Successfully defended nationwide retail pharmacy in a False Claims Act case in the Central District of Illinois involving allegations related to usual and customary pricing, resulting in the Court’s grant of a Motion for Summary Judgment and dismissal of case.{{ FIELD }}Successfully defended several higher education institutions, academic medical centers, and life sciences companies in responding to Civil Investigative Demands and other government investigation, including conducting internal investigations and presenting to the government.{{ FIELD }}Advised several higher education institutions on legal and compliance issues, including developing, implementing, and providing training to employees.{{ FIELD }}Advised hospital systems regarding affiliation agreements and other complex transactions.{{ FIELD }}Advised and provided due diligence support to healthcare companies and hospital systems for mergers and acquisitions.{{ FIELD }}Advised hospital system regarding data privacy and HIPAA compliance issues in responding to third-party subpoenas.{{ FIELD }}Successfully defended a government defense contractor in a False Claims Act case in the Eastern District of Texas involving allegations of kickbacks and failure to comply with certain Federal Acquisition Regulations.{{ FIELD }}Successfully defended a pharmaceutical company in several product liability cases in federal and state courts across the country.{{ FIELD }}Successfully represented hospitals systems and other healthcare providers in Texas federal and state court cases involving allegations of breach of contract, violations of Texas Deceptive Trade Practices Act and Texas Uniform Fraudulent Transfer Act, and health care liability claim cases.{{ FIELD }}Successfully represented a hospital system in responding to Medicare RAC audits, securing full reimbursements for hospital system.{{ FIELD }}Represented a Louisiana hospital system in federal antitrust case.{{ FIELD }}Successfully defended a managed care organization in response to investigation by the Texas Office of Inspector General, resulting in a favorable result for the client.{{ FIELD }}Successfully represented a hospital system in responding to third-party subpoenas successfully securing full reimbursements for hospital systems, including obtaining recovery of attorneys’ fees after prosecuting numerous motions to quash and motions for protection of medical and forensic records in civil, family, and criminal cases.{{ FIELD }}Sara Brinkmann represents healthcare and life sciences clients in investigations and litigation in federal courts, state courts, arbitrations, and administrative proceedings across the country.  Sara has particular expertise in handling matters that arise under the federal False Claims Act and its state law analogues.  Sara also focuses on managed care litigation and has successfully recovered millions of dollars for healthcare providers in disputes against heath plans. \nAn experienced litigator, Sara also represents her clients in disputes involving contracts, business torts, antitrust, and products liability issues. Sara's clients include hospitals, academic medical centers, medical groups, retail pharmacies, medical device companies, pharmaceutical companies, and other life sciences companies.  \nIn additional to her litigation practice, she regularly advises clients on regulatory and compliance matters, including those that involved the Stark Law, the Anti-Kickback Statute, and other fraud and abuse laws. She also provides counseling and training regarding policies, compliance programs, self-disclosures, and billing matters.  \nThrough Chambers USA, her clients have said: \n     \"Sara Brinkmann is an excellent litigator. She is very knowledgeable, highly organized, and a pleasure to work with.\"\n     \"She cares about each of her cases and comes up with creative ideas to problem-solve.\" \n     \"Sara Brinkmann is a fantastic lawyer.\"\nSara is regularly recognized by publications like Chambers, Best Lawyers in America, and Super Lawyers. She is the past Chair of the Health Law Section of the Houston Bar Association. She is also a frequent speaker and presenter on a variety of healthcare topics. Partner \"She is very calm, organized and responsive.\" Chambers USA, 2025 \"Sara has a very service-oriented ethos in how she practices.\" Chambers USA, 2025 Ranked as a Band 3 lawyer for Healthcare: Government Matters \u0026amp; Regulation Chambers USA, 2025 Ranked as a Key Lawyer for Healthcare: Service Providers Legal 500 USA, 2025 \"Sara is very good at keeping larger business outcomes in mind.\" Chambers USA 2024 \"Sara is intelligent and customer-focused, responsive and competent.\" Chambers USA 2024 \"Sara is an exceptional attorney who provided outstanding legal analysis.\" Chambers USA 2024 Ranked Band 3 for Healthcare in Texas Chambers USA 2024 Women in the Law Best Lawyers, 2022 Top Rated Houston, TX Health Care Attorney Super Lawyers, 2023-2024 Top Women Attorneys in Texas 2024 Best Lawyers in America Best Lawyers - Texas, 2021 - 2023 Top Ranked Lawyer, Healthcare Chambers USA, Texas, 2021-2023 “Sara Brinkmann comes recommended for her expert handling of qui tam actions brought under the False Claims Act.” Chambers USA 2022 “Sara offers notable experience in litigation and administrative proceedings.” Chambers USA 2022 “Sara Brinkmann possesses significant experience and knowledge on complex issues.” Chambers USA 2022 Sara is “organized and approachable, and offers thoughtful approaches on ways to achieve the desired result.” Chambers USA 2022 “She is a really sharp lawyer.” Chambers USA 2022 Baylor University Baylor University School of Law University of Houston University of Houston Law Center University of Houston University of Houston Law Center Texas Houston Bar Association, Member (Health Law Section, Chair 2021-2022; Campaign for the Homeless Committee, Former Member; Law Week Committee, Former Member) Federal Bar Association, Member State Bar of Texas, Member Texas Bar Foundation, Fellow Defense Research Institute, Member Greater Houston Society for Healthcare Risk Management Law Clerk, Hon. David Hittner, Texas Successfully defended a nationwide retail pharmacy client in a False Claims Act case in the Southern District of Texas and on appeal in the Fifth Circuit Court of Appeals involving allegations of regulatory violations related to the dispensing of certain pharmaceuticals, resulting in a full dismissal of the case prior to discovery and was affirmed on appeal at the Fifth Circuit. Successfully defended a hospital system in a False Claims Act case in the Southern District of Texas involving allegations of Stark Law and Anti-Kickback Statute violations related to physician recruitment and compensation arrangements, resulting in a favorable settlement for the client. Successfully defended a hospital system in a False Claims Act case in the Eastern District of Wisconsin involving allegations of Stark Law and Anti-Kickback Statute violations related to physician group compensation, resulting in a favorable settlement for the client. Successfully defended an international medical device company in a False Claims Act case in the District of New Jersey involving allegations of coding errors on claim submissions, resulting in a favorable settlement for the client. Successfully defended nationwide retail pharmacy in a False Claims Act case in the Central District of Illinois involving allegations related to usual and customary pricing, resulting in the Court’s grant of a Motion for Summary Judgment and dismissal of case. Successfully defended several higher education institutions, academic medical centers, and life sciences companies in responding to Civil Investigative Demands and other government investigation, including conducting internal investigations and presenting to the government. Advised several higher education institutions on legal and compliance issues, including developing, implementing, and providing training to employees. Advised hospital systems regarding affiliation agreements and other complex transactions. Advised and provided due diligence support to healthcare companies and hospital systems for mergers and acquisitions. Advised hospital system regarding data privacy and HIPAA compliance issues in responding to third-party subpoenas. Successfully defended a government defense contractor in a False Claims Act case in the Eastern District of Texas involving allegations of kickbacks and failure to comply with certain Federal Acquisition Regulations. Successfully defended a pharmaceutical company in several product liability cases in federal and state courts across the country. Successfully represented hospitals systems and other healthcare providers in Texas federal and state court cases involving allegations of breach of contract, violations of Texas Deceptive Trade Practices Act and Texas Uniform Fraudulent Transfer Act, and health care liability claim cases. Successfully represented a hospital system in responding to Medicare RAC audits, securing full reimbursements for hospital system. Represented a Louisiana hospital system in federal antitrust case. Successfully defended a managed care organization in response to investigation by the Texas Office of Inspector General, resulting in a favorable result for the client. Successfully represented a hospital system in responding to third-party subpoenas successfully securing full reimbursements for hospital systems, including obtaining recovery of attorneys’ fees after prosecuting numerous motions to quash and motions for protection of medical and forensic records in civil, family, and criminal cases.","searchable_name":"Sara Brinkmann","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":442372,"version":1,"owner_type":"Person","owner_id":883,"payload":{"bio":"\u003cp\u003eMark Brown is nationally recognized in Food \u0026amp; Drug Administration regulatory matters, civil litigation, criminal investigations and prosecutions, compliance matters and comprehensive risk assessments. Mark advises pharmaceutical, medical device and biotech companies, and pharmacies, on a broad range of FDA requirements and FDA regulatory issues that arise in products liability litigation and other disputes. A former Associate Chief Counsel for FDA, Mark is the Chair of the FDA and Life Sciences practice.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eMark has developed a national reputation for successfully resolving difficult and complex FDA compliance matters and enforcement actions. For pharmaceutical, medical device and food companies, and pharmacies, he has successfully negotiated and managed numerous complex consent decrees of injunction, successfully defended an injunction action brought by FDA, and persuaded the government not to bring enforcement actions in other civil and criminal matters.\u003c/p\u003e\n\u003cp\u003eMark regularly counsels clients on drug safety issues, clinical trials, adverse event reporting, quality systems and manufacturing practices for drugs and devices. He also provides guidance concerning product failure investigations, factory inspections, recalls, product labeling, drug compounding, advertising, promotion, sales and marketing practices, and regularly advises clients on strategies for obtaining FDA approval and clearance for medical products.\u003c/p\u003e\n\u003cp\u003eMark also handles FDA-related issues in product liability and commercial litigation. He was an architect of the preemption defense for both pharmaceutical and medical device clients, developing supporting evidence, briefing and arguing federal preemption motions in various federal and state courts.\u003c/p\u003e\n\u003cp\u003eBefore joining the FDA, Mark was an attorney in the Bureau of Consumer Protection at the Federal Trade Commission, where he concentrated on consumer fraud, healthcare advertising and promotional activities. He developed FTC enforcement actions against weight-loss centers, in vitro fertilization clinics and Northern Virginia infertility doctor Cecil B. Jacobson, who was later convicted of defrauding patients.\u003c/p\u003e","slug":"mark-brown","email":"mbrown@kslaw.com","phone":null,"matters":["\u003cp\u003e\u003cem data-redactor-tag=\"em\"\u003e\u003cstrong data-redactor-tag=\"strong\"\u003ePhillip Morris USA\u003c/strong\u003e v. FDA\u003c/em\u003e, 202 F.Supp. 3d (D.D.C. 2016). Represented one of the plaintiffs in a successful legal challenge to an FDA guidance governing the Substantial Equivalence Review process for tobacco products.\u003c/p\u003e","\u003cp\u003e\u003cem data-redactor-tag=\"em\"\u003eUnited States v. \u003cstrong data-redactor-tag=\"strong\"\u003eFranck's Lab\u003c/strong\u003e\u003c/em\u003e\u003cstrong data-redactor-tag=\"strong\"\u003e,\u003c/strong\u003e 2011 WL 4031102 (M.D. Fla., Sept. 12, 2011). Lead counsel in successful defense of FDA enforcement action against pharmacy compounder of veterinary drugs.\u003c/p\u003e","\u003cp\u003eDuring his 30-year career, he has served as lead counsel and negotiator for numerous consent decrees of injunction, both during his tenure with FDA (1990\u0026ndash;1994), and since 1994 in private practice. For example, he has negotiated consent decrees some of the world's largest device manufacturers, including \u003cstrong data-redactor-tag=\"strong\"\u003eMedtronic\u003c/strong\u003e (2008 and 2015), \u003cstrong data-redactor-tag=\"strong\"\u003eThe General Electric Company\u003c/strong\u003e (2007) and \u003cstrong data-redactor-tag=\"strong\"\u003eBaxter Healthcare\u003c/strong\u003e (2006).\u003c/p\u003e","\u003cp\u003eSince 2002, served on the national counsel team for \u003cstrong data-redactor-tag=\"strong\"\u003eGlaxoSmithKline\u003c/strong\u003e in the Paxil Products Liability Litigation. Represented GSK on all FDA-related issues, including federal preemption. Argued and won a summary judgment motion on federal preemption grounds in \u003cem data-redactor-tag=\"em\"\u003eO'Neal v. \u003cstrong data-redactor-tag=\"strong\"\u003eSmithKline Beecham\u003c/strong\u003e\u003c/em\u003e (E.D. Cal 2008). In 2002, represented GSK in successfully defending an injunction seeking to enjoin GSK from making claims in direct-to-consumer television advertising for Paxil.\u003c/p\u003e","\u003cp\u003eFrom 1995 to 2001, served on \u003cstrong data-redactor-tag=\"strong\"\u003e3M\u003c/strong\u003e's National Trial Team in the Silicone Gel-Filled Breast Implant Litigation. Responsible for virtually all FDA issues and had primary responsibility for preparation and handling of defense expert witnesses, and cross-examination of adverse witnesses on FDA issues.\u003c/p\u003e","\u003cp\u003e\u003cem data-redactor-tag=\"em\"\u003eConnaught Laboratories v. \u003cstrong data-redactor-tag=\"strong\"\u003eSmithKline Beecham\u003c/strong\u003e\u003c/em\u003e\u003cstrong data-redactor-tag=\"strong\"\u003e,\u003c/strong\u003e 7 F.Supp. 2d 477 (D.Del. 1998), appeal dismissed, 165 F.3d 1368 (1999). Represented SmithKline Beecham in winning one of the few successful motions to compel FDA to provide testimony by its research scientists in patent litigation relating to purified form of pertactin, a component of the pertussis vaccine.\u003c/p\u003e","\u003cp\u003e\u003cem data-redactor-tag=\"em\"\u003e\u003cstrong data-redactor-tag=\"strong\"\u003eNext Nutrition\u003c/strong\u003e\u003cstrong data-redactor-tag=\"strong\"\u003e, Inc.\u003c/strong\u003e\u003c/em\u003e \u003cem data-redactor-tag=\"em\"\u003ev. SportPharma USA, Inc.\u003c/em\u003e, No. 97-CV-1898J (1997). Served as lead counsel to a dietary supplement company that brought an action under the Lanham Act alleging false and misleading comparative advertising relating to competing products. Successfully negotiated a favorable settlement by obtaining a consent decree of permanent injunction and a damage award.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical manufacturers\u003c/strong\u003e in grand jury investigations regarding data integrity concerns in regulatory submissions to FDA, and alleged cGMP violations. In both cases, the U.S. Department of Justice declined to prosecute the company and individuals under investigation.\u003c/p\u003e","\u003cp\u003eConducted internal investigations into the sales and marketing practices of \u003cstrong data-redactor-tag=\"strong\"\u003emultiple international pharmaceutical and biotech companies\u003c/strong\u003e to develop a risk profile and recommendations for reducing potential liability and risk exposure.\u003c/p\u003e","\u003cp\u003eConducted comprehensive prelaunch risk assessments for \u003cstrong data-redactor-tag=\"strong\"\u003ea Top 10 pharmaceutical company\u003c/strong\u003e\u003cstrong data-redactor-tag=\"strong\"\u003e\u0026rsquo;s\u003c/strong\u003e blockbuster drug to identify potential medical, scientific, regulatory and products liability risk areas.\u003c/p\u003e","\u003cp\u003eConducted a risk assessment for \u003cstrong data-redactor-tag=\"strong\"\u003ea top tier biotechnology company\u0026rsquo;s\u003c/strong\u003e drug safety system to identify areas for possible improvement in pharmacovigilence planning, postmarket signal detection and investigation, and business decision-making.\u003c/p\u003e","\u003cp\u003eLed numerous internal investigations for \u003cstrong data-redactor-tag=\"strong\"\u003ebiotechnology, pharmaceutical and medical device manufacturers\u003c/strong\u003e into allegations made by current and former employees regarding product integrity issues, sales and marketing activities, and manufacturing quality issues.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003eseveral drug and device manufacturers\u003c/strong\u003e concerning product approvals, and in responding to FDA requests for information relating to promotion and advertising, manufacturing practices, field alerts, recalls and numerous post-market issues.\u003c/p\u003e","\u003cp\u003eRepresented one of the nation\u0026rsquo;s foremost cardiovascular institutes and some of the leading interventional cardiologists in responding to deficiencies identified during FDA inspections and developing appropriate corrective action to avoid further FDA regulatory enforcement.\u003c/p\u003e","\u003cp\u003eRepresented a device manufacturer in obtaining expedited PMA review and approval in 90 days for a first-of-a-kind device to treat aneurysms in the renal vascular arteries. Successfully obtained approval for a major PMA supplement for the same product.\u003c/p\u003e","\u003cp\u003eRepresented a device manufacturer and coordinated an extensive product investigation into reported failures of an implantable device featuring sophisticated failure analyses and clinical assessments.\u003c/p\u003e","\u003cp\u003eConducted extensive training on FDA regulatory, IRB and protocol requirements for clinical investigators participating in the study of implantable devices.\u003c/p\u003e","\u003cp\u003eAssisted numerous companies in preparing for FDA inspections, developing responses to FDA observations (FDA-483 forms) and warning letters related to manufacturing practices, quality systems, adverse event reporting, deviations from approved drug master files and manufacturing processes, and a variety of other regulatory matters. Assisted these companies in preparing for meetings with FDA compliance officials in District Offices, centers for drugs and devices, and the Office of Chief Counsel.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":51}]},"expertise":[{"id":21,"guid":"21.capabilities","index":0,"source":"capabilities"},{"id":11,"guid":"11.capabilities","index":1,"source":"capabilities"},{"id":2,"guid":"2.capabilities","index":2,"source":"capabilities"},{"id":106,"guid":"106.capabilities","index":3,"source":"capabilities"},{"id":3,"guid":"3.capabilities","index":4,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":5,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":6,"source":"capabilities"},{"id":17,"guid":"17.capabilities","index":7,"source":"capabilities"},{"id":80,"guid":"80.capabilities","index":8,"source":"capabilities"},{"id":122,"guid":"122.capabilities","index":9,"source":"capabilities"},{"id":1303,"guid":"1303.smart_tags","index":10,"source":"smartTags"},{"id":970,"guid":"970.smart_tags","index":11,"source":"smartTags"},{"id":114,"guid":"114.capabilities","index":12,"source":"capabilities"}],"is_active":true,"last_name":"Brown","nick_name":"Mark","clerkships":[],"first_name":"Mark","title_rank":9999,"updated_by":196,"law_schools":[],"middle_name":"S.","name_suffix":"","recognitions":[{"title":"Recognized by Super Lawyers as Top Rated FDA Attorney ","detail":"Law \u0026 Politics, 2007, 2010–2011, 2013–2017"},{"title":"Ranked Among the Best Life Sciences Lawyers in the U.S. ","detail":"Legal 500, 2016"},{"title":"Named Life Sciences Star ","detail":"LMG Life Sciences, 2012–2016"},{"title":"Recognized as one of Washington’s Best Lawyers ","detail":"Washingtonian magazine, 2004–2016"},{"title":"Superior Achievement Award ","detail":"U.S. Department of Health \u0026 Human Services, 1992"},{"title":"Commendable Service Award ","detail":"FDA, 1992–1994"}],"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eMark Brown is nationally recognized in Food \u0026amp; Drug Administration regulatory matters, civil litigation, criminal investigations and prosecutions, compliance matters and comprehensive risk assessments. Mark advises pharmaceutical, medical device and biotech companies, and pharmacies, on a broad range of FDA requirements and FDA regulatory issues that arise in products liability litigation and other disputes. A former Associate Chief Counsel for FDA, Mark is the Chair of the FDA and Life Sciences practice.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eMark has developed a national reputation for successfully resolving difficult and complex FDA compliance matters and enforcement actions. For pharmaceutical, medical device and food companies, and pharmacies, he has successfully negotiated and managed numerous complex consent decrees of injunction, successfully defended an injunction action brought by FDA, and persuaded the government not to bring enforcement actions in other civil and criminal matters.\u003c/p\u003e\n\u003cp\u003eMark regularly counsels clients on drug safety issues, clinical trials, adverse event reporting, quality systems and manufacturing practices for drugs and devices. He also provides guidance concerning product failure investigations, factory inspections, recalls, product labeling, drug compounding, advertising, promotion, sales and marketing practices, and regularly advises clients on strategies for obtaining FDA approval and clearance for medical products.\u003c/p\u003e\n\u003cp\u003eMark also handles FDA-related issues in product liability and commercial litigation. He was an architect of the preemption defense for both pharmaceutical and medical device clients, developing supporting evidence, briefing and arguing federal preemption motions in various federal and state courts.\u003c/p\u003e\n\u003cp\u003eBefore joining the FDA, Mark was an attorney in the Bureau of Consumer Protection at the Federal Trade Commission, where he concentrated on consumer fraud, healthcare advertising and promotional activities. He developed FTC enforcement actions against weight-loss centers, in vitro fertilization clinics and Northern Virginia infertility doctor Cecil B. Jacobson, who was later convicted of defrauding patients.\u003c/p\u003e","matters":["\u003cp\u003e\u003cem data-redactor-tag=\"em\"\u003e\u003cstrong data-redactor-tag=\"strong\"\u003ePhillip Morris USA\u003c/strong\u003e v. FDA\u003c/em\u003e, 202 F.Supp. 3d (D.D.C. 2016). Represented one of the plaintiffs in a successful legal challenge to an FDA guidance governing the Substantial Equivalence Review process for tobacco products.\u003c/p\u003e","\u003cp\u003e\u003cem data-redactor-tag=\"em\"\u003eUnited States v. \u003cstrong data-redactor-tag=\"strong\"\u003eFranck's Lab\u003c/strong\u003e\u003c/em\u003e\u003cstrong data-redactor-tag=\"strong\"\u003e,\u003c/strong\u003e 2011 WL 4031102 (M.D. Fla., Sept. 12, 2011). Lead counsel in successful defense of FDA enforcement action against pharmacy compounder of veterinary drugs.\u003c/p\u003e","\u003cp\u003eDuring his 30-year career, he has served as lead counsel and negotiator for numerous consent decrees of injunction, both during his tenure with FDA (1990\u0026ndash;1994), and since 1994 in private practice. For example, he has negotiated consent decrees some of the world's largest device manufacturers, including \u003cstrong data-redactor-tag=\"strong\"\u003eMedtronic\u003c/strong\u003e (2008 and 2015), \u003cstrong data-redactor-tag=\"strong\"\u003eThe General Electric Company\u003c/strong\u003e (2007) and \u003cstrong data-redactor-tag=\"strong\"\u003eBaxter Healthcare\u003c/strong\u003e (2006).\u003c/p\u003e","\u003cp\u003eSince 2002, served on the national counsel team for \u003cstrong data-redactor-tag=\"strong\"\u003eGlaxoSmithKline\u003c/strong\u003e in the Paxil Products Liability Litigation. Represented GSK on all FDA-related issues, including federal preemption. Argued and won a summary judgment motion on federal preemption grounds in \u003cem data-redactor-tag=\"em\"\u003eO'Neal v. \u003cstrong data-redactor-tag=\"strong\"\u003eSmithKline Beecham\u003c/strong\u003e\u003c/em\u003e (E.D. Cal 2008). In 2002, represented GSK in successfully defending an injunction seeking to enjoin GSK from making claims in direct-to-consumer television advertising for Paxil.\u003c/p\u003e","\u003cp\u003eFrom 1995 to 2001, served on \u003cstrong data-redactor-tag=\"strong\"\u003e3M\u003c/strong\u003e's National Trial Team in the Silicone Gel-Filled Breast Implant Litigation. Responsible for virtually all FDA issues and had primary responsibility for preparation and handling of defense expert witnesses, and cross-examination of adverse witnesses on FDA issues.\u003c/p\u003e","\u003cp\u003e\u003cem data-redactor-tag=\"em\"\u003eConnaught Laboratories v. \u003cstrong data-redactor-tag=\"strong\"\u003eSmithKline Beecham\u003c/strong\u003e\u003c/em\u003e\u003cstrong data-redactor-tag=\"strong\"\u003e,\u003c/strong\u003e 7 F.Supp. 2d 477 (D.Del. 1998), appeal dismissed, 165 F.3d 1368 (1999). Represented SmithKline Beecham in winning one of the few successful motions to compel FDA to provide testimony by its research scientists in patent litigation relating to purified form of pertactin, a component of the pertussis vaccine.\u003c/p\u003e","\u003cp\u003e\u003cem data-redactor-tag=\"em\"\u003e\u003cstrong data-redactor-tag=\"strong\"\u003eNext Nutrition\u003c/strong\u003e\u003cstrong data-redactor-tag=\"strong\"\u003e, Inc.\u003c/strong\u003e\u003c/em\u003e \u003cem data-redactor-tag=\"em\"\u003ev. SportPharma USA, Inc.\u003c/em\u003e, No. 97-CV-1898J (1997). Served as lead counsel to a dietary supplement company that brought an action under the Lanham Act alleging false and misleading comparative advertising relating to competing products. Successfully negotiated a favorable settlement by obtaining a consent decree of permanent injunction and a damage award.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical manufacturers\u003c/strong\u003e in grand jury investigations regarding data integrity concerns in regulatory submissions to FDA, and alleged cGMP violations. In both cases, the U.S. Department of Justice declined to prosecute the company and individuals under investigation.\u003c/p\u003e","\u003cp\u003eConducted internal investigations into the sales and marketing practices of \u003cstrong data-redactor-tag=\"strong\"\u003emultiple international pharmaceutical and biotech companies\u003c/strong\u003e to develop a risk profile and recommendations for reducing potential liability and risk exposure.\u003c/p\u003e","\u003cp\u003eConducted comprehensive prelaunch risk assessments for \u003cstrong data-redactor-tag=\"strong\"\u003ea Top 10 pharmaceutical company\u003c/strong\u003e\u003cstrong data-redactor-tag=\"strong\"\u003e\u0026rsquo;s\u003c/strong\u003e blockbuster drug to identify potential medical, scientific, regulatory and products liability risk areas.\u003c/p\u003e","\u003cp\u003eConducted a risk assessment for \u003cstrong data-redactor-tag=\"strong\"\u003ea top tier biotechnology company\u0026rsquo;s\u003c/strong\u003e drug safety system to identify areas for possible improvement in pharmacovigilence planning, postmarket signal detection and investigation, and business decision-making.\u003c/p\u003e","\u003cp\u003eLed numerous internal investigations for \u003cstrong data-redactor-tag=\"strong\"\u003ebiotechnology, pharmaceutical and medical device manufacturers\u003c/strong\u003e into allegations made by current and former employees regarding product integrity issues, sales and marketing activities, and manufacturing quality issues.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003eseveral drug and device manufacturers\u003c/strong\u003e concerning product approvals, and in responding to FDA requests for information relating to promotion and advertising, manufacturing practices, field alerts, recalls and numerous post-market issues.\u003c/p\u003e","\u003cp\u003eRepresented one of the nation\u0026rsquo;s foremost cardiovascular institutes and some of the leading interventional cardiologists in responding to deficiencies identified during FDA inspections and developing appropriate corrective action to avoid further FDA regulatory enforcement.\u003c/p\u003e","\u003cp\u003eRepresented a device manufacturer in obtaining expedited PMA review and approval in 90 days for a first-of-a-kind device to treat aneurysms in the renal vascular arteries. Successfully obtained approval for a major PMA supplement for the same product.\u003c/p\u003e","\u003cp\u003eRepresented a device manufacturer and coordinated an extensive product investigation into reported failures of an implantable device featuring sophisticated failure analyses and clinical assessments.\u003c/p\u003e","\u003cp\u003eConducted extensive training on FDA regulatory, IRB and protocol requirements for clinical investigators participating in the study of implantable devices.\u003c/p\u003e","\u003cp\u003eAssisted numerous companies in preparing for FDA inspections, developing responses to FDA observations (FDA-483 forms) and warning letters related to manufacturing practices, quality systems, adverse event reporting, deviations from approved drug master files and manufacturing processes, and a variety of other regulatory matters. Assisted these companies in preparing for meetings with FDA compliance officials in District Offices, centers for drugs and devices, and the Office of Chief Counsel.\u003c/p\u003e"],"recognitions":[{"title":"Recognized by Super Lawyers as Top Rated FDA Attorney ","detail":"Law \u0026 Politics, 2007, 2010–2011, 2013–2017"},{"title":"Ranked Among the Best Life Sciences Lawyers in the U.S. ","detail":"Legal 500, 2016"},{"title":"Named Life Sciences Star ","detail":"LMG Life Sciences, 2012–2016"},{"title":"Recognized as one of Washington’s Best Lawyers ","detail":"Washingtonian magazine, 2004–2016"},{"title":"Superior Achievement Award ","detail":"U.S. Department of Health \u0026 Human Services, 1992"},{"title":"Commendable Service Award ","detail":"FDA, 1992–1994"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":746}]},"capability_group_id":2},"created_at":"2025-11-05T05:03:44.000Z","updated_at":"2025-11-05T05:03:44.000Z","searchable_text":"Brown{{ FIELD }}{:title=\u0026gt;\"Recognized by Super Lawyers as Top Rated FDA Attorney \", :detail=\u0026gt;\"Law \u0026amp; Politics, 2007, 2010–2011, 2013–2017\"}{{ FIELD }}{:title=\u0026gt;\"Ranked Among the Best Life Sciences Lawyers in the U.S. \", :detail=\u0026gt;\"Legal 500, 2016\"}{{ FIELD }}{:title=\u0026gt;\"Named Life Sciences Star \", :detail=\u0026gt;\"LMG Life Sciences, 2012–2016\"}{{ FIELD }}{:title=\u0026gt;\"Recognized as one of Washington’s Best Lawyers \", :detail=\u0026gt;\"Washingtonian magazine, 2004–2016\"}{{ FIELD }}{:title=\u0026gt;\"Superior Achievement Award \", :detail=\u0026gt;\"U.S. Department of Health \u0026amp; Human Services, 1992\"}{{ FIELD }}{:title=\u0026gt;\"Commendable Service Award \", :detail=\u0026gt;\"FDA, 1992–1994\"}{{ FIELD }}Phillip Morris USA v. FDA, 202 F.Supp. 3d (D.D.C. 2016). Represented one of the plaintiffs in a successful legal challenge to an FDA guidance governing the Substantial Equivalence Review process for tobacco products.{{ FIELD }}United States v. Franck's Lab, 2011 WL 4031102 (M.D. Fla., Sept. 12, 2011). Lead counsel in successful defense of FDA enforcement action against pharmacy compounder of veterinary drugs.{{ FIELD }}During his 30-year career, he has served as lead counsel and negotiator for numerous consent decrees of injunction, both during his tenure with FDA (1990–1994), and since 1994 in private practice. For example, he has negotiated consent decrees some of the world's largest device manufacturers, including Medtronic (2008 and 2015), The General Electric Company (2007) and Baxter Healthcare (2006).{{ FIELD }}Since 2002, served on the national counsel team for GlaxoSmithKline in the Paxil Products Liability Litigation. Represented GSK on all FDA-related issues, including federal preemption. Argued and won a summary judgment motion on federal preemption grounds in O'Neal v. SmithKline Beecham (E.D. Cal 2008). In 2002, represented GSK in successfully defending an injunction seeking to enjoin GSK from making claims in direct-to-consumer television advertising for Paxil.{{ FIELD }}From 1995 to 2001, served on 3M's National Trial Team in the Silicone Gel-Filled Breast Implant Litigation. Responsible for virtually all FDA issues and had primary responsibility for preparation and handling of defense expert witnesses, and cross-examination of adverse witnesses on FDA issues.{{ FIELD }}Connaught Laboratories v. SmithKline Beecham, 7 F.Supp. 2d 477 (D.Del. 1998), appeal dismissed, 165 F.3d 1368 (1999). Represented SmithKline Beecham in winning one of the few successful motions to compel FDA to provide testimony by its research scientists in patent litigation relating to purified form of pertactin, a component of the pertussis vaccine.{{ FIELD }}Next Nutrition, Inc. v. SportPharma USA, Inc., No. 97-CV-1898J (1997). Served as lead counsel to a dietary supplement company that brought an action under the Lanham Act alleging false and misleading comparative advertising relating to competing products. Successfully negotiated a favorable settlement by obtaining a consent decree of permanent injunction and a damage award.{{ FIELD }}Represented pharmaceutical manufacturers in grand jury investigations regarding data integrity concerns in regulatory submissions to FDA, and alleged cGMP violations. In both cases, the U.S. Department of Justice declined to prosecute the company and individuals under investigation.{{ FIELD }}Conducted internal investigations into the sales and marketing practices of multiple international pharmaceutical and biotech companies to develop a risk profile and recommendations for reducing potential liability and risk exposure.{{ FIELD }}Conducted comprehensive prelaunch risk assessments for a Top 10 pharmaceutical company’s blockbuster drug to identify potential medical, scientific, regulatory and products liability risk areas.{{ FIELD }}Conducted a risk assessment for a top tier biotechnology company’s drug safety system to identify areas for possible improvement in pharmacovigilence planning, postmarket signal detection and investigation, and business decision-making.{{ FIELD }}Led numerous internal investigations for biotechnology, pharmaceutical and medical device manufacturers into allegations made by current and former employees regarding product integrity issues, sales and marketing activities, and manufacturing quality issues.{{ FIELD }}Represented several drug and device manufacturers concerning product approvals, and in responding to FDA requests for information relating to promotion and advertising, manufacturing practices, field alerts, recalls and numerous post-market issues.{{ FIELD }}Represented one of the nation’s foremost cardiovascular institutes and some of the leading interventional cardiologists in responding to deficiencies identified during FDA inspections and developing appropriate corrective action to avoid further FDA regulatory enforcement.{{ FIELD }}Represented a device manufacturer in obtaining expedited PMA review and approval in 90 days for a first-of-a-kind device to treat aneurysms in the renal vascular arteries. Successfully obtained approval for a major PMA supplement for the same product.{{ FIELD }}Represented a device manufacturer and coordinated an extensive product investigation into reported failures of an implantable device featuring sophisticated failure analyses and clinical assessments.{{ FIELD }}Conducted extensive training on FDA regulatory, IRB and protocol requirements for clinical investigators participating in the study of implantable devices.{{ FIELD }}Assisted numerous companies in preparing for FDA inspections, developing responses to FDA observations (FDA-483 forms) and warning letters related to manufacturing practices, quality systems, adverse event reporting, deviations from approved drug master files and manufacturing processes, and a variety of other regulatory matters. Assisted these companies in preparing for meetings with FDA compliance officials in District Offices, centers for drugs and devices, and the Office of Chief Counsel.{{ FIELD }}Mark Brown is nationally recognized in Food \u0026amp; Drug Administration regulatory matters, civil litigation, criminal investigations and prosecutions, compliance matters and comprehensive risk assessments. Mark advises pharmaceutical, medical device and biotech companies, and pharmacies, on a broad range of FDA requirements and FDA regulatory issues that arise in products liability litigation and other disputes. A former Associate Chief Counsel for FDA, Mark is the Chair of the FDA and Life Sciences practice.\nMark has developed a national reputation for successfully resolving difficult and complex FDA compliance matters and enforcement actions. For pharmaceutical, medical device and food companies, and pharmacies, he has successfully negotiated and managed numerous complex consent decrees of injunction, successfully defended an injunction action brought by FDA, and persuaded the government not to bring enforcement actions in other civil and criminal matters.\nMark regularly counsels clients on drug safety issues, clinical trials, adverse event reporting, quality systems and manufacturing practices for drugs and devices. He also provides guidance concerning product failure investigations, factory inspections, recalls, product labeling, drug compounding, advertising, promotion, sales and marketing practices, and regularly advises clients on strategies for obtaining FDA approval and clearance for medical products.\nMark also handles FDA-related issues in product liability and commercial litigation. He was an architect of the preemption defense for both pharmaceutical and medical device clients, developing supporting evidence, briefing and arguing federal preemption motions in various federal and state courts.\nBefore joining the FDA, Mark was an attorney in the Bureau of Consumer Protection at the Federal Trade Commission, where he concentrated on consumer fraud, healthcare advertising and promotional activities. He developed FTC enforcement actions against weight-loss centers, in vitro fertilization clinics and Northern Virginia infertility doctor Cecil B. Jacobson, who was later convicted of defrauding patients. Mark S Brown Partner Recognized by Super Lawyers as Top Rated FDA Attorney  Law \u0026amp; Politics, 2007, 2010–2011, 2013–2017 Ranked Among the Best Life Sciences Lawyers in the U.S.  Legal 500, 2016 Named Life Sciences Star  LMG Life Sciences, 2012–2016 Recognized as one of Washington’s Best Lawyers  Washingtonian magazine, 2004–2016 Superior Achievement Award  U.S. Department of Health \u0026amp; Human Services, 1992 Commendable Service Award  FDA, 1992–1994 University of Michigan University of Michigan Law School St. Louis University  U.S. Court of Appeals for the Federal Circuit U.S. Court of Appeals for the Second Circuit U.S. Court of Appeals for the Seventh Circuit U.S. Court of Appeals for the Ninth Circuit U.S. Court of Appeals for the Tenth Circuit U.S. District Court for the District of Maryland U.S. District Court for the Eastern District of Wisconsin District of Columbia Maryland Pennsylvania District of Columbia Bar Maryland State Bar Phillip Morris USA v. FDA, 202 F.Supp. 3d (D.D.C. 2016). Represented one of the plaintiffs in a successful legal challenge to an FDA guidance governing the Substantial Equivalence Review process for tobacco products. United States v. Franck's Lab, 2011 WL 4031102 (M.D. Fla., Sept. 12, 2011). Lead counsel in successful defense of FDA enforcement action against pharmacy compounder of veterinary drugs. During his 30-year career, he has served as lead counsel and negotiator for numerous consent decrees of injunction, both during his tenure with FDA (1990–1994), and since 1994 in private practice. For example, he has negotiated consent decrees some of the world's largest device manufacturers, including Medtronic (2008 and 2015), The General Electric Company (2007) and Baxter Healthcare (2006). Since 2002, served on the national counsel team for GlaxoSmithKline in the Paxil Products Liability Litigation. Represented GSK on all FDA-related issues, including federal preemption. Argued and won a summary judgment motion on federal preemption grounds in O'Neal v. SmithKline Beecham (E.D. Cal 2008). In 2002, represented GSK in successfully defending an injunction seeking to enjoin GSK from making claims in direct-to-consumer television advertising for Paxil. From 1995 to 2001, served on 3M's National Trial Team in the Silicone Gel-Filled Breast Implant Litigation. Responsible for virtually all FDA issues and had primary responsibility for preparation and handling of defense expert witnesses, and cross-examination of adverse witnesses on FDA issues. Connaught Laboratories v. SmithKline Beecham, 7 F.Supp. 2d 477 (D.Del. 1998), appeal dismissed, 165 F.3d 1368 (1999). Represented SmithKline Beecham in winning one of the few successful motions to compel FDA to provide testimony by its research scientists in patent litigation relating to purified form of pertactin, a component of the pertussis vaccine. Next Nutrition, Inc. v. SportPharma USA, Inc., No. 97-CV-1898J (1997). Served as lead counsel to a dietary supplement company that brought an action under the Lanham Act alleging false and misleading comparative advertising relating to competing products. Successfully negotiated a favorable settlement by obtaining a consent decree of permanent injunction and a damage award. Represented pharmaceutical manufacturers in grand jury investigations regarding data integrity concerns in regulatory submissions to FDA, and alleged cGMP violations. In both cases, the U.S. Department of Justice declined to prosecute the company and individuals under investigation. Conducted internal investigations into the sales and marketing practices of multiple international pharmaceutical and biotech companies to develop a risk profile and recommendations for reducing potential liability and risk exposure. Conducted comprehensive prelaunch risk assessments for a Top 10 pharmaceutical company’s blockbuster drug to identify potential medical, scientific, regulatory and products liability risk areas. Conducted a risk assessment for a top tier biotechnology company’s drug safety system to identify areas for possible improvement in pharmacovigilence planning, postmarket signal detection and investigation, and business decision-making. Led numerous internal investigations for biotechnology, pharmaceutical and medical device manufacturers into allegations made by current and former employees regarding product integrity issues, sales and marketing activities, and manufacturing quality issues. Represented several drug and device manufacturers concerning product approvals, and in responding to FDA requests for information relating to promotion and advertising, manufacturing practices, field alerts, recalls and numerous post-market issues. Represented one of the nation’s foremost cardiovascular institutes and some of the leading interventional cardiologists in responding to deficiencies identified during FDA inspections and developing appropriate corrective action to avoid further FDA regulatory enforcement. Represented a device manufacturer in obtaining expedited PMA review and approval in 90 days for a first-of-a-kind device to treat aneurysms in the renal vascular arteries. Successfully obtained approval for a major PMA supplement for the same product. Represented a device manufacturer and coordinated an extensive product investigation into reported failures of an implantable device featuring sophisticated failure analyses and clinical assessments. Conducted extensive training on FDA regulatory, IRB and protocol requirements for clinical investigators participating in the study of implantable devices. Assisted numerous companies in preparing for FDA inspections, developing responses to FDA observations (FDA-483 forms) and warning letters related to manufacturing practices, quality systems, adverse event reporting, deviations from approved drug master files and manufacturing processes, and a variety of other regulatory matters. Assisted these companies in preparing for meetings with FDA compliance officials in District Offices, centers for drugs and devices, and the Office of Chief Counsel.","searchable_name":"Mark S. Brown","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":196,"capability_group_featured":null,"home_page_featured":null},{"id":427549,"version":1,"owner_type":"Person","owner_id":613,"payload":{"bio":"\u003cp\u003eChris Burris focuses on white-collar criminal defense, corporate internal investigations, regulatory enforcement action defense and complex litigation. As a partner in our Special Matters and Government Investigations practice, Chris defends corporations and individuals in a variety of criminal, regulatory, False Claims Act and other matters.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAs a defense lawyer, Chris represents leading corporations and individuals in criminal and regulatory enforcement matters. He has particular experience with defending clients in False Claims Act/\u003cem\u003equi tam\u003c/em\u003e\u0026nbsp;matters, handling dozens of cases concerning a variety of issues.\u003c/p\u003e\n\u003cp\u003eIn addition, Chris counsels clients in matters concerning privacy, information security and related issues. He also conducts internal investigations on behalf of management, boards of directors and audit committees.\u003c/p\u003e\n\u003cp\u003ePreviously, Chris served on active duty in the U.S. Navy Judge Advocate General\u0026rsquo;s Corps for nearly six years, where he gained broad experience in trial prosecution and defense, appeals and internal investigations. As a Commander in the Naval Reserves, he currently serves as the Executive Officer of the Navy Reserve unit overseeing issues involving international and operational law, admiralty and maritime law, environmental law, and information operations and intelligence law.\u003c/p\u003e","slug":"christopher-burris","email":"cburris@kslaw.com","phone":null,"matters":["\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea major international financial institution\u003c/strong\u003e in the internal investigation and self-disclosure of accusations of employee participation in an alleged Ponzi scheme.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea large publicly traded manufacturing company\u003c/strong\u003e in the internal investigation and self-disclosure of potential Bank Secrecy Act violations.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ean elected state official\u003c/strong\u003e during a federal investigation of public corruption, which led to no charges being filed.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ean owner of a large privately held manufacturing company\u003c/strong\u003e in the defense of a federal criminal tax investigation.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ean owner of a privately held national pharmaceutical distributor\u003c/strong\u003e in Section 2255 proceedings regarding his conviction on mail/wire fraud and RICO charges stemming from allegations of grey market recycling of drugs.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003enumerous national retail and specialty pharmacy chains\u003c/strong\u003e in multiple False Claims Act /\u003cem data-redactor-tag=\"em\"\u003equi tam\u003c/em\u003e matters focusing on a variety of issues, including allegations of the payment of kickbacks, improper submission of dosage quantities, the failure to timely refund credit balances, coordination of benefits issues, the submission of incorrect \u0026ldquo;usual and customary\u0026rdquo; prices to government payors and the dispensing of expired drugs.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea major national financial institution\u003c/strong\u003e in False Claims Act /\u003cem data-redactor-tag=\"em\"\u003equi tam\u003c/em\u003e litigation involving allegations of charging borrowers unallowable fees under the Veteran Administration's Home Loan Guaranty Program.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea major national skilled nursing facility chain\u003c/strong\u003e in False Claims Act /\u003cem data-redactor-tag=\"em\"\u003equi tam\u003c/em\u003e litigation focusing on quality of care issues.\u003c/p\u003e","\u003cp\u003eConducted independent internal investigations on various issues, including allegations of improper accounting, theft of corporate resources, backdated stock option, FCPA violations, and misconduct in the execution of government contracts and grant programs.\u003c/p\u003e","\u003cp\u003eConducted an internal review for \u003cstrong data-redactor-tag=\"strong\"\u003ean international nongovernmenta\u003c/strong\u003e\u003cstrong data-redactor-tag=\"strong\"\u003el organization\u003c/strong\u003e regarding potential FCPA issues related to an ongoing cooperative project with a foreign government.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea large publicly traded corporation\u003c/strong\u003e in one of the first national investigations by a multi-state attorneys' general task force focusing on the loss of consumer information held by the company.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea Fortune 500 financial services company\u003c/strong\u003e in a data breach response and in ensuing investigations by the Financial Industry Regulatory Authority (FINRA) and the Securities and Exchange Commission (SEC), which focused on Regulation S-P\u0026rsquo;s requirement to safeguard consumer financial and personal information.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea Fortune 100 healthcare company\u003c/strong\u003e in responding to a data security incident \u0026mdash; and an ensuing DHHS OCR investigation \u0026mdash; involving the theft of customers\u0026rsquo; personal and medical information. The internal investigation that was conducted led to DHHS OCR and customer disclosures pursuant to the requirements of HIPAA and various state data breach disclosure statutes.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea major international telecommunications company\u003c/strong\u003e in its response to the disclosure of the United States' Terrorist Surveillance Program (TSP), and issues and litigation arising from the company\u0026rsquo;s alleged cooperation with the TSP.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":24}]},"expertise":[{"id":107,"guid":"107.capabilities","index":0,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":1,"source":"capabilities"},{"id":2,"guid":"2.capabilities","index":2,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":3,"source":"capabilities"},{"id":20,"guid":"20.capabilities","index":4,"source":"capabilities"},{"id":6,"guid":"6.capabilities","index":5,"source":"capabilities"},{"id":750,"guid":"750.smart_tags","index":6,"source":"smartTags"},{"id":780,"guid":"780.smart_tags","index":7,"source":"smartTags"},{"id":766,"guid":"766.smart_tags","index":8,"source":"smartTags"},{"id":11,"guid":"11.capabilities","index":9,"source":"capabilities"},{"id":952,"guid":"952.smart_tags","index":10,"source":"smartTags"}],"is_active":true,"last_name":"Burris","nick_name":"Chris","clerkships":[],"first_name":"Christopher","title_rank":9999,"updated_by":101,"law_schools":[],"middle_name":"C.","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eChris Burris focuses on white-collar criminal defense, corporate internal investigations, regulatory enforcement action defense and complex litigation. As a partner in our Special Matters and Government Investigations practice, Chris defends corporations and individuals in a variety of criminal, regulatory, False Claims Act and other matters.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAs a defense lawyer, Chris represents leading corporations and individuals in criminal and regulatory enforcement matters. He has particular experience with defending clients in False Claims Act/\u003cem\u003equi tam\u003c/em\u003e\u0026nbsp;matters, handling dozens of cases concerning a variety of issues.\u003c/p\u003e\n\u003cp\u003eIn addition, Chris counsels clients in matters concerning privacy, information security and related issues. He also conducts internal investigations on behalf of management, boards of directors and audit committees.\u003c/p\u003e\n\u003cp\u003ePreviously, Chris served on active duty in the U.S. Navy Judge Advocate General\u0026rsquo;s Corps for nearly six years, where he gained broad experience in trial prosecution and defense, appeals and internal investigations. As a Commander in the Naval Reserves, he currently serves as the Executive Officer of the Navy Reserve unit overseeing issues involving international and operational law, admiralty and maritime law, environmental law, and information operations and intelligence law.\u003c/p\u003e","matters":["\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea major international financial institution\u003c/strong\u003e in the internal investigation and self-disclosure of accusations of employee participation in an alleged Ponzi scheme.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea large publicly traded manufacturing company\u003c/strong\u003e in the internal investigation and self-disclosure of potential Bank Secrecy Act violations.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ean elected state official\u003c/strong\u003e during a federal investigation of public corruption, which led to no charges being filed.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ean owner of a large privately held manufacturing company\u003c/strong\u003e in the defense of a federal criminal tax investigation.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ean owner of a privately held national pharmaceutical distributor\u003c/strong\u003e in Section 2255 proceedings regarding his conviction on mail/wire fraud and RICO charges stemming from allegations of grey market recycling of drugs.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003enumerous national retail and specialty pharmacy chains\u003c/strong\u003e in multiple False Claims Act /\u003cem data-redactor-tag=\"em\"\u003equi tam\u003c/em\u003e matters focusing on a variety of issues, including allegations of the payment of kickbacks, improper submission of dosage quantities, the failure to timely refund credit balances, coordination of benefits issues, the submission of incorrect \u0026ldquo;usual and customary\u0026rdquo; prices to government payors and the dispensing of expired drugs.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea major national financial institution\u003c/strong\u003e in False Claims Act /\u003cem data-redactor-tag=\"em\"\u003equi tam\u003c/em\u003e litigation involving allegations of charging borrowers unallowable fees under the Veteran Administration's Home Loan Guaranty Program.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea major national skilled nursing facility chain\u003c/strong\u003e in False Claims Act /\u003cem data-redactor-tag=\"em\"\u003equi tam\u003c/em\u003e litigation focusing on quality of care issues.\u003c/p\u003e","\u003cp\u003eConducted independent internal investigations on various issues, including allegations of improper accounting, theft of corporate resources, backdated stock option, FCPA violations, and misconduct in the execution of government contracts and grant programs.\u003c/p\u003e","\u003cp\u003eConducted an internal review for \u003cstrong data-redactor-tag=\"strong\"\u003ean international nongovernmenta\u003c/strong\u003e\u003cstrong data-redactor-tag=\"strong\"\u003el organization\u003c/strong\u003e regarding potential FCPA issues related to an ongoing cooperative project with a foreign government.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea large publicly traded corporation\u003c/strong\u003e in one of the first national investigations by a multi-state attorneys' general task force focusing on the loss of consumer information held by the company.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea Fortune 500 financial services company\u003c/strong\u003e in a data breach response and in ensuing investigations by the Financial Industry Regulatory Authority (FINRA) and the Securities and Exchange Commission (SEC), which focused on Regulation S-P\u0026rsquo;s requirement to safeguard consumer financial and personal information.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea Fortune 100 healthcare company\u003c/strong\u003e in responding to a data security incident \u0026mdash; and an ensuing DHHS OCR investigation \u0026mdash; involving the theft of customers\u0026rsquo; personal and medical information. The internal investigation that was conducted led to DHHS OCR and customer disclosures pursuant to the requirements of HIPAA and various state data breach disclosure statutes.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea major international telecommunications company\u003c/strong\u003e in its response to the disclosure of the United States' Terrorist Surveillance Program (TSP), and issues and litigation arising from the company\u0026rsquo;s alleged cooperation with the TSP.\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":4195}]},"capability_group_id":2},"created_at":"2025-05-26T05:02:00.000Z","updated_at":"2025-05-26T05:02:00.000Z","searchable_text":"Burris{{ FIELD }}Represented a major international financial institution in the internal investigation and self-disclosure of accusations of employee participation in an alleged Ponzi scheme.{{ FIELD }}Represented a large publicly traded manufacturing company in the internal investigation and self-disclosure of potential Bank Secrecy Act violations.{{ FIELD }}Represented an elected state official during a federal investigation of public corruption, which led to no charges being filed.{{ FIELD }}Represented an owner of a large privately held manufacturing company in the defense of a federal criminal tax investigation.{{ FIELD }}Represented an owner of a privately held national pharmaceutical distributor in Section 2255 proceedings regarding his conviction on mail/wire fraud and RICO charges stemming from allegations of grey market recycling of drugs.{{ FIELD }}Represented numerous national retail and specialty pharmacy chains in multiple False Claims Act /qui tam matters focusing on a variety of issues, including allegations of the payment of kickbacks, improper submission of dosage quantities, the failure to timely refund credit balances, coordination of benefits issues, the submission of incorrect “usual and customary” prices to government payors and the dispensing of expired drugs.{{ FIELD }}Represented a major national financial institution in False Claims Act /qui tam litigation involving allegations of charging borrowers unallowable fees under the Veteran Administration's Home Loan Guaranty Program.{{ FIELD }}Represented a major national skilled nursing facility chain in False Claims Act /qui tam litigation focusing on quality of care issues.{{ FIELD }}Conducted independent internal investigations on various issues, including allegations of improper accounting, theft of corporate resources, backdated stock option, FCPA violations, and misconduct in the execution of government contracts and grant programs.{{ FIELD }}Conducted an internal review for an international nongovernmental organization regarding potential FCPA issues related to an ongoing cooperative project with a foreign government.{{ FIELD }}Represented a large publicly traded corporation in one of the first national investigations by a multi-state attorneys' general task force focusing on the loss of consumer information held by the company.{{ FIELD }}Represented a Fortune 500 financial services company in a data breach response and in ensuing investigations by the Financial Industry Regulatory Authority (FINRA) and the Securities and Exchange Commission (SEC), which focused on Regulation S-P’s requirement to safeguard consumer financial and personal information.{{ FIELD }}Represented a Fortune 100 healthcare company in responding to a data security incident — and an ensuing DHHS OCR investigation — involving the theft of customers’ personal and medical information. The internal investigation that was conducted led to DHHS OCR and customer disclosures pursuant to the requirements of HIPAA and various state data breach disclosure statutes.{{ FIELD }}Represented a major international telecommunications company in its response to the disclosure of the United States' Terrorist Surveillance Program (TSP), and issues and litigation arising from the company’s alleged cooperation with the TSP.{{ FIELD }}Chris Burris focuses on white-collar criminal defense, corporate internal investigations, regulatory enforcement action defense and complex litigation. As a partner in our Special Matters and Government Investigations practice, Chris defends corporations and individuals in a variety of criminal, regulatory, False Claims Act and other matters.\nAs a defense lawyer, Chris represents leading corporations and individuals in criminal and regulatory enforcement matters. He has particular experience with defending clients in False Claims Act/qui tam matters, handling dozens of cases concerning a variety of issues.\nIn addition, Chris counsels clients in matters concerning privacy, information security and related issues. He also conducts internal investigations on behalf of management, boards of directors and audit committees.\nPreviously, Chris served on active duty in the U.S. Navy Judge Advocate General’s Corps for nearly six years, where he gained broad experience in trial prosecution and defense, appeals and internal investigations. As a Commander in the Naval Reserves, he currently serves as the Executive Officer of the Navy Reserve unit overseeing issues involving international and operational law, admiralty and maritime law, environmental law, and information operations and intelligence law. Christopher C Burris Partner Vanderbilt University Vanderbilt University School of Law University of North Carolina at Chapel Hill University of North Carolina School of Law Georgetown University Georgetown University Law Center Supreme Court of the United States U.S. District Court for the Western District of North Carolina Georgia North Carolina Represented a major international financial institution in the internal investigation and self-disclosure of accusations of employee participation in an alleged Ponzi scheme. Represented a large publicly traded manufacturing company in the internal investigation and self-disclosure of potential Bank Secrecy Act violations. Represented an elected state official during a federal investigation of public corruption, which led to no charges being filed. Represented an owner of a large privately held manufacturing company in the defense of a federal criminal tax investigation. Represented an owner of a privately held national pharmaceutical distributor in Section 2255 proceedings regarding his conviction on mail/wire fraud and RICO charges stemming from allegations of grey market recycling of drugs. Represented numerous national retail and specialty pharmacy chains in multiple False Claims Act /qui tam matters focusing on a variety of issues, including allegations of the payment of kickbacks, improper submission of dosage quantities, the failure to timely refund credit balances, coordination of benefits issues, the submission of incorrect “usual and customary” prices to government payors and the dispensing of expired drugs. Represented a major national financial institution in False Claims Act /qui tam litigation involving allegations of charging borrowers unallowable fees under the Veteran Administration's Home Loan Guaranty Program. Represented a major national skilled nursing facility chain in False Claims Act /qui tam litigation focusing on quality of care issues. Conducted independent internal investigations on various issues, including allegations of improper accounting, theft of corporate resources, backdated stock option, FCPA violations, and misconduct in the execution of government contracts and grant programs. Conducted an internal review for an international nongovernmental organization regarding potential FCPA issues related to an ongoing cooperative project with a foreign government. Represented a large publicly traded corporation in one of the first national investigations by a multi-state attorneys' general task force focusing on the loss of consumer information held by the company. Represented a Fortune 500 financial services company in a data breach response and in ensuing investigations by the Financial Industry Regulatory Authority (FINRA) and the Securities and Exchange Commission (SEC), which focused on Regulation S-P’s requirement to safeguard consumer financial and personal information. Represented a Fortune 100 healthcare company in responding to a data security incident — and an ensuing DHHS OCR investigation — involving the theft of customers’ personal and medical information. The internal investigation that was conducted led to DHHS OCR and customer disclosures pursuant to the requirements of HIPAA and various state data breach disclosure statutes. Represented a major international telecommunications company in its response to the disclosure of the United States' Terrorist Surveillance Program (TSP), and issues and litigation arising from the company’s alleged cooperation with the TSP.","searchable_name":"Christopher C. Burris (Chris)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":101,"capability_group_featured":null,"home_page_featured":null},{"id":442383,"version":1,"owner_type":"Person","owner_id":1005,"payload":{"bio":"\u003cp\u003eRandy Butterfield helps lead the firm\u0026rsquo;s Atlanta Environmental, Health and Safety Practice Group, where he concentrates his practice on environmental and toxic tort litigation as well as\u0026nbsp;emergency incident response. Randy's practice focuses in particular on assisting clients in the wake of catastrophic emergency incidents, such as explosions, fires, industrial accidents, chemical releases, spills, and other environmental and industrial calamities. In that capacity, Randy is frequently called upon in the immediate aftermath of these emergencies to provide time-critical crisis management addressing a wide range of pressing concerns, including forensic investigation; workplace safety; site security and evidence preservation; regulatory disclosures, investigation, and potential enforcement; environmental remediation; internal investigations; and insurance coverage. Recent incidents on which Randy has helped lead the response have involved over $2 billion in property damages, business losses, and insurance claims; significant personal injury lawsuits; as well as enforcement actions from federal and state regulators.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eIn addition, Randy has handled numerous mass joinder and class action cases involving personal injury and property damage claims, both at the trial and appellate levels. Randy has played a particularly significant role in preparing and defending the defense experts\u0026mdash;as well as deposing and critiquing plaintiffs\u0026rsquo; experts\u0026mdash;on a wide variety of technical topics, such as air and groundwater modeling, emission inventories, dose reconstruction, geostatistics, human health risk assessment, toxicology, epidemiology,\u0026nbsp;fate and transport,\u0026nbsp;remediation,\u0026nbsp;property valuation, and damage assessments. Over his career, Randy\u0026rsquo;s litigation matters have involved nearly every major piece of environmental legislation as well as the entire spectrum of common law tort claims.\u003c/p\u003e\n\u003cp\u003eRandy has published several articles involving the potential application and use of federal and state regulatory standards in the toxic tort context. He has also co-authored a chapter on legal defenses in toxic tort cases in a treatise published by the American Bar Association as well as a chapter on administrative appeals published by LexisNexis. Randy served on the Environmental and Toxic Tort Section of the Atlanta Bar Association, including as Board Chair in 2018. Randy also served on\u0026nbsp;\u003cem\u003eLaw360\u003c/em\u003e\u0026rsquo;s Environmental Editorial Advisory Board from 2021-2022.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eBooks, Articles \u0026amp; Presentations\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u0026bull; LexisNexis Practice Guide:\u0026nbsp;\u003cem\u003eGeorgia Environmental Law\u003c/em\u003e, 2022 ed.\u003c/p\u003e\n\u003cp\u003e\u0026bull; Randy J. Butterfield, moderator, Roundtable with Georgia Office of State Administrative Hearing Judges\u0026nbsp;\u0026amp; Litigants, Atlanta Bar Association, Toxic Tort and Environmental Law CLE, Feb. 1, 2018\u003c/p\u003e\n\u003cp\u003e\u0026bull; Randy J. Butterfield \u0026amp; Stephen A. McCullers,\u0026nbsp;\u003cem\u003eRaising the Class Action Certification Bar in Georgia:\u0026nbsp;\u003c/em\u003eGeorgia-Pacific Consumer Products, LP v. Ratner, Perspectives on Georgia\u0026rsquo;s Environment (State Bar of\u0026nbsp;Georgia), Spring 2015, at 6-9\u003c/p\u003e\n\u003cp\u003e\u0026bull; Randy J. Butterfield,\u0026nbsp;\u003cem\u003eRecent \u0026amp; Recurring Issues in Toxic Tort Cases\u003c/em\u003e, State Bar of Georgia, Toxic Tort\u0026nbsp;Litigation CLE, Mar. 2014\u003c/p\u003e\n\u003cp\u003e\u0026bull; J Kevin Buster \u0026amp; Randy J. Butterfield,\u0026nbsp;\u003cem\u003eCommon Defenses in Toxic Tort Litigation\u003c/em\u003e\u0026nbsp;(book chapter) (ABA\u0026nbsp;2d ed. 2013)\u003c/p\u003e\n\u003cp\u003e\u0026bull; Randy J. Butterfield, Note,\u0026nbsp;\u003cem\u003eRecovering Environmental Cleanup Costs Under the Resource Conservation\u0026nbsp;and Recovery Act: A Potential Solution to a Persistent Problem\u003c/em\u003e, 49 Vand. L. Rev. 689 (1997)\u003c/p\u003e","slug":"randall-butterfield","email":"rbutterfield@kslaw.com","phone":null,"matters":["\u003cp\u003eA midstream energy company in connection with investigations by Federal and State environmental agencies as well as the Occupational Safety and Health Administration (OSHA) into an explosion and fire at a natural gas processing facility resulting in catastrophic loss. Oversaw root cause investigation, coordinated responses to agency inquiries, and provided advice and counsel in connection with successful insurance recovery.\u003c/p\u003e","\u003cp\u003eOne of the world\u0026rsquo;s largest producers of methanol from natural gas as standby incident response counsel, including in connection with environmental investigations into spills and releases.\u003c/p\u003e","\u003cp\u003eAn LNG facility in connection with government investigations by the Pipeline and Hazardous Materials Safety Administration (PHMSA) and the U.S. Chemical Safety and Hazard Investigation Board (CSB) arising out of an explosion that resulted in operational shutdown and extensive damage to piping and other equipment and in connection with insurance coverage concerns.\u003c/p\u003e","\u003cp\u003eA Fortune 50 energy company in connection with the February 2023 Norfolk Southern freight train derailment in East Palestine, Ohio.\u003c/p\u003e","\u003cp\u003eAn international chemical manufacturer in response to an explosion at its largest U.S. manufacturing facility, including helping to lead the emergency incident response and internal investigation as well as responding to regulatory inquiries by, among others OSHA; State and Federal environmental agencies; the CSB; and the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF).\u003c/p\u003e","\u003cp\u003eThe country\u0026rsquo;s largest specialty paper company following the catastrophic explosion of two continuous pulp digesters. Helped lead the team handling the emergency response, including handling the root cause investigation, successfully resolving investigations by the U.S. Environmental Protection Agency, OSHA, CSB, and numerous state regulatory agencies, and securing a significant settlement of its insurance claim.\u003c/p\u003e","\u003cp\u003eA worldwide mining and petroleum company as standby incident response counsel.\u003c/p\u003e","\u003cp\u003eAn engineering and construction company in connection with a trench collapse resulting in a fatality, including responding to OSHA\u0026rsquo;s resulting investigation and implementing a nationwide safety audit.\u003c/p\u003e","\u003cp\u003eA carbon capture company in connection with building collapse resulting in extensive damages to multiple rail cars. Led root cause investigation.\u003c/p\u003e","\u003cp\u003eA water and wastewater treatment provider in connection with a civil and criminal investigation into wastewater treatment plant compliance involving allegations of falsification of records.\u003c/p\u003e","\u003cp\u003eOne of the largest specialty pulp and paper manufacturers in the United States in connection with investigations by EPA, OSHA, and various state and local agencies arising out of a catastrophic explosion.\u003c/p\u003e","\u003cp\u003eA chemical facility following release of trichlorosilane during line break that resulted in serious injuries to contractors.\u003c/p\u003e","\u003cp\u003eA chemical facility in connection with explosion caused by the failure of an expansion joint, resulting in numerous injuries and one fatality.\u003c/p\u003e","\u003cp\u003eA medical sterilization company in pending litigation involving air emissions of ethylene oxide (EtO) from its facility in Colorado.\u003c/p\u003e","\u003cp\u003eA world-leading manufacturer to defend the claims of 3,000 plaintiffs stemming from air emissions of lead, arsenic, and other substances from a polymetallic smelter in Peru.\u003c/p\u003e","\u003cp\u003eSuccessfully resolved regulatory enforcement actions against a Fortune 100 company involving EPA\u0026rsquo;s Lead Renovation, Repair and Painting (\u0026ldquo;RRP\u0026rdquo;) Rule under the Toxic Substances Control Act (\u0026ldquo;TSCA\u0026rdquo;).\u003c/p\u003e","\u003cp\u003eA large paper manufacturer following a catastrophic fire at its New Jersey production facility. Helped lead the core team that successfully resolved all State and Federal regulatory investigations and secured a significant settlement of its insurance claims.\u003c/p\u003e","\u003cp\u003eRayonier Performance Fibers in securing renewal of the NPDES discharge permit for its Jesup pulp mill, the world's largest producer of cellulose specialty products. The permit had been reversed by the administrative law judge, who imposed a novel and unreasonable construction of the narrative water quality standard. That erroneous decision, which threatened the permitting program for all industrial and municipal dischargers in Georgia, was reversed on appeal, ultimately leading to affirmance of the renewed permit.\u0026nbsp;\u003cem\u003eAltamaha Riverkeeper, Inc. v. Rayonier Performance Fibers, LLC\u003c/em\u003e, 816 S.E.2d 125 (Ga. Ct. App. 2018), cert. denied (Aug. 5, 2019).\u003c/p\u003e","\u003cp\u003eRayonier Performance Fibers in a citizen suit alleging that the pulp mill was violating its NPDES discharge permit. District court granted summary judgment in favor of Rayonier on all counts.\u0026nbsp;\u003cem\u003eAltamaha Riverkeeper, Inc. v. Rayonier, Inc.\u003c/em\u003e, No. CV 214-44, 2015 U.S. Dist. LEXIS 42849 (S.D. Ga. Mar. 31, 2015).\u003c/p\u003e","\u003cp\u003eSea Island Company in securing, and successfully defending to an Administrative Law Judge and then to Superior Court, the state Shore Protection Act permit for a controversial beach nourishment, dune construction, and groin project along three miles of beachfront property. In subsequent related litigation brought in federal court, obtained summary judgment upholding the contested permits.\u0026nbsp;\u003cem\u003eAltamaha Riverkeeper v. U.S. Army Corps of Eng\u0026rsquo;rs\u003c/em\u003e, No. CV 418-251, 2020 WL 5837650 (S.D. Ga. Sept. 30, 2020).\u003c/p\u003e","\u003cp\u003eA large electric utility company in toxic tort litigation involving approximately 150 residents living near Plant Scherer, one of the largest coal-fired power plants in the country. Following oral argument on an early motion to dismiss, plaintiffs voluntarily dismissed all claims.\u003c/p\u003e","\u003cp\u003eA carbon black manufacturer in mass joinder actions filed in West Virginia by hundreds of current and former neighbors, asserting nuisance, trespass, negligence and medical monitoring claims.\u003c/p\u003e","\u003cp\u003eDefense contractors in a putative personal injury and property damage class action seeking some $200 million for alleged exposure to lead, PCBs, and other chemicals associated with historic forge and foundry operations in Anniston, Alabama. Cases ultimately resolved in nuisance value settlements.\u003c/p\u003e","\u003cp\u003eThe City of Atlanta and other local governments in the tri-state \u0026ldquo;water wars\u0026rdquo; litigation involving Georgia, Alabama, and Florida, including the successful defense of Florida\u0026rsquo;s claims that the operation of Georgia reservoirs on the Chattahoochee River have harmed endangered species.\u003c/p\u003e","\u003cp\u003eA chemical manufacturer against claims related to the contamination of a former fertilizer manufacturing facility. Following extensive fact and expert discovery, the district court granted summary judgment in favor of the company on all claims, a decision later affirmed by the U.S. Court of Appeals for the Fourth Circuit.\u003c/p\u003e","\u003cp\u003eA Fortune 50 energy company in the appeal of a $27 million jury verdict in a \u0026ldquo;dram shop\u0026rdquo; case asserting agency liability based upon the use of brand standards for independent service stations. The South Carolina Supreme Court reversed the jury verdict and rendered judgment in favor of the company.\u003c/p\u003e","\u003cp\u003eA chemical manufacturer in a mixture of class actions and individual lawsuits filed in state and federal courts concerning alleged mercury and PCB contamination from the company\u0026rsquo;s former chlor-alkali plant.\u003c/p\u003e","\u003cp\u003eMore than a dozen manufacturers, distributors, or sellers of welding products in several Georgia cases brought on behalf of approximately 500 plaintiffs who alleged personal injury due to inhalation of manganese particles produced by the welding process.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":71,"guid":"71.capabilities","index":0,"source":"capabilities"},{"id":16,"guid":"16.capabilities","index":1,"source":"capabilities"},{"id":1015,"guid":"1015.smart_tags","index":2,"source":"smartTags"},{"id":111,"guid":"111.capabilities","index":3,"source":"capabilities"},{"id":1236,"guid":"1236.smart_tags","index":4,"source":"smartTags"},{"id":1168,"guid":"1168.smart_tags","index":5,"source":"smartTags"},{"id":102,"guid":"102.capabilities","index":6,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":7,"source":"capabilities"},{"id":17,"guid":"17.capabilities","index":8,"source":"capabilities"},{"id":764,"guid":"764.smart_tags","index":9,"source":"smartTags"},{"id":11,"guid":"11.capabilities","index":10,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":11,"source":"capabilities"}],"is_active":true,"last_name":"Butterfield","nick_name":"Randy","clerkships":[{"name":"Law Clerk, Chief Judge Robert L. Echols, U.S. District Court for the Middle District of Tennessee","years_held":"1997 - 1999"}],"first_name":"Randall","title_rank":9999,"updated_by":34,"law_schools":[],"middle_name":"J.","name_suffix":"","recognitions":[{"title":"Law360 Selects Nine from King \u0026 Spalding to Serve on 2021 Editorial Advisory Boards","detail":"Law 360, April 2021"}],"linked_in_url":"https://www.linkedin.com/in/randy-butterfield-237ab87/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eRandy Butterfield helps lead the firm\u0026rsquo;s Atlanta Environmental, Health and Safety Practice Group, where he concentrates his practice on environmental and toxic tort litigation as well as\u0026nbsp;emergency incident response. Randy's practice focuses in particular on assisting clients in the wake of catastrophic emergency incidents, such as explosions, fires, industrial accidents, chemical releases, spills, and other environmental and industrial calamities. In that capacity, Randy is frequently called upon in the immediate aftermath of these emergencies to provide time-critical crisis management addressing a wide range of pressing concerns, including forensic investigation; workplace safety; site security and evidence preservation; regulatory disclosures, investigation, and potential enforcement; environmental remediation; internal investigations; and insurance coverage. Recent incidents on which Randy has helped lead the response have involved over $2 billion in property damages, business losses, and insurance claims; significant personal injury lawsuits; as well as enforcement actions from federal and state regulators.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eIn addition, Randy has handled numerous mass joinder and class action cases involving personal injury and property damage claims, both at the trial and appellate levels. Randy has played a particularly significant role in preparing and defending the defense experts\u0026mdash;as well as deposing and critiquing plaintiffs\u0026rsquo; experts\u0026mdash;on a wide variety of technical topics, such as air and groundwater modeling, emission inventories, dose reconstruction, geostatistics, human health risk assessment, toxicology, epidemiology,\u0026nbsp;fate and transport,\u0026nbsp;remediation,\u0026nbsp;property valuation, and damage assessments. Over his career, Randy\u0026rsquo;s litigation matters have involved nearly every major piece of environmental legislation as well as the entire spectrum of common law tort claims.\u003c/p\u003e\n\u003cp\u003eRandy has published several articles involving the potential application and use of federal and state regulatory standards in the toxic tort context. He has also co-authored a chapter on legal defenses in toxic tort cases in a treatise published by the American Bar Association as well as a chapter on administrative appeals published by LexisNexis. Randy served on the Environmental and Toxic Tort Section of the Atlanta Bar Association, including as Board Chair in 2018. Randy also served on\u0026nbsp;\u003cem\u003eLaw360\u003c/em\u003e\u0026rsquo;s Environmental Editorial Advisory Board from 2021-2022.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eBooks, Articles \u0026amp; Presentations\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u0026bull; LexisNexis Practice Guide:\u0026nbsp;\u003cem\u003eGeorgia Environmental Law\u003c/em\u003e, 2022 ed.\u003c/p\u003e\n\u003cp\u003e\u0026bull; Randy J. Butterfield, moderator, Roundtable with Georgia Office of State Administrative Hearing Judges\u0026nbsp;\u0026amp; Litigants, Atlanta Bar Association, Toxic Tort and Environmental Law CLE, Feb. 1, 2018\u003c/p\u003e\n\u003cp\u003e\u0026bull; Randy J. Butterfield \u0026amp; Stephen A. McCullers,\u0026nbsp;\u003cem\u003eRaising the Class Action Certification Bar in Georgia:\u0026nbsp;\u003c/em\u003eGeorgia-Pacific Consumer Products, LP v. Ratner, Perspectives on Georgia\u0026rsquo;s Environment (State Bar of\u0026nbsp;Georgia), Spring 2015, at 6-9\u003c/p\u003e\n\u003cp\u003e\u0026bull; Randy J. Butterfield,\u0026nbsp;\u003cem\u003eRecent \u0026amp; Recurring Issues in Toxic Tort Cases\u003c/em\u003e, State Bar of Georgia, Toxic Tort\u0026nbsp;Litigation CLE, Mar. 2014\u003c/p\u003e\n\u003cp\u003e\u0026bull; J Kevin Buster \u0026amp; Randy J. Butterfield,\u0026nbsp;\u003cem\u003eCommon Defenses in Toxic Tort Litigation\u003c/em\u003e\u0026nbsp;(book chapter) (ABA\u0026nbsp;2d ed. 2013)\u003c/p\u003e\n\u003cp\u003e\u0026bull; Randy J. Butterfield, Note,\u0026nbsp;\u003cem\u003eRecovering Environmental Cleanup Costs Under the Resource Conservation\u0026nbsp;and Recovery Act: A Potential Solution to a Persistent Problem\u003c/em\u003e, 49 Vand. L. Rev. 689 (1997)\u003c/p\u003e","matters":["\u003cp\u003eA midstream energy company in connection with investigations by Federal and State environmental agencies as well as the Occupational Safety and Health Administration (OSHA) into an explosion and fire at a natural gas processing facility resulting in catastrophic loss. Oversaw root cause investigation, coordinated responses to agency inquiries, and provided advice and counsel in connection with successful insurance recovery.\u003c/p\u003e","\u003cp\u003eOne of the world\u0026rsquo;s largest producers of methanol from natural gas as standby incident response counsel, including in connection with environmental investigations into spills and releases.\u003c/p\u003e","\u003cp\u003eAn LNG facility in connection with government investigations by the Pipeline and Hazardous Materials Safety Administration (PHMSA) and the U.S. Chemical Safety and Hazard Investigation Board (CSB) arising out of an explosion that resulted in operational shutdown and extensive damage to piping and other equipment and in connection with insurance coverage concerns.\u003c/p\u003e","\u003cp\u003eA Fortune 50 energy company in connection with the February 2023 Norfolk Southern freight train derailment in East Palestine, Ohio.\u003c/p\u003e","\u003cp\u003eAn international chemical manufacturer in response to an explosion at its largest U.S. manufacturing facility, including helping to lead the emergency incident response and internal investigation as well as responding to regulatory inquiries by, among others OSHA; State and Federal environmental agencies; the CSB; and the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF).\u003c/p\u003e","\u003cp\u003eThe country\u0026rsquo;s largest specialty paper company following the catastrophic explosion of two continuous pulp digesters. Helped lead the team handling the emergency response, including handling the root cause investigation, successfully resolving investigations by the U.S. Environmental Protection Agency, OSHA, CSB, and numerous state regulatory agencies, and securing a significant settlement of its insurance claim.\u003c/p\u003e","\u003cp\u003eA worldwide mining and petroleum company as standby incident response counsel.\u003c/p\u003e","\u003cp\u003eAn engineering and construction company in connection with a trench collapse resulting in a fatality, including responding to OSHA\u0026rsquo;s resulting investigation and implementing a nationwide safety audit.\u003c/p\u003e","\u003cp\u003eA carbon capture company in connection with building collapse resulting in extensive damages to multiple rail cars. Led root cause investigation.\u003c/p\u003e","\u003cp\u003eA water and wastewater treatment provider in connection with a civil and criminal investigation into wastewater treatment plant compliance involving allegations of falsification of records.\u003c/p\u003e","\u003cp\u003eOne of the largest specialty pulp and paper manufacturers in the United States in connection with investigations by EPA, OSHA, and various state and local agencies arising out of a catastrophic explosion.\u003c/p\u003e","\u003cp\u003eA chemical facility following release of trichlorosilane during line break that resulted in serious injuries to contractors.\u003c/p\u003e","\u003cp\u003eA chemical facility in connection with explosion caused by the failure of an expansion joint, resulting in numerous injuries and one fatality.\u003c/p\u003e","\u003cp\u003eA medical sterilization company in pending litigation involving air emissions of ethylene oxide (EtO) from its facility in Colorado.\u003c/p\u003e","\u003cp\u003eA world-leading manufacturer to defend the claims of 3,000 plaintiffs stemming from air emissions of lead, arsenic, and other substances from a polymetallic smelter in Peru.\u003c/p\u003e","\u003cp\u003eSuccessfully resolved regulatory enforcement actions against a Fortune 100 company involving EPA\u0026rsquo;s Lead Renovation, Repair and Painting (\u0026ldquo;RRP\u0026rdquo;) Rule under the Toxic Substances Control Act (\u0026ldquo;TSCA\u0026rdquo;).\u003c/p\u003e","\u003cp\u003eA large paper manufacturer following a catastrophic fire at its New Jersey production facility. Helped lead the core team that successfully resolved all State and Federal regulatory investigations and secured a significant settlement of its insurance claims.\u003c/p\u003e","\u003cp\u003eRayonier Performance Fibers in securing renewal of the NPDES discharge permit for its Jesup pulp mill, the world's largest producer of cellulose specialty products. The permit had been reversed by the administrative law judge, who imposed a novel and unreasonable construction of the narrative water quality standard. That erroneous decision, which threatened the permitting program for all industrial and municipal dischargers in Georgia, was reversed on appeal, ultimately leading to affirmance of the renewed permit.\u0026nbsp;\u003cem\u003eAltamaha Riverkeeper, Inc. v. Rayonier Performance Fibers, LLC\u003c/em\u003e, 816 S.E.2d 125 (Ga. Ct. App. 2018), cert. denied (Aug. 5, 2019).\u003c/p\u003e","\u003cp\u003eRayonier Performance Fibers in a citizen suit alleging that the pulp mill was violating its NPDES discharge permit. District court granted summary judgment in favor of Rayonier on all counts.\u0026nbsp;\u003cem\u003eAltamaha Riverkeeper, Inc. v. Rayonier, Inc.\u003c/em\u003e, No. CV 214-44, 2015 U.S. Dist. LEXIS 42849 (S.D. Ga. Mar. 31, 2015).\u003c/p\u003e","\u003cp\u003eSea Island Company in securing, and successfully defending to an Administrative Law Judge and then to Superior Court, the state Shore Protection Act permit for a controversial beach nourishment, dune construction, and groin project along three miles of beachfront property. In subsequent related litigation brought in federal court, obtained summary judgment upholding the contested permits.\u0026nbsp;\u003cem\u003eAltamaha Riverkeeper v. U.S. Army Corps of Eng\u0026rsquo;rs\u003c/em\u003e, No. CV 418-251, 2020 WL 5837650 (S.D. Ga. Sept. 30, 2020).\u003c/p\u003e","\u003cp\u003eA large electric utility company in toxic tort litigation involving approximately 150 residents living near Plant Scherer, one of the largest coal-fired power plants in the country. Following oral argument on an early motion to dismiss, plaintiffs voluntarily dismissed all claims.\u003c/p\u003e","\u003cp\u003eA carbon black manufacturer in mass joinder actions filed in West Virginia by hundreds of current and former neighbors, asserting nuisance, trespass, negligence and medical monitoring claims.\u003c/p\u003e","\u003cp\u003eDefense contractors in a putative personal injury and property damage class action seeking some $200 million for alleged exposure to lead, PCBs, and other chemicals associated with historic forge and foundry operations in Anniston, Alabama. Cases ultimately resolved in nuisance value settlements.\u003c/p\u003e","\u003cp\u003eThe City of Atlanta and other local governments in the tri-state \u0026ldquo;water wars\u0026rdquo; litigation involving Georgia, Alabama, and Florida, including the successful defense of Florida\u0026rsquo;s claims that the operation of Georgia reservoirs on the Chattahoochee River have harmed endangered species.\u003c/p\u003e","\u003cp\u003eA chemical manufacturer against claims related to the contamination of a former fertilizer manufacturing facility. Following extensive fact and expert discovery, the district court granted summary judgment in favor of the company on all claims, a decision later affirmed by the U.S. Court of Appeals for the Fourth Circuit.\u003c/p\u003e","\u003cp\u003eA Fortune 50 energy company in the appeal of a $27 million jury verdict in a \u0026ldquo;dram shop\u0026rdquo; case asserting agency liability based upon the use of brand standards for independent service stations. The South Carolina Supreme Court reversed the jury verdict and rendered judgment in favor of the company.\u003c/p\u003e","\u003cp\u003eA chemical manufacturer in a mixture of class actions and individual lawsuits filed in state and federal courts concerning alleged mercury and PCB contamination from the company\u0026rsquo;s former chlor-alkali plant.\u003c/p\u003e","\u003cp\u003eMore than a dozen manufacturers, distributors, or sellers of welding products in several Georgia cases brought on behalf of approximately 500 plaintiffs who alleged personal injury due to inhalation of manganese particles produced by the welding process.\u003c/p\u003e"],"recognitions":[{"title":"Law360 Selects Nine from King \u0026 Spalding to Serve on 2021 Editorial Advisory Boards","detail":"Law 360, April 2021"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":757}]},"capability_group_id":2},"created_at":"2025-11-05T05:04:00.000Z","updated_at":"2025-11-05T05:04:00.000Z","searchable_text":"Butterfield{{ FIELD }}{:title=\u0026gt;\"Law360 Selects Nine from King \u0026amp; Spalding to Serve on 2021 Editorial Advisory Boards\", :detail=\u0026gt;\"Law 360, April 2021\"}{{ FIELD }}A midstream energy company in connection with investigations by Federal and State environmental agencies as well as the Occupational Safety and Health Administration (OSHA) into an explosion and fire at a natural gas processing facility resulting in catastrophic loss. Oversaw root cause investigation, coordinated responses to agency inquiries, and provided advice and counsel in connection with successful insurance recovery.{{ FIELD }}One of the world’s largest producers of methanol from natural gas as standby incident response counsel, including in connection with environmental investigations into spills and releases.{{ FIELD }}An LNG facility in connection with government investigations by the Pipeline and Hazardous Materials Safety Administration (PHMSA) and the U.S. Chemical Safety and Hazard Investigation Board (CSB) arising out of an explosion that resulted in operational shutdown and extensive damage to piping and other equipment and in connection with insurance coverage concerns.{{ FIELD }}A Fortune 50 energy company in connection with the February 2023 Norfolk Southern freight train derailment in East Palestine, Ohio.{{ FIELD }}An international chemical manufacturer in response to an explosion at its largest U.S. manufacturing facility, including helping to lead the emergency incident response and internal investigation as well as responding to regulatory inquiries by, among others OSHA; State and Federal environmental agencies; the CSB; and the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF).{{ FIELD }}The country’s largest specialty paper company following the catastrophic explosion of two continuous pulp digesters. Helped lead the team handling the emergency response, including handling the root cause investigation, successfully resolving investigations by the U.S. Environmental Protection Agency, OSHA, CSB, and numerous state regulatory agencies, and securing a significant settlement of its insurance claim.{{ FIELD }}A worldwide mining and petroleum company as standby incident response counsel.{{ FIELD }}An engineering and construction company in connection with a trench collapse resulting in a fatality, including responding to OSHA’s resulting investigation and implementing a nationwide safety audit.{{ FIELD }}A carbon capture company in connection with building collapse resulting in extensive damages to multiple rail cars. Led root cause investigation.{{ FIELD }}A water and wastewater treatment provider in connection with a civil and criminal investigation into wastewater treatment plant compliance involving allegations of falsification of records.{{ FIELD }}One of the largest specialty pulp and paper manufacturers in the United States in connection with investigations by EPA, OSHA, and various state and local agencies arising out of a catastrophic explosion.{{ FIELD }}A chemical facility following release of trichlorosilane during line break that resulted in serious injuries to contractors.{{ FIELD }}A chemical facility in connection with explosion caused by the failure of an expansion joint, resulting in numerous injuries and one fatality.{{ FIELD }}A medical sterilization company in pending litigation involving air emissions of ethylene oxide (EtO) from its facility in Colorado.{{ FIELD }}A world-leading manufacturer to defend the claims of 3,000 plaintiffs stemming from air emissions of lead, arsenic, and other substances from a polymetallic smelter in Peru.{{ FIELD }}Successfully resolved regulatory enforcement actions against a Fortune 100 company involving EPA’s Lead Renovation, Repair and Painting (“RRP”) Rule under the Toxic Substances Control Act (“TSCA”).{{ FIELD }}A large paper manufacturer following a catastrophic fire at its New Jersey production facility. Helped lead the core team that successfully resolved all State and Federal regulatory investigations and secured a significant settlement of its insurance claims.{{ FIELD }}Rayonier Performance Fibers in securing renewal of the NPDES discharge permit for its Jesup pulp mill, the world's largest producer of cellulose specialty products. The permit had been reversed by the administrative law judge, who imposed a novel and unreasonable construction of the narrative water quality standard. That erroneous decision, which threatened the permitting program for all industrial and municipal dischargers in Georgia, was reversed on appeal, ultimately leading to affirmance of the renewed permit. Altamaha Riverkeeper, Inc. v. Rayonier Performance Fibers, LLC, 816 S.E.2d 125 (Ga. Ct. App. 2018), cert. denied (Aug. 5, 2019).{{ FIELD }}Rayonier Performance Fibers in a citizen suit alleging that the pulp mill was violating its NPDES discharge permit. District court granted summary judgment in favor of Rayonier on all counts. Altamaha Riverkeeper, Inc. v. Rayonier, Inc., No. CV 214-44, 2015 U.S. Dist. LEXIS 42849 (S.D. Ga. Mar. 31, 2015).{{ FIELD }}Sea Island Company in securing, and successfully defending to an Administrative Law Judge and then to Superior Court, the state Shore Protection Act permit for a controversial beach nourishment, dune construction, and groin project along three miles of beachfront property. In subsequent related litigation brought in federal court, obtained summary judgment upholding the contested permits. Altamaha Riverkeeper v. U.S. Army Corps of Eng’rs, No. CV 418-251, 2020 WL 5837650 (S.D. Ga. Sept. 30, 2020).{{ FIELD }}A large electric utility company in toxic tort litigation involving approximately 150 residents living near Plant Scherer, one of the largest coal-fired power plants in the country. Following oral argument on an early motion to dismiss, plaintiffs voluntarily dismissed all claims.{{ FIELD }}A carbon black manufacturer in mass joinder actions filed in West Virginia by hundreds of current and former neighbors, asserting nuisance, trespass, negligence and medical monitoring claims.{{ FIELD }}Defense contractors in a putative personal injury and property damage class action seeking some $200 million for alleged exposure to lead, PCBs, and other chemicals associated with historic forge and foundry operations in Anniston, Alabama. Cases ultimately resolved in nuisance value settlements.{{ FIELD }}The City of Atlanta and other local governments in the tri-state “water wars” litigation involving Georgia, Alabama, and Florida, including the successful defense of Florida’s claims that the operation of Georgia reservoirs on the Chattahoochee River have harmed endangered species.{{ FIELD }}A chemical manufacturer against claims related to the contamination of a former fertilizer manufacturing facility. Following extensive fact and expert discovery, the district court granted summary judgment in favor of the company on all claims, a decision later affirmed by the U.S. Court of Appeals for the Fourth Circuit.{{ FIELD }}A Fortune 50 energy company in the appeal of a $27 million jury verdict in a “dram shop” case asserting agency liability based upon the use of brand standards for independent service stations. The South Carolina Supreme Court reversed the jury verdict and rendered judgment in favor of the company.{{ FIELD }}A chemical manufacturer in a mixture of class actions and individual lawsuits filed in state and federal courts concerning alleged mercury and PCB contamination from the company’s former chlor-alkali plant.{{ FIELD }}More than a dozen manufacturers, distributors, or sellers of welding products in several Georgia cases brought on behalf of approximately 500 plaintiffs who alleged personal injury due to inhalation of manganese particles produced by the welding process.{{ FIELD }}Randy Butterfield helps lead the firm’s Atlanta Environmental, Health and Safety Practice Group, where he concentrates his practice on environmental and toxic tort litigation as well as emergency incident response. Randy's practice focuses in particular on assisting clients in the wake of catastrophic emergency incidents, such as explosions, fires, industrial accidents, chemical releases, spills, and other environmental and industrial calamities. In that capacity, Randy is frequently called upon in the immediate aftermath of these emergencies to provide time-critical crisis management addressing a wide range of pressing concerns, including forensic investigation; workplace safety; site security and evidence preservation; regulatory disclosures, investigation, and potential enforcement; environmental remediation; internal investigations; and insurance coverage. Recent incidents on which Randy has helped lead the response have involved over $2 billion in property damages, business losses, and insurance claims; significant personal injury lawsuits; as well as enforcement actions from federal and state regulators.\nIn addition, Randy has handled numerous mass joinder and class action cases involving personal injury and property damage claims, both at the trial and appellate levels. Randy has played a particularly significant role in preparing and defending the defense experts—as well as deposing and critiquing plaintiffs’ experts—on a wide variety of technical topics, such as air and groundwater modeling, emission inventories, dose reconstruction, geostatistics, human health risk assessment, toxicology, epidemiology, fate and transport, remediation, property valuation, and damage assessments. Over his career, Randy’s litigation matters have involved nearly every major piece of environmental legislation as well as the entire spectrum of common law tort claims.\nRandy has published several articles involving the potential application and use of federal and state regulatory standards in the toxic tort context. He has also co-authored a chapter on legal defenses in toxic tort cases in a treatise published by the American Bar Association as well as a chapter on administrative appeals published by LexisNexis. Randy served on the Environmental and Toxic Tort Section of the Atlanta Bar Association, including as Board Chair in 2018. Randy also served on Law360’s Environmental Editorial Advisory Board from 2021-2022.\nBooks, Articles \u0026amp; Presentations\n• LexisNexis Practice Guide: Georgia Environmental Law, 2022 ed.\n• Randy J. Butterfield, moderator, Roundtable with Georgia Office of State Administrative Hearing Judges \u0026amp; Litigants, Atlanta Bar Association, Toxic Tort and Environmental Law CLE, Feb. 1, 2018\n• Randy J. Butterfield \u0026amp; Stephen A. McCullers, Raising the Class Action Certification Bar in Georgia: Georgia-Pacific Consumer Products, LP v. Ratner, Perspectives on Georgia’s Environment (State Bar of Georgia), Spring 2015, at 6-9\n• Randy J. Butterfield, Recent \u0026amp; Recurring Issues in Toxic Tort Cases, State Bar of Georgia, Toxic Tort Litigation CLE, Mar. 2014\n• J Kevin Buster \u0026amp; Randy J. Butterfield, Common Defenses in Toxic Tort Litigation (book chapter) (ABA 2d ed. 2013)\n• Randy J. Butterfield, Note, Recovering Environmental Cleanup Costs Under the Resource Conservation and Recovery Act: A Potential Solution to a Persistent Problem, 49 Vand. L. Rev. 689 (1997) Partner Law360 Selects Nine from King \u0026amp; Spalding to Serve on 2021 Editorial Advisory Boards Law 360, April 2021 Arizona State University Sandra Day O'Connor College of Law Vanderbilt University Vanderbilt University School of Law U.S. Court of Appeals for the Fourth Circuit U.S. Court of Appeals for the Fifth Circuit U.S. Court of Appeals for the Eleventh Circuit U.S. District Court for the Northern District of Georgia Georgia Texas Court of Appeals of Georgia Supreme Court of Georgia State Bar of Georgia, Environmental Law Section Atlanta Bar Association, Environmental and Toxic Tort Section (past President) American Bar Association, Section on Natural Resources, Energy and Environmental Law Defense Research Institute (DRI) Law Clerk, Chief Judge Robert L. Echols, U.S. District Court for the Middle District of Tennessee A midstream energy company in connection with investigations by Federal and State environmental agencies as well as the Occupational Safety and Health Administration (OSHA) into an explosion and fire at a natural gas processing facility resulting in catastrophic loss. Oversaw root cause investigation, coordinated responses to agency inquiries, and provided advice and counsel in connection with successful insurance recovery. One of the world’s largest producers of methanol from natural gas as standby incident response counsel, including in connection with environmental investigations into spills and releases. An LNG facility in connection with government investigations by the Pipeline and Hazardous Materials Safety Administration (PHMSA) and the U.S. Chemical Safety and Hazard Investigation Board (CSB) arising out of an explosion that resulted in operational shutdown and extensive damage to piping and other equipment and in connection with insurance coverage concerns. A Fortune 50 energy company in connection with the February 2023 Norfolk Southern freight train derailment in East Palestine, Ohio. An international chemical manufacturer in response to an explosion at its largest U.S. manufacturing facility, including helping to lead the emergency incident response and internal investigation as well as responding to regulatory inquiries by, among others OSHA; State and Federal environmental agencies; the CSB; and the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF). The country’s largest specialty paper company following the catastrophic explosion of two continuous pulp digesters. Helped lead the team handling the emergency response, including handling the root cause investigation, successfully resolving investigations by the U.S. Environmental Protection Agency, OSHA, CSB, and numerous state regulatory agencies, and securing a significant settlement of its insurance claim. A worldwide mining and petroleum company as standby incident response counsel. An engineering and construction company in connection with a trench collapse resulting in a fatality, including responding to OSHA’s resulting investigation and implementing a nationwide safety audit. A carbon capture company in connection with building collapse resulting in extensive damages to multiple rail cars. Led root cause investigation. A water and wastewater treatment provider in connection with a civil and criminal investigation into wastewater treatment plant compliance involving allegations of falsification of records. One of the largest specialty pulp and paper manufacturers in the United States in connection with investigations by EPA, OSHA, and various state and local agencies arising out of a catastrophic explosion. A chemical facility following release of trichlorosilane during line break that resulted in serious injuries to contractors. A chemical facility in connection with explosion caused by the failure of an expansion joint, resulting in numerous injuries and one fatality. A medical sterilization company in pending litigation involving air emissions of ethylene oxide (EtO) from its facility in Colorado. A world-leading manufacturer to defend the claims of 3,000 plaintiffs stemming from air emissions of lead, arsenic, and other substances from a polymetallic smelter in Peru. Successfully resolved regulatory enforcement actions against a Fortune 100 company involving EPA’s Lead Renovation, Repair and Painting (“RRP”) Rule under the Toxic Substances Control Act (“TSCA”). A large paper manufacturer following a catastrophic fire at its New Jersey production facility. Helped lead the core team that successfully resolved all State and Federal regulatory investigations and secured a significant settlement of its insurance claims. Rayonier Performance Fibers in securing renewal of the NPDES discharge permit for its Jesup pulp mill, the world's largest producer of cellulose specialty products. The permit had been reversed by the administrative law judge, who imposed a novel and unreasonable construction of the narrative water quality standard. That erroneous decision, which threatened the permitting program for all industrial and municipal dischargers in Georgia, was reversed on appeal, ultimately leading to affirmance of the renewed permit. Altamaha Riverkeeper, Inc. v. Rayonier Performance Fibers, LLC, 816 S.E.2d 125 (Ga. Ct. App. 2018), cert. denied (Aug. 5, 2019). Rayonier Performance Fibers in a citizen suit alleging that the pulp mill was violating its NPDES discharge permit. District court granted summary judgment in favor of Rayonier on all counts. Altamaha Riverkeeper, Inc. v. Rayonier, Inc., No. CV 214-44, 2015 U.S. Dist. LEXIS 42849 (S.D. Ga. Mar. 31, 2015). Sea Island Company in securing, and successfully defending to an Administrative Law Judge and then to Superior Court, the state Shore Protection Act permit for a controversial beach nourishment, dune construction, and groin project along three miles of beachfront property. In subsequent related litigation brought in federal court, obtained summary judgment upholding the contested permits. Altamaha Riverkeeper v. U.S. Army Corps of Eng’rs, No. CV 418-251, 2020 WL 5837650 (S.D. Ga. Sept. 30, 2020). A large electric utility company in toxic tort litigation involving approximately 150 residents living near Plant Scherer, one of the largest coal-fired power plants in the country. Following oral argument on an early motion to dismiss, plaintiffs voluntarily dismissed all claims. A carbon black manufacturer in mass joinder actions filed in West Virginia by hundreds of current and former neighbors, asserting nuisance, trespass, negligence and medical monitoring claims. Defense contractors in a putative personal injury and property damage class action seeking some $200 million for alleged exposure to lead, PCBs, and other chemicals associated with historic forge and foundry operations in Anniston, Alabama. Cases ultimately resolved in nuisance value settlements. The City of Atlanta and other local governments in the tri-state “water wars” litigation involving Georgia, Alabama, and Florida, including the successful defense of Florida’s claims that the operation of Georgia reservoirs on the Chattahoochee River have harmed endangered species. A chemical manufacturer against claims related to the contamination of a former fertilizer manufacturing facility. Following extensive fact and expert discovery, the district court granted summary judgment in favor of the company on all claims, a decision later affirmed by the U.S. Court of Appeals for the Fourth Circuit. A Fortune 50 energy company in the appeal of a $27 million jury verdict in a “dram shop” case asserting agency liability based upon the use of brand standards for independent service stations. The South Carolina Supreme Court reversed the jury verdict and rendered judgment in favor of the company. A chemical manufacturer in a mixture of class actions and individual lawsuits filed in state and federal courts concerning alleged mercury and PCB contamination from the company’s former chlor-alkali plant. More than a dozen manufacturers, distributors, or sellers of welding products in several Georgia cases brought on behalf of approximately 500 plaintiffs who alleged personal injury due to inhalation of manganese particles produced by the welding process.","searchable_name":"Randall J. Butterfield (Randy)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":34,"capability_group_featured":null,"home_page_featured":null},{"id":446321,"version":1,"owner_type":"Person","owner_id":5906,"payload":{"bio":"\u003cp\u003eFormer U.S. Attorney Craig Carpenito is a partner in King \u0026amp; Spalding\u0026rsquo;s Special Matters \u0026amp; Government Investigations practice. Craig\u0026rsquo;s experience heading one of the nation\u0026rsquo;s largest U.S. Attorney\u0026rsquo;s Offices, co-chairing the litigation department of an AmLaw 50 law firm and as an SEC enforcement attorney helps him solve his clients\u0026rsquo; most complex and sensitive problems.\u0026nbsp; Bringing over two decades of experience as a litigator in private and public practice, Craig has a proven track record of success in counseling financial services and healthcare clients through government investigations and high-stakes litigation.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eImmediately prior to joining King \u0026amp; Spalding, Craig served as the United States Attorney for the District of New Jersey, directing all federal criminal and civil matters in the state of New Jersey.\u0026nbsp; As U.S. Attorney, Craig made significant organizational changes, including creating the nation\u0026rsquo;s first standalone opioid enforcement unit and the District\u0026rsquo;s first cybercrimes unit.\u0026nbsp; Craig also expanded the\u0026nbsp; number of federal prosecutors in New Jersey addressing healthcare, government fraud and civil rights investigations and prosecutions.\u0026nbsp; \u0026nbsp;In August 2018, working with DOJ\u0026rsquo;s Fraud Section, he announced the formation of the first Medicare Strike Force in New Jersey.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eDuring his tenure as U.S. Attorney, Craig was personally engaged on a number of investigations and prosecutions, including oversite of DOJ\u0026rsquo;s Consent Decree with the Newark Police Department and significant healthcare, accounting and financial fraud matters, as well as matters involving key federal enforcement statutes, including the Foreign Corrupt Practices Act, False Claims Act, and Food, Drug and Cosmetic Act.\u0026nbsp; In 2019, while he was U.S. Attorney, Craig successfully tried a case to verdict, convicting the leader of a drug trafficking organization and securing a 24-year prison term at sentencing.\u0026nbsp; Craig also brings extensive crisis management experience from his tenure, including notably chairing DOJ\u0026rsquo;s national COVID-19 Hoarding and Price Gouging Task Force, as well as directly overseeing investigations of two hate-based domestic terrorism attacks in New Jersey during his tenure.\u0026nbsp; He was a member of the Attorney General\u0026rsquo;s advisory subcommittees on healthcare fraud and cyber security and cryptocurrencies.\u003c/p\u003e\n\u003cp\u003ePrior to his service as U.S. Attorney, Craig spent ten years as a partner at an AmLaw 50 law firm, where he was co-chair of the firm\u0026rsquo;s litigation and trial practice group and also led its white collar, government and internal investigations team.\u0026nbsp; Craig represented corporate and individual clients in domestic investigations by the DOJ, SEC, CFTC, HHS, OFAC, and IRS, as well as FINRA, BATS, ICE, CME and various states' attorneys general offices. He counseled companies and individuals in international investigations, including matters before the SEC\u0026rsquo;s Office of International Affairs and the UK\u0026rsquo;s Financial Conduct Authority and Serious Fraud Office.\u0026nbsp; Craig also represented clients in complex civil litigations and trials in federal and state courts.\u003c/p\u003e\n\u003cp\u003eEarlier in his career, Craig served as an Assistant U.S. Attorney in the Securities and Health Care Fraud Unit in New Jersey where he investigated and prosecuted numerous complex fraud cases, including the successful trial of Cendant Corp. CEO Walter Forbes.\u0026nbsp; Craig also served as a senior counsel in the New York Regional Office of the Securities and Exchange Commission\u0026rsquo;s Division of Enforcement.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecent Publication:\u003cbr /\u003e\u003c/strong\u003eCo-authored a chapter in PLI\u0026rsquo;s \u003cem\u003eSEC Compliance and Enforcement Answer Book on Multinational Aspects of SEC Investigations\u003c/em\u003e\u003c/p\u003e","slug":"craig-carpenito","email":"ccarpenito@kslaw.com","phone":"","matters":["\u003cp\u003eConducted high-stakes internal investigations for major financial services and healthcare companies involving the federal securities and commodities laws, broker-dealer and investment advisor regulations, and healthcare laws and regulations.\u003c/p\u003e","\u003cp\u003eRepresented a multinational financial services company in parallel investigations by federal and state regulators relating to its RMBS practices.\u003c/p\u003e","\u003cp\u003eRepresented a sitting Governor in a criminal investigation concerning allegations of official misconduct.\u003c/p\u003e","\u003cp\u003eRepresented a key figure in the \u0026ldquo;Bridgegate\u0026rdquo; matter in parallel investigations by the New Jersey Legislative Select Committee on Investigations and the Department of Justice.\u003c/p\u003e","\u003cp\u003eRepresented high-level executives of global financial institutions in multinational investigations into the possible manipulation of key financial benchmarks, including LIBOR, EURIBOR and ISDAfix.\u003c/p\u003e","\u003cp\u003eRepresented a senior health care executive in parallel investigations concerning alleged violations of federal and state False Claims Act and Anti-Kickback Statutes.\u003c/p\u003e","\u003cp\u003eRepresented a former Dewey \u0026amp; Leboeuf employee in the New York County District Attorney\u0026rsquo;s Office\u0026rsquo;s investigation of the downfall of the firm, successfully obtaining immunity for the client.\u003c/p\u003e","\u003cp\u003eRepresented multiple traders and sales personnel in investigations by the DOJ and SEC into the RMBS and CMBS trading practices.\u003c/p\u003e","\u003cp\u003eConducted an internal investigation and represented a health care provider in parallel investigations concerning federal and state False Claims Act violations.\u003c/p\u003e","\u003cp\u003eConducted an internal investigation on behalf of the Special Committee of an international corporation concerning potential financial improprieties resulting in a restatement, violations of the of the Foreign Corrupt Practices Act and potential insider trading by a key employee, and represented the Committee in resulting parallel investigations by the DOJ and SEC.\u003c/p\u003e","\u003cp\u003eRepresented a worldwide financial services provider in an internal investigation of potential violations of the Foreign Corrupt Practices Act and OFAC regulations by an employee who attempted to broker deals with the Iranian government.\u003c/p\u003e","\u003cp\u003eDefended a registered investment advisor from the most serious fraud allegations being investigated by the SEC and CFTC stemming from its valuation of Level III assets.\u003c/p\u003e","\u003cp\u003eRepresented investment companies, broker-dealers, funds and numerous individuals in several high-profile insider trading investigations and prosecutions by the SEC, FINRA, DOJ, CFTC and foreign regulators, including those stemming from the high-profile \u0026ldquo;expert networking\u0026rdquo; investigation.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":11,"guid":"11.capabilities","index":0,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":1,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":2,"source":"capabilities"},{"id":20,"guid":"20.capabilities","index":3,"source":"capabilities"},{"id":111,"guid":"111.capabilities","index":4,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":5,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":6,"source":"capabilities"},{"id":780,"guid":"780.smart_tags","index":7,"source":"smartTags"},{"id":699,"guid":"699.smart_tags","index":8,"source":"smartTags"},{"id":952,"guid":"952.smart_tags","index":9,"source":"smartTags"},{"id":120,"guid":"120.capabilities","index":10,"source":"capabilities"},{"id":750,"guid":"750.smart_tags","index":11,"source":"smartTags"},{"id":1188,"guid":"1188.smart_tags","index":12,"source":"smartTags"},{"id":1261,"guid":"1261.smart_tags","index":13,"source":"smartTags"},{"id":1270,"guid":"1270.smart_tags","index":14,"source":"smartTags"},{"id":133,"guid":"133.capabilities","index":15,"source":"capabilities"},{"id":803,"guid":"803.smart_tags","index":16,"source":"smartTags"},{"id":1248,"guid":"1248.smart_tags","index":17,"source":"smartTags"},{"id":1434,"guid":"1434.smart_tags","index":18,"source":"smartTags"}],"is_active":true,"last_name":"Carpenito","nick_name":"Craig","clerkships":[],"first_name":"Craig","title_rank":9999,"updated_by":32,"law_schools":[{"id":1790,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"2000-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":[{"title":"Ranked as a leading lawyer in two practice areas: White-Collar Crime \u0026 Government Investigations and Healthcare","detail":"Chambers USA"},{"title":"Described as \"an outstanding attorney and seasoned white-collar adviser\" that is “extremely dedicated to his clients”","detail":"Chambers USA"},{"title":"\"He brings great judgment in everything from legal strategy to public affairs to all the things that matter in a crisis\"","detail":"Chambers USA"},{"title":"Described by a healthcare client as having \"deep subject matter knowledge.\"","detail":"Chambers USA"},{"title":"Ranked as a leading financial services lawyer \"with extensive governmental and regulatory expertise.\"","detail":"Legal 500"},{"title":"Named a Rising Star in white-collar defense and government/internal investigations","detail":"Law360, 2012"},{"title":"Selected to New York Metro Super Lawyers from 2011 until his DOJ appointment in 2018","detail":"Super Lawyers"}],"linked_in_url":"https://www.linkedin.com/in/craig-carpenito-a3269612/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eFormer U.S. Attorney Craig Carpenito is a partner in King \u0026amp; Spalding\u0026rsquo;s Special Matters \u0026amp; Government Investigations practice. Craig\u0026rsquo;s experience heading one of the nation\u0026rsquo;s largest U.S. Attorney\u0026rsquo;s Offices, co-chairing the litigation department of an AmLaw 50 law firm and as an SEC enforcement attorney helps him solve his clients\u0026rsquo; most complex and sensitive problems.\u0026nbsp; Bringing over two decades of experience as a litigator in private and public practice, Craig has a proven track record of success in counseling financial services and healthcare clients through government investigations and high-stakes litigation.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eImmediately prior to joining King \u0026amp; Spalding, Craig served as the United States Attorney for the District of New Jersey, directing all federal criminal and civil matters in the state of New Jersey.\u0026nbsp; As U.S. Attorney, Craig made significant organizational changes, including creating the nation\u0026rsquo;s first standalone opioid enforcement unit and the District\u0026rsquo;s first cybercrimes unit.\u0026nbsp; Craig also expanded the\u0026nbsp; number of federal prosecutors in New Jersey addressing healthcare, government fraud and civil rights investigations and prosecutions.\u0026nbsp; \u0026nbsp;In August 2018, working with DOJ\u0026rsquo;s Fraud Section, he announced the formation of the first Medicare Strike Force in New Jersey.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eDuring his tenure as U.S. Attorney, Craig was personally engaged on a number of investigations and prosecutions, including oversite of DOJ\u0026rsquo;s Consent Decree with the Newark Police Department and significant healthcare, accounting and financial fraud matters, as well as matters involving key federal enforcement statutes, including the Foreign Corrupt Practices Act, False Claims Act, and Food, Drug and Cosmetic Act.\u0026nbsp; In 2019, while he was U.S. Attorney, Craig successfully tried a case to verdict, convicting the leader of a drug trafficking organization and securing a 24-year prison term at sentencing.\u0026nbsp; Craig also brings extensive crisis management experience from his tenure, including notably chairing DOJ\u0026rsquo;s national COVID-19 Hoarding and Price Gouging Task Force, as well as directly overseeing investigations of two hate-based domestic terrorism attacks in New Jersey during his tenure.\u0026nbsp; He was a member of the Attorney General\u0026rsquo;s advisory subcommittees on healthcare fraud and cyber security and cryptocurrencies.\u003c/p\u003e\n\u003cp\u003ePrior to his service as U.S. Attorney, Craig spent ten years as a partner at an AmLaw 50 law firm, where he was co-chair of the firm\u0026rsquo;s litigation and trial practice group and also led its white collar, government and internal investigations team.\u0026nbsp; Craig represented corporate and individual clients in domestic investigations by the DOJ, SEC, CFTC, HHS, OFAC, and IRS, as well as FINRA, BATS, ICE, CME and various states' attorneys general offices. He counseled companies and individuals in international investigations, including matters before the SEC\u0026rsquo;s Office of International Affairs and the UK\u0026rsquo;s Financial Conduct Authority and Serious Fraud Office.\u0026nbsp; Craig also represented clients in complex civil litigations and trials in federal and state courts.\u003c/p\u003e\n\u003cp\u003eEarlier in his career, Craig served as an Assistant U.S. Attorney in the Securities and Health Care Fraud Unit in New Jersey where he investigated and prosecuted numerous complex fraud cases, including the successful trial of Cendant Corp. CEO Walter Forbes.\u0026nbsp; Craig also served as a senior counsel in the New York Regional Office of the Securities and Exchange Commission\u0026rsquo;s Division of Enforcement.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecent Publication:\u003cbr /\u003e\u003c/strong\u003eCo-authored a chapter in PLI\u0026rsquo;s \u003cem\u003eSEC Compliance and Enforcement Answer Book on Multinational Aspects of SEC Investigations\u003c/em\u003e\u003c/p\u003e","matters":["\u003cp\u003eConducted high-stakes internal investigations for major financial services and healthcare companies involving the federal securities and commodities laws, broker-dealer and investment advisor regulations, and healthcare laws and regulations.\u003c/p\u003e","\u003cp\u003eRepresented a multinational financial services company in parallel investigations by federal and state regulators relating to its RMBS practices.\u003c/p\u003e","\u003cp\u003eRepresented a sitting Governor in a criminal investigation concerning allegations of official misconduct.\u003c/p\u003e","\u003cp\u003eRepresented a key figure in the \u0026ldquo;Bridgegate\u0026rdquo; matter in parallel investigations by the New Jersey Legislative Select Committee on Investigations and the Department of Justice.\u003c/p\u003e","\u003cp\u003eRepresented high-level executives of global financial institutions in multinational investigations into the possible manipulation of key financial benchmarks, including LIBOR, EURIBOR and ISDAfix.\u003c/p\u003e","\u003cp\u003eRepresented a senior health care executive in parallel investigations concerning alleged violations of federal and state False Claims Act and Anti-Kickback Statutes.\u003c/p\u003e","\u003cp\u003eRepresented a former Dewey \u0026amp; Leboeuf employee in the New York County District Attorney\u0026rsquo;s Office\u0026rsquo;s investigation of the downfall of the firm, successfully obtaining immunity for the client.\u003c/p\u003e","\u003cp\u003eRepresented multiple traders and sales personnel in investigations by the DOJ and SEC into the RMBS and CMBS trading practices.\u003c/p\u003e","\u003cp\u003eConducted an internal investigation and represented a health care provider in parallel investigations concerning federal and state False Claims Act violations.\u003c/p\u003e","\u003cp\u003eConducted an internal investigation on behalf of the Special Committee of an international corporation concerning potential financial improprieties resulting in a restatement, violations of the of the Foreign Corrupt Practices Act and potential insider trading by a key employee, and represented the Committee in resulting parallel investigations by the DOJ and SEC.\u003c/p\u003e","\u003cp\u003eRepresented a worldwide financial services provider in an internal investigation of potential violations of the Foreign Corrupt Practices Act and OFAC regulations by an employee who attempted to broker deals with the Iranian government.\u003c/p\u003e","\u003cp\u003eDefended a registered investment advisor from the most serious fraud allegations being investigated by the SEC and CFTC stemming from its valuation of Level III assets.\u003c/p\u003e","\u003cp\u003eRepresented investment companies, broker-dealers, funds and numerous individuals in several high-profile insider trading investigations and prosecutions by the SEC, FINRA, DOJ, CFTC and foreign regulators, including those stemming from the high-profile \u0026ldquo;expert networking\u0026rdquo; investigation.\u003c/p\u003e"],"recognitions":[{"title":"Ranked as a leading lawyer in two practice areas: White-Collar Crime \u0026 Government Investigations and Healthcare","detail":"Chambers USA"},{"title":"Described as \"an outstanding attorney and seasoned white-collar adviser\" that is “extremely dedicated to his clients”","detail":"Chambers USA"},{"title":"\"He brings great judgment in everything from legal strategy to public affairs to all the things that matter in a crisis\"","detail":"Chambers USA"},{"title":"Described by a healthcare client as having \"deep subject matter knowledge.\"","detail":"Chambers USA"},{"title":"Ranked as a leading financial services lawyer \"with extensive governmental and regulatory expertise.\"","detail":"Legal 500"},{"title":"Named a Rising Star in white-collar defense and government/internal investigations","detail":"Law360, 2012"},{"title":"Selected to New York Metro Super Lawyers from 2011 until his DOJ appointment in 2018","detail":"Super Lawyers"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":8527}]},"capability_group_id":2},"created_at":"2026-03-02T21:59:43.000Z","updated_at":"2026-03-02T21:59:43.000Z","searchable_text":"Carpenito{{ FIELD }}{:title=\u0026gt;\"Ranked as a leading lawyer in two practice areas: White-Collar Crime \u0026amp; Government Investigations and Healthcare\", :detail=\u0026gt;\"Chambers USA\"}{{ FIELD }}{:title=\u0026gt;\"Described as \\\"an outstanding attorney and seasoned white-collar adviser\\\" that is “extremely dedicated to his clients”\", :detail=\u0026gt;\"Chambers USA\"}{{ FIELD }}{:title=\u0026gt;\"\\\"He brings great judgment in everything from legal strategy to public affairs to all the things that matter in a crisis\\\"\", :detail=\u0026gt;\"Chambers USA\"}{{ FIELD }}{:title=\u0026gt;\"Described by a healthcare client as having \\\"deep subject matter knowledge.\\\"\", :detail=\u0026gt;\"Chambers USA\"}{{ FIELD }}{:title=\u0026gt;\"Ranked as a leading financial services lawyer \\\"with extensive governmental and regulatory expertise.\\\"\", :detail=\u0026gt;\"Legal 500\"}{{ FIELD }}{:title=\u0026gt;\"Named a Rising Star in white-collar defense and government/internal investigations\", :detail=\u0026gt;\"Law360, 2012\"}{{ FIELD }}{:title=\u0026gt;\"Selected to New York Metro Super Lawyers from 2011 until his DOJ appointment in 2018\", :detail=\u0026gt;\"Super Lawyers\"}{{ FIELD }}Conducted high-stakes internal investigations for major financial services and healthcare companies involving the federal securities and commodities laws, broker-dealer and investment advisor regulations, and healthcare laws and regulations.{{ FIELD }}Represented a multinational financial services company in parallel investigations by federal and state regulators relating to its RMBS practices.{{ FIELD }}Represented a sitting Governor in a criminal investigation concerning allegations of official misconduct.{{ FIELD }}Represented a key figure in the “Bridgegate” matter in parallel investigations by the New Jersey Legislative Select Committee on Investigations and the Department of Justice.{{ FIELD }}Represented high-level executives of global financial institutions in multinational investigations into the possible manipulation of key financial benchmarks, including LIBOR, EURIBOR and ISDAfix.{{ FIELD }}Represented a senior health care executive in parallel investigations concerning alleged violations of federal and state False Claims Act and Anti-Kickback Statutes.{{ FIELD }}Represented a former Dewey \u0026amp; Leboeuf employee in the New York County District Attorney’s Office’s investigation of the downfall of the firm, successfully obtaining immunity for the client.{{ FIELD }}Represented multiple traders and sales personnel in investigations by the DOJ and SEC into the RMBS and CMBS trading practices.{{ FIELD }}Conducted an internal investigation and represented a health care provider in parallel investigations concerning federal and state False Claims Act violations.{{ FIELD }}Conducted an internal investigation on behalf of the Special Committee of an international corporation concerning potential financial improprieties resulting in a restatement, violations of the of the Foreign Corrupt Practices Act and potential insider trading by a key employee, and represented the Committee in resulting parallel investigations by the DOJ and SEC.{{ FIELD }}Represented a worldwide financial services provider in an internal investigation of potential violations of the Foreign Corrupt Practices Act and OFAC regulations by an employee who attempted to broker deals with the Iranian government.{{ FIELD }}Defended a registered investment advisor from the most serious fraud allegations being investigated by the SEC and CFTC stemming from its valuation of Level III assets.{{ FIELD }}Represented investment companies, broker-dealers, funds and numerous individuals in several high-profile insider trading investigations and prosecutions by the SEC, FINRA, DOJ, CFTC and foreign regulators, including those stemming from the high-profile “expert networking” investigation.{{ FIELD }}Former U.S. Attorney Craig Carpenito is a partner in King \u0026amp; Spalding’s Special Matters \u0026amp; Government Investigations practice. Craig’s experience heading one of the nation’s largest U.S. Attorney’s Offices, co-chairing the litigation department of an AmLaw 50 law firm and as an SEC enforcement attorney helps him solve his clients’ most complex and sensitive problems.  Bringing over two decades of experience as a litigator in private and public practice, Craig has a proven track record of success in counseling financial services and healthcare clients through government investigations and high-stakes litigation.\nImmediately prior to joining King \u0026amp; Spalding, Craig served as the United States Attorney for the District of New Jersey, directing all federal criminal and civil matters in the state of New Jersey.  As U.S. Attorney, Craig made significant organizational changes, including creating the nation’s first standalone opioid enforcement unit and the District’s first cybercrimes unit.  Craig also expanded the  number of federal prosecutors in New Jersey addressing healthcare, government fraud and civil rights investigations and prosecutions.   In August 2018, working with DOJ’s Fraud Section, he announced the formation of the first Medicare Strike Force in New Jersey. \nDuring his tenure as U.S. Attorney, Craig was personally engaged on a number of investigations and prosecutions, including oversite of DOJ’s Consent Decree with the Newark Police Department and significant healthcare, accounting and financial fraud matters, as well as matters involving key federal enforcement statutes, including the Foreign Corrupt Practices Act, False Claims Act, and Food, Drug and Cosmetic Act.  In 2019, while he was U.S. Attorney, Craig successfully tried a case to verdict, convicting the leader of a drug trafficking organization and securing a 24-year prison term at sentencing.  Craig also brings extensive crisis management experience from his tenure, including notably chairing DOJ’s national COVID-19 Hoarding and Price Gouging Task Force, as well as directly overseeing investigations of two hate-based domestic terrorism attacks in New Jersey during his tenure.  He was a member of the Attorney General’s advisory subcommittees on healthcare fraud and cyber security and cryptocurrencies.\nPrior to his service as U.S. Attorney, Craig spent ten years as a partner at an AmLaw 50 law firm, where he was co-chair of the firm’s litigation and trial practice group and also led its white collar, government and internal investigations team.  Craig represented corporate and individual clients in domestic investigations by the DOJ, SEC, CFTC, HHS, OFAC, and IRS, as well as FINRA, BATS, ICE, CME and various states' attorneys general offices. He counseled companies and individuals in international investigations, including matters before the SEC’s Office of International Affairs and the UK’s Financial Conduct Authority and Serious Fraud Office.  Craig also represented clients in complex civil litigations and trials in federal and state courts.\nEarlier in his career, Craig served as an Assistant U.S. Attorney in the Securities and Health Care Fraud Unit in New Jersey where he investigated and prosecuted numerous complex fraud cases, including the successful trial of Cendant Corp. CEO Walter Forbes.  Craig also served as a senior counsel in the New York Regional Office of the Securities and Exchange Commission’s Division of Enforcement.\nRecent Publication:Co-authored a chapter in PLI’s SEC Compliance and Enforcement Answer Book on Multinational Aspects of SEC Investigations Partner Ranked as a leading lawyer in two practice areas: White-Collar Crime \u0026amp; Government Investigations and Healthcare Chambers USA Described as \"an outstanding attorney and seasoned white-collar adviser\" that is “extremely dedicated to his clients” Chambers USA \"He brings great judgment in everything from legal strategy to public affairs to all the things that matter in a crisis\" Chambers USA Described by a healthcare client as having \"deep subject matter knowledge.\" Chambers USA Ranked as a leading financial services lawyer \"with extensive governmental and regulatory expertise.\" Legal 500 Named a Rising Star in white-collar defense and government/internal investigations Law360, 2012 Selected to New York Metro Super Lawyers from 2011 until his DOJ appointment in 2018 Super Lawyers Rider University  Seton Hall University Seton Hall University School of Law U.S. Court of Appeals for the Second Circuit U.S. Court of Appeals for the Third Circuit U.S. District Court for the Eastern District of New York U.S. District Court for the Northern District of New York U.S. District Court for the Southern District of New York U.S. District Court for the Western District of New York U.S. District Court for the District of New Jersey New Jersey New York American Bar Association National Association of Former United States Attorneys (NAFUSA) The New York Council of Defense Lawyers (NYCDL) The Association of Criminal Defense Lawyers of New Jersey New Jersey Reentry Corporation Training Center Board of Trustees New York State Bar Association New Jersey State Bar Association Association of the Federal Bar of New Jersey (Advisory Committee Member) SIFMA, Legal and Compliance Division Association of Securities and Exchange Commission Alumni The United States Attorney’s Office for the District of New Jersey Alumni Association United States District Court for the District of New Jersey Lawyer’s Advisory Committee Seton Hall University School of Law Board of Visitors Conducted high-stakes internal investigations for major financial services and healthcare companies involving the federal securities and commodities laws, broker-dealer and investment advisor regulations, and healthcare laws and regulations. Represented a multinational financial services company in parallel investigations by federal and state regulators relating to its RMBS practices. Represented a sitting Governor in a criminal investigation concerning allegations of official misconduct. Represented a key figure in the “Bridgegate” matter in parallel investigations by the New Jersey Legislative Select Committee on Investigations and the Department of Justice. Represented high-level executives of global financial institutions in multinational investigations into the possible manipulation of key financial benchmarks, including LIBOR, EURIBOR and ISDAfix. Represented a senior health care executive in parallel investigations concerning alleged violations of federal and state False Claims Act and Anti-Kickback Statutes. Represented a former Dewey \u0026amp; Leboeuf employee in the New York County District Attorney’s Office’s investigation of the downfall of the firm, successfully obtaining immunity for the client. Represented multiple traders and sales personnel in investigations by the DOJ and SEC into the RMBS and CMBS trading practices. Conducted an internal investigation and represented a health care provider in parallel investigations concerning federal and state False Claims Act violations. Conducted an internal investigation on behalf of the Special Committee of an international corporation concerning potential financial improprieties resulting in a restatement, violations of the of the Foreign Corrupt Practices Act and potential insider trading by a key employee, and represented the Committee in resulting parallel investigations by the DOJ and SEC. Represented a worldwide financial services provider in an internal investigation of potential violations of the Foreign Corrupt Practices Act and OFAC regulations by an employee who attempted to broker deals with the Iranian government. Defended a registered investment advisor from the most serious fraud allegations being investigated by the SEC and CFTC stemming from its valuation of Level III assets. Represented investment companies, broker-dealers, funds and numerous individuals in several high-profile insider trading investigations and prosecutions by the SEC, FINRA, DOJ, CFTC and foreign regulators, including those stemming from the high-profile “expert networking” investigation.","searchable_name":"Craig Carpenito","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":32,"capability_group_featured":null,"home_page_featured":null},{"id":442988,"version":1,"owner_type":"Person","owner_id":2849,"payload":{"bio":"\u003cp\u003eJohn Carroll is a partner in King \u0026amp; Spalding\u0026rsquo;s Antitrust \u0026amp; Competition Practice Group in the Washington, D.C. office. For over two decades, John\u0026rsquo;s practice has focused on civil and criminal antitrust matters, including mergers \u0026amp; acquisitions, strategic counseling and compliance, and global cartel investigations. He represents clients before the Federal Trade Commission, Department of Justice, Antitrust Division, and international and state antitrust enforcement authorities. [[--readmore--]]\u003c/p\u003e\n\u003cp\u003ePrior to private practice, John was in the Mergers I Division of the Federal Trade Commission\u0026rsquo;s Bureau of Competition for several years. While with the FTC, he investigated, challenged, and negotiated settlements in a number of potentially anti-competitive business combinations in the aerospace, technology, consumer products, defense, healthcare, and pharmaceutical industries. He received an Award for Meritorious Service for work on merger litigation.\u003c/p\u003e\n\u003cp\u003eJohn has been recognized by leading publications such as \u003cem\u003eLegal 500\u003c/em\u003e and \u003cem\u003eBest Lawyers\u003c/em\u003e and has held leadership positions in the American Bar Association and American Health Lawyer Association. He frequently speaks and writes on antitrust issues across industries.\u003c/p\u003e","slug":"john-carroll","email":"jdcarroll@kslaw.com","phone":null,"matters":["\u003cp\u003e\u003cstrong\u003eHealthcare \u0026amp; Life Sciences\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eServed as lead antitrust counsel for health systems on dozens of transactions that cleared federal and state antitrust reviews.\u003c/p\u003e","\u003cp\u003eLed antitrust efforts for VillageMD in achieving antitrust clearance for its\u0026nbsp;$8.9 billion acquisition of Summit Health.\u003c/p\u003e","\u003cp\u003eSuccessfully represented clinically and financially integrated provider networks in nonpublic government investigations.\u003c/p\u003e","\u003cp\u003eAdvising private equity firms, health systems, and physician groups on a variety of antitrust issues, including potential transactions.\u003c/p\u003e","\u003cp\u003eAdvising pharmaceutical and medical device companies on all aspects of competitor collaborations, including mergers, acquisitions, and joint ventures.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eConsumer Products \u0026amp; Entertainment\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresents clients in the food \u0026amp; beverage, luxury, technology, retail, and fashion industries on antitrust issues.\u003c/p\u003e","\u003cp\u003eAdvises entertainment and media companies on antitrust aspects of transactions and commercial activities, such as pricing and distribution.\u003c/p\u003e","\u003cp\u003eRepresented Energizer Holdings, Inc. on antitrust aspects of it $2 billion acquisition of Spectrum Brands.\u003c/p\u003e","\u003cp\u003eRepresented Carmike Cinemas in the Department of Justice investigation of their sale to AMC theatres, creating the nation\u0026rsquo;s largest movie theatre chain.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eEnergy\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresenting a Fortune 500 public company in the energy industry on antitrust aspects of a joint venture with a competitor.\u003c/p\u003e","\u003cp\u003eAdvising a number of energy companies on a range of antitrust issues related to infrastructure projects, teaming arrangements, and other collaborations.\u003c/p\u003e","\u003cp\u003eSuccessfully represented leading gasoline retailer on achieving FTC clearance for its strategic transaction without enforcement action.\u003c/p\u003e","\u003cp\u003eDevised and implemented antitrust compliance strategies for coalitions of energy industry competitors.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eManufacturing\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresented leading chemical and building products companies in transactions and defended them in government investigations.\u003c/p\u003e","\u003cp\u003eRepresented WestRock Company on antitrust aspects of its $4.9 billion acquisition of KapStone Paper Packaging.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eGlobal Cartel Investigations\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eDefended multinational companies in criminal investigations alleging antitrust conspiracies.\u003c/p\u003e","\u003cp\u003eRepresented an executive of international auto parts company in connection with a cartel investigation in that industry.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":81,"guid":"81.capabilities","index":0,"source":"capabilities"},{"id":5,"guid":"5.capabilities","index":1,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":2,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":3,"source":"capabilities"},{"id":1,"guid":"1.capabilities","index":4,"source":"capabilities"},{"id":11,"guid":"11.capabilities","index":5,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":6,"source":"capabilities"},{"id":102,"guid":"102.capabilities","index":7,"source":"capabilities"},{"id":105,"guid":"105.capabilities","index":8,"source":"capabilities"},{"id":1147,"guid":"1147.smart_tags","index":9,"source":"smartTags"},{"id":687,"guid":"687.smart_tags","index":10,"source":"smartTags"},{"id":826,"guid":"826.smart_tags","index":11,"source":"smartTags"}],"is_active":true,"last_name":"Carroll","nick_name":"John","clerkships":[],"first_name":"John","title_rank":9999,"updated_by":34,"law_schools":[],"middle_name":"","name_suffix":"","recognitions":[{"title":"Top Author","detail":"JD Supra Readers’ Choice Awards, 2025"},{"title":"Best Lawyers: Ones to Watch","detail":"Best Lawyers, 2023-2024"},{"title":"Recommended Lawyers – Antitrust","detail":"Legal 500, 2022-2025"},{"title":"Leading Lawyer – Antitrust","detail":"Legal 500, 2020"},{"title":"Rising Star – Antitrust","detail":"Washington Super Lawyers, 2016"}],"linked_in_url":"https://www.linkedin.com/in/john-carroll-1384a022/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eJohn Carroll is a partner in King \u0026amp; Spalding\u0026rsquo;s Antitrust \u0026amp; Competition Practice Group in the Washington, D.C. office. For over two decades, John\u0026rsquo;s practice has focused on civil and criminal antitrust matters, including mergers \u0026amp; acquisitions, strategic counseling and compliance, and global cartel investigations. He represents clients before the Federal Trade Commission, Department of Justice, Antitrust Division, and international and state antitrust enforcement authorities. [[--readmore--]]\u003c/p\u003e\n\u003cp\u003ePrior to private practice, John was in the Mergers I Division of the Federal Trade Commission\u0026rsquo;s Bureau of Competition for several years. While with the FTC, he investigated, challenged, and negotiated settlements in a number of potentially anti-competitive business combinations in the aerospace, technology, consumer products, defense, healthcare, and pharmaceutical industries. He received an Award for Meritorious Service for work on merger litigation.\u003c/p\u003e\n\u003cp\u003eJohn has been recognized by leading publications such as \u003cem\u003eLegal 500\u003c/em\u003e and \u003cem\u003eBest Lawyers\u003c/em\u003e and has held leadership positions in the American Bar Association and American Health Lawyer Association. He frequently speaks and writes on antitrust issues across industries.\u003c/p\u003e","matters":["\u003cp\u003e\u003cstrong\u003eHealthcare \u0026amp; Life Sciences\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eServed as lead antitrust counsel for health systems on dozens of transactions that cleared federal and state antitrust reviews.\u003c/p\u003e","\u003cp\u003eLed antitrust efforts for VillageMD in achieving antitrust clearance for its\u0026nbsp;$8.9 billion acquisition of Summit Health.\u003c/p\u003e","\u003cp\u003eSuccessfully represented clinically and financially integrated provider networks in nonpublic government investigations.\u003c/p\u003e","\u003cp\u003eAdvising private equity firms, health systems, and physician groups on a variety of antitrust issues, including potential transactions.\u003c/p\u003e","\u003cp\u003eAdvising pharmaceutical and medical device companies on all aspects of competitor collaborations, including mergers, acquisitions, and joint ventures.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eConsumer Products \u0026amp; Entertainment\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresents clients in the food \u0026amp; beverage, luxury, technology, retail, and fashion industries on antitrust issues.\u003c/p\u003e","\u003cp\u003eAdvises entertainment and media companies on antitrust aspects of transactions and commercial activities, such as pricing and distribution.\u003c/p\u003e","\u003cp\u003eRepresented Energizer Holdings, Inc. on antitrust aspects of it $2 billion acquisition of Spectrum Brands.\u003c/p\u003e","\u003cp\u003eRepresented Carmike Cinemas in the Department of Justice investigation of their sale to AMC theatres, creating the nation\u0026rsquo;s largest movie theatre chain.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eEnergy\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresenting a Fortune 500 public company in the energy industry on antitrust aspects of a joint venture with a competitor.\u003c/p\u003e","\u003cp\u003eAdvising a number of energy companies on a range of antitrust issues related to infrastructure projects, teaming arrangements, and other collaborations.\u003c/p\u003e","\u003cp\u003eSuccessfully represented leading gasoline retailer on achieving FTC clearance for its strategic transaction without enforcement action.\u003c/p\u003e","\u003cp\u003eDevised and implemented antitrust compliance strategies for coalitions of energy industry competitors.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eManufacturing\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRepresented leading chemical and building products companies in transactions and defended them in government investigations.\u003c/p\u003e","\u003cp\u003eRepresented WestRock Company on antitrust aspects of its $4.9 billion acquisition of KapStone Paper Packaging.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eGlobal Cartel Investigations\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eDefended multinational companies in criminal investigations alleging antitrust conspiracies.\u003c/p\u003e","\u003cp\u003eRepresented an executive of international auto parts company in connection with a cartel investigation in that industry.\u003c/p\u003e"],"recognitions":[{"title":"Top Author","detail":"JD Supra Readers’ Choice Awards, 2025"},{"title":"Best Lawyers: Ones to Watch","detail":"Best Lawyers, 2023-2024"},{"title":"Recommended Lawyers – Antitrust","detail":"Legal 500, 2022-2025"},{"title":"Leading Lawyer – Antitrust","detail":"Legal 500, 2020"},{"title":"Rising Star – Antitrust","detail":"Washington Super Lawyers, 2016"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":13154}]},"capability_group_id":2},"created_at":"2025-11-17T21:52:05.000Z","updated_at":"2025-11-17T21:52:05.000Z","searchable_text":"Carroll{{ FIELD }}{:title=\u0026gt;\"Top Author\", :detail=\u0026gt;\"JD Supra Readers’ Choice Awards, 2025\"}{{ FIELD }}{:title=\u0026gt;\"Best Lawyers: Ones to Watch\", :detail=\u0026gt;\"Best Lawyers, 2023-2024\"}{{ FIELD }}{:title=\u0026gt;\"Recommended Lawyers – Antitrust\", :detail=\u0026gt;\"Legal 500, 2022-2025\"}{{ FIELD }}{:title=\u0026gt;\"Leading Lawyer – Antitrust\", :detail=\u0026gt;\"Legal 500, 2020\"}{{ FIELD }}{:title=\u0026gt;\"Rising Star – Antitrust\", :detail=\u0026gt;\"Washington Super Lawyers, 2016\"}{{ FIELD }}Healthcare \u0026amp; Life Sciences\nServed as lead antitrust counsel for health systems on dozens of transactions that cleared federal and state antitrust reviews.{{ FIELD }}Led antitrust efforts for VillageMD in achieving antitrust clearance for its $8.9 billion acquisition of Summit Health.{{ FIELD }}Successfully represented clinically and financially integrated provider networks in nonpublic government investigations.{{ FIELD }}Advising private equity firms, health systems, and physician groups on a variety of antitrust issues, including potential transactions.{{ FIELD }}Advising pharmaceutical and medical device companies on all aspects of competitor collaborations, including mergers, acquisitions, and joint ventures.{{ FIELD }}Consumer Products \u0026amp; Entertainment\nRepresents clients in the food \u0026amp; beverage, luxury, technology, retail, and fashion industries on antitrust issues.{{ FIELD }}Advises entertainment and media companies on antitrust aspects of transactions and commercial activities, such as pricing and distribution.{{ FIELD }}Represented Energizer Holdings, Inc. on antitrust aspects of it $2 billion acquisition of Spectrum Brands.{{ FIELD }}Represented Carmike Cinemas in the Department of Justice investigation of their sale to AMC theatres, creating the nation’s largest movie theatre chain.{{ FIELD }}Energy\nRepresenting a Fortune 500 public company in the energy industry on antitrust aspects of a joint venture with a competitor.{{ FIELD }}Advising a number of energy companies on a range of antitrust issues related to infrastructure projects, teaming arrangements, and other collaborations.{{ FIELD }}Successfully represented leading gasoline retailer on achieving FTC clearance for its strategic transaction without enforcement action.{{ FIELD }}Devised and implemented antitrust compliance strategies for coalitions of energy industry competitors.{{ FIELD }}Manufacturing\nRepresented leading chemical and building products companies in transactions and defended them in government investigations.{{ FIELD }}Represented WestRock Company on antitrust aspects of its $4.9 billion acquisition of KapStone Paper Packaging.{{ FIELD }}Global Cartel Investigations\nDefended multinational companies in criminal investigations alleging antitrust conspiracies.{{ FIELD }}Represented an executive of international auto parts company in connection with a cartel investigation in that industry.{{ FIELD }}John Carroll is a partner in King \u0026amp; Spalding’s Antitrust \u0026amp; Competition Practice Group in the Washington, D.C. office. For over two decades, John’s practice has focused on civil and criminal antitrust matters, including mergers \u0026amp; acquisitions, strategic counseling and compliance, and global cartel investigations. He represents clients before the Federal Trade Commission, Department of Justice, Antitrust Division, and international and state antitrust enforcement authorities. \nPrior to private practice, John was in the Mergers I Division of the Federal Trade Commission’s Bureau of Competition for several years. While with the FTC, he investigated, challenged, and negotiated settlements in a number of potentially anti-competitive business combinations in the aerospace, technology, consumer products, defense, healthcare, and pharmaceutical industries. He received an Award for Meritorious Service for work on merger litigation.\nJohn has been recognized by leading publications such as Legal 500 and Best Lawyers and has held leadership positions in the American Bar Association and American Health Lawyer Association. He frequently speaks and writes on antitrust issues across industries. Partner Top Author JD Supra Readers’ Choice Awards, 2025 Best Lawyers: Ones to Watch Best Lawyers, 2023-2024 Recommended Lawyers – Antitrust Legal 500, 2022-2025 Leading Lawyer – Antitrust Legal 500, 2020 Rising Star – Antitrust Washington Super Lawyers, 2016 University of Michigan University of Michigan Law School George Washington University George Washington University Law School Supreme Court of the United States District of Columbia Maryland ABA Antitrust Section, Vice-Chair of the Media \u0026amp; Technologies Committee (2021-2022, 2022-2023) Healthcare \u0026amp; Life Sciences\nServed as lead antitrust counsel for health systems on dozens of transactions that cleared federal and state antitrust reviews. Led antitrust efforts for VillageMD in achieving antitrust clearance for its $8.9 billion acquisition of Summit Health. Successfully represented clinically and financially integrated provider networks in nonpublic government investigations. Advising private equity firms, health systems, and physician groups on a variety of antitrust issues, including potential transactions. Advising pharmaceutical and medical device companies on all aspects of competitor collaborations, including mergers, acquisitions, and joint ventures. Consumer Products \u0026amp; Entertainment\nRepresents clients in the food \u0026amp; beverage, luxury, technology, retail, and fashion industries on antitrust issues. Advises entertainment and media companies on antitrust aspects of transactions and commercial activities, such as pricing and distribution. Represented Energizer Holdings, Inc. on antitrust aspects of it $2 billion acquisition of Spectrum Brands. Represented Carmike Cinemas in the Department of Justice investigation of their sale to AMC theatres, creating the nation’s largest movie theatre chain. Energy\nRepresenting a Fortune 500 public company in the energy industry on antitrust aspects of a joint venture with a competitor. Advising a number of energy companies on a range of antitrust issues related to infrastructure projects, teaming arrangements, and other collaborations. Successfully represented leading gasoline retailer on achieving FTC clearance for its strategic transaction without enforcement action. Devised and implemented antitrust compliance strategies for coalitions of energy industry competitors. Manufacturing\nRepresented leading chemical and building products companies in transactions and defended them in government investigations. Represented WestRock Company on antitrust aspects of its $4.9 billion acquisition of KapStone Paper Packaging. Global Cartel Investigations\nDefended multinational companies in criminal investigations alleging antitrust conspiracies. Represented an executive of international auto parts company in connection with a cartel investigation in that industry.","searchable_name":"John Carroll","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":34,"capability_group_featured":null,"home_page_featured":null}]}}